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ABSTRACT 
Crosstalk between epithelial cells and macrophages in the gut: the role of 
TNFR2 – Maja Kristek 
 
In order to cope with the overwhelming amount of commensal bacteria, dietary and 
environmental antigens, homeostasis in the intestine relies upon the fine tuned 
crosstalk between the immune cells and their environment. One of the key regulators 
of homeostasis in the intestine are macrophages. Unlike other macrophage 
populations in the body, intestinal macrophages are in a state of partial activation 
showing no response to inflammatory stimuli, no production of pro-inflammatory 
cytokines and low expression levels of innate response receptors. Although their 
phenotype is largely characterised, it still remains unclear how they acquire this 
phenotype and thus exert these anti-inflammatory properties.  
We optimised a method using cell sorting to isolate intestinal macrophages and 
characterised their phenotype in homeostasis and inflammation. Furthermore, in 
order to explore how intestinal macrophages acquire this phenotype we investigated 
the influence of intestinal epithelial cells on macrophages in vitro by conditioning 
J774A.1 macrophages with supernatants from the murine colonic epithelial cell line, 
CMT-93. Conditioned macrophages acquired a regulatory phenotype that resembles 
the intestinal macrophages, with decreased production of IL-12p40, IL-6 and other 
pro-inflammatory mediators. Furthermore, conditioned macrophages became less 
responsive to Toll-like receptor stimulation, while they kept their phagocytic abilities 
and maintained TNF-α production. Interestingly, higher expression of TNF receptor 
2 (TNFR2) was observed in conditioned macrophages. This receptor has been linked 
with anti-inflammatory and immunosuppressive effects of TNF-α. Our in vivo study 
on DSS-induced colitis in mice also demonstrated regulation of TNFR2 in the later 
stage of colitis, correlating with disease resolution. Furthermore, we provide 
evidence that TNFR2 is also involved in the resolution of disease in the Clostridium 
difficile model of infection.     
Our findings show that intestinal epithelial cells can produce factors that change and 
shape macrophage response and implicate TNFR2 as one of the mechanisms by 
which intestinal macrophages exert their homeostatic properties.  
 
  
x 
 
ABBREVIATIONS 
 
APC   allophycocyanin 
BMMØ  bone marrow-derived macrophage 
BSA   bovine serum albumin 
CD   cluster of differentiation 
DC   dendritic cell 
DMEM  Dulbecco’s modified eagle medium 
DNA   deoxyribonucleic acid 
dNTP   deoxyribonucleotide triphosphates 
DSS   dextran sulphate sodium 
EDTA   ethylenediaminetetraacetic acid 
ELISA   enzyme-linked immunosorbent assay 
FACS   fluorescence activated cell sorting 
FBS   foetal bovine serum 
FCS   foetal calf serum 
FITC   fluorescein isothiocyanate 
FSC   forward scatter 
HBSS   Hank’s balanced salt solution 
IBD   inflammatory bowel disease 
IL   interleukin 
IκB   inhibitor of kappa B 
LPS   lipopolysaccharide 
MCP   monocyte chemoattractant protein 
M-CSF  macrophage colony stimulating factor 
MHC   major histocompatibility complex 
MIP   macrophage inflammatory protein 
MØ   macrophage 
mRNA   messenger ribonucleic acid 
mTNF   membrane bound TNF 
MyD88  myeloid differentiation primary response gene 88 
NF-κB   nuclear factor kappa-light-chain-enhancer of activated B cells 
xi 
 
NLR   Nod-like receptor 
NO   nitric oxide 
PAMP   pathogen-associated molecular pattern 
PBS   phosphate buffered saline 
PI   propidium iodide 
PRR   pattern recognition receptor 
qRT-PCR  quantitative real time polymerase chain reaction 
RLR   Rig-I like receptor 
RNA   ribonucleic acid 
RPMI   Roswell Park Memorial Institute medium 
RT   room temperature 
SSC   side scatter 
sTNF   soluble TNF 
TGF   transforming growth factor 
TLR   Toll-like receptor 
TNF   tumour necrosis factor 
TNFR   tumour necrosis factor receptor 
Treg   regulatory T-cells 
TSLP   thymic stromal lymphopoietin 
  
xii 
 
PUBLICATIONS 
 
Soluble factors from colonic epithelial cells contribute to gut homeostasis by 
modulating macrophage phenotype (2013) 
Kristek M, Collins LE, DeCourcey J, McEvoy FA, Loscher CE 
Innate Immunity, Manuscript ID INI-13-0125, resubmitted following revisions, 
December 2013 
 
Surface Layer Proteins Isolated from Clostridium difficile Induce Clearance 
Responses in Macrophages (2013) 
Collins LE, Lynch M, 
 
Marszalowska I, Kristek M, Rochfort K, O’Connell M, Windle 
H, Kelleher D, Loscher CE 
Microbes and Infection, Manuscript ID MICINF-D-13-00278, resubmitted following 
revisions, December 2013 
 
The role of macrophage TNFR2 in the resolution of intestinal inflammation 
Kristek M, DeCourcey J, Lynch M, Darby T, Quinlan A, Murphy CT, Casey P,  Hill 
C, Melgar S, Loscher CE (manuscript in preparation) 
 
Clostridium difficile ribotype 027 induces a more severe infection in 
vivo compared to ribotype 001 
Lynch M, Kristek M, DeCourcey J, Casey P, MacAogain M, Rodgers T, Loscher CE 
(manuscript in preparation) 
 
xiii 
 
Syntaxin 11 negatively regulates IFN-γ secretion in early Th17 differentiation 
 DeCourcey J, Lynch M, Kristek M, Collins LE, Darby T, Murphy CT, Quinlan A, 
Melgar S, Sur-Stadt U, Bulfone-Paus S and Loscher CE (manuscript in preparation) 
 
PRESENTATIONS 
Irish Society of Immunology Annual Meeting, Dublin, October 2010  
A model to examine the role of colonic macrophages in inflammatory disease 
Maja Kristek, Arman Rahman, Mary Canavan, Christine E. Loscher 
 
British Society of Immunology Annual Meeting, Liverpool, December 2010 
A model to examine the role of colonic macrophages in inflammatory disease 
Maja Kristek, Arman Rahman, Mary Canavan, Christine E. Loscher 
Source: IMMUNOLOGY Volume: 131 Supplement: 1 Pagers 174-174 Published: 
DEC 2010 
 
School of Biotechnology Annual Research Day, Dublin, January 2011 
A model to examine the role of colonic macrophages in inflammatory disease 
Maja Kristek, Arman Rahman, Mary Canavan, Christine E. Loscher 
 
Irish Society of Immunology Annual Meeting, Galway, September 2011 
Crosstalk between colonic epithelial cells and macrophages  
Maja Kristek, Arman Rahman, Christine E. Loscher 
 
  
xiv 
 
American Association of Immunologists Annual Meeting, Boston, May 2012 
Crosstalk between colonic epithelial cells and macrophages  
Maja Kristek, Arman Rahman, Christine E. Loscher 
Source: JOURNAL OF IMMUNOLOGY Volume: 188   Published: MAY 1 2012 
 
European Mucosal Immunology Group Meeting, Dublin, October 2012 
Crosstalk between colonic epithelial cells and macrophages  
Maja Kristek, Arman Rahman, Christine E. Loscher 
 
School of Biotechnology Annual Research Day, Dublin, January 2013 
Crosstalk between epithelial cells and macrophages in the gut 
Maja Kristek, Aoife Quinlan, Silvia Melgar, Christine E. Loscher 
 
Irish Society of Immunology Annual Meeting, Dublin, September 2013 
The role of macrophage TNFR2 in gut homeostasis 
Maja Kristek, Trevor Darby, Aoife Quinlan, Silvia Melgar, Christine E. Loscher 
 
1 
 
 
 
 
 
 
 
 
 
CHAPTER 1 
1 GENERAL INTRODUCTION  
2 
 
1 The intestinal immune system 
 
The gastrointestinal tract consists of the small intestine, the caecum, the large 
intestine (colon) and the rectum. The small intestine is divided into the duodenum, 
the jejunum, and the ileum. The majority of digestion takes place in the small 
intestine, whereas the colon is primarily responsible for reabsorbing water. 
Immediately after birth, the intestine is colonised by a vast microbial community that 
reaches 10
13
-10
14
 bacteria per gram of luminal content (Ley et al., 2006, Gill et al., 
2006). Alongside the exposure to these commensal bacteria the intestine is also 
exposed to a variety of food proteins and pathogenic organisms, which means that it 
constantly encounters more antigens that any other part of the body (Ley et al., 
2006). In order to protect against infection but at the same time avoid the 
unnecessary inflammatory responses to beneficial microbiota and food, the immune 
system in the intestine has evolved into the largest and most complex part of the host 
immune system. The homeostasis here is balanced through a strict hierarchy of 
mechanisms that include many immune and non-immune cells.  
The gut-associated lymphoid tissue (GALT) protects the gastrointestinal tract from 
the stomach to the colon. It comprises of lymphoid tissues such as Peyer’s patches, 
isolated lymphoid follicles and mesenteric lymph nodes. Peyer’s patches lie in the 
small intestine, while isolated lymphoid follicles, which resemble Peyer’s patches, 
can be found in the colon (Jung et al., 2010). The role of these tissues is in immune 
surveillance and the induction of immune response. The effector sites of the intestine 
are the mucosal epithelium and underlying lamina propria. Lamina propria contains 
many different immune cells, including macrophages, dendritic cells, plasma cells, 
mast cells, T and B lymphocytes (Doe, 1989). 
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The first line of defence in the intestine are epithelial cells and macrophages that lie 
just underneath the epithelium. In this introduction we will concentrate on the 
functions and adaptations of these two cell types and their role in homeostasis and 
disease. The second part of the introduction focuses on the important macrophage 
cytokine, TNF-α, its receptors and their role in inflammation as well as protective 
aspects of macrophage biology.  
 
1.1 Intestinal epithelial cells 
A single layer of intestinal epithelial cells forms a barrier between the lumen which 
is colonised by bacteria and the sub-epithelial tissue that contains immune cells. 
Apart from providing this physical barrier, intestinal epithelial cells can 
communicate with their environment, influencing and being influenced by both 
commensal bacteria and the cells of intestinal immune system (Goto and Ivanov, 
2013).  
 
1.1.1 Intestinal epithelial cells as a barrier 
The entire epithelium is renewed every 5 days in humans, through differentiation and 
proliferation of pluripotent stem cells that are located in the base of intestinal crypts. 
These cells differentiate into three different cell lineages: enterocytes, 
enteroendocrine cells and goblet cells (Pinto et al., 2003) [Figure 1.1]. In the small 
intestine, stem cells also differentiate into Paneth cells (Salzman et al., 2007). The 
most abundant intestinal surface cell is the enterocyte. Enterocytes form tight 
junctions with their neighbouring cells which prevents bacterial penetration, while 
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allowing nutrient flux into host tissue. They also secrete a variety of antimicrobial 
proteins, such as defensins, cathelicidins and C-type lectins (Mukherjee et al., 2008). 
These antimicrobial proteins are natural antibiotics that promote bacterial killing 
through enzymatic attack of the bacterial cell wall or by disrupting the bacterial inner 
membrane (Mukherjee et al., 2008). In the small intestine Paneth cells also produce 
antimicrobial proteins such as defensines and lyzozyme (Salzman et al., 2007). The 
enterocyte monolayer is interrupted by the presence of enteroendocrine cells and 
goblet cells. Enteroendocrine cells produce peptide hormones involved in cellular 
trophism, tissue repair, angiogenesis and enterocyte differentiation (Roda et al., 
2010). Goblet cells secrete large quantities of mucin glycoproteins. These 
glycoproteins assemble into a viscous, protective layer that extends up to 150μm 
from the epithelial surface (Gum et al., 1994) and forms two distinct strata 
(Johansson et al., 2008); the outer and the inner layer. The outer layer is colonised by 
bacteria, while the inner layer is resistant to bacterial penetration and forms a 
protected zone just above the epithelial surface (Johansson et al., 2008). Mice that 
lack mucin are unable to maintain the outer layer and suffer from intestinal 
inflammation  (Johansson et al., 2008).  
  
5 
 
 
Figure 1.1 The intestinal epithelial cell barrier A single layer of intestinal 
epithelial cells provides a physical barrier between commensal bacteria from the 
intestinal lumen and lamina propria. Different intestinal epithelial cells produce 
antimicrobial proteins and mucus that form a protective layer.  
 
 
1.1.2 Intestinal epithelial cells as the sentinels of intestinal immune 
system 
For a long time, intestinal epithelial cells were considered to be just a physical 
barrier between the intestinal lumen and underlying immune cells. Tight junction 
complexes and the thick mucus layer were thought to be impermeable to commensal 
bacteria and enough to prevent an inflammatory response to these microorganisms. 
However it became evident that there is a crosstalk between microbes and their 
metabolites, epithelial cells and other cell types in the mucosa. Similarly to 
conventional innate immune cells, intestinal epithelial cells express pattern-
recognition receptors (PRRs) to detect common microbial ligands. These are Toll-
like receptors (TLRs), Nod-like receptors (NLRs) and Rig-I like receptors (RLRs) 
(Goto and Ivanov, 2013). As explained in the following paragraphs, these PRRs 
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work as a tightly regulated machinery to keep the optimal function of the epithelial 
barrier.   
 
1.1.2.1 Toll-like receptors 
The TLR family is the best characterised family of PRRs. It contains 10 members in 
humans and 13 in mice which can recognise microbes through pathogen-associated 
molecular patterns (PAMPs) and initiate an immune response (Akira et al., 2001). 
For example, TLR2 recognises bacterial lipopeptides and lipoteichoic acid from the 
cell wall of Gram positive bacteria and cooperates with TLR1 and TLR6 (Takeuchi 
et al., 1999). TLR3 recognises RNA from double and single stranded viruses 
(Alexopoulou et al., 2001). TLR4 is a major receptor for lipopolysaccharide (LPS) 
from the outer membrane of Gram negative bacteria (Takeuchi et al., 1999). TLR5 
ligands are flagellin and flagellated bacteria (Hayashi et al., 2001), while TLR9 
recognised unmethylated CpG DNA from DNA viruses (Hemmi et al., 2000) and 
TLR11 is activated by uropathogenic bacteria (Zhang et al., 2004).  
Almost all TLRs are expressed at the mRNA level in the epithelial cells of the 
human colon and the expression of TLR1, TLR2, TLR3, TLR4, TLR5 and TLR9 has 
been confirmed in the epithelial cells in the small intestine (Otte et al., 2004). 
Activation of TLRs in the healthy intestine, however, does not initiate an immune 
response. Rather, signalling through TLRs is proven to be protective and crucial for 
the maintenance of intestinal homeostasis. TLR2 and TLR4 deficient mice have 
increased susceptibility to dextran sulphate sodium (DSS)-induced colitis (Rakoff-
Nahoum et al., 2004). Furthermore, mice deficient in MyD88, a signalling adaptor 
used by all TLRs showed severe susceptibility to colonic injury and severe mortality 
(Rakoff-Nahoum et al., 2004). TLR5 knockout mice have a tendency to develop 
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spontaneous colitis (Wells et al., 2011). On the other hand, administration of TLR4 
or TLR2 ligand via the oral route completely protected intestinal microflora-depleted 
mice from the DSS-induced mortality (Rakoff-Nahoum et al., 2004). Other TLRs 
also have a protective effect against DSS-induced injury. Systemic administration of 
flagellin (Vijay-Kumar et al., 2008) and oral or systemic administration of CpG 
(Rachmilewitz et al., 2004), both protect against DSS-induced colitis. 
TLRs are also required for epithelial cell proliferation following injury. TLR4 is 
required for the induction of cyclooxygenase 2 (COX2) which then leads to 
epithelial cell production of prostaglandin E2 (PGE2) and induction of epidermal 
growth factor members (Fukata et al., 2009). TLR signalling is also responsible for 
the movement of mesenchymal stromal cells to a position adjacent to epithelial stem 
cell. In the absence of MyD88 this re-positioning does not happen and stromal cells 
do not secrete factors responsible for the induction of epithelial cell proliferation 
(Brown et al., 2007).  
Furthermore, TLRs, especially TLR2, have been shown to be involved in the 
regulation of barrier function. Treatment of epithelial cells with TLR2 ligands during 
recovery from induced colitis resulted in the improved tight junction function and 
decreased epithelial cell apoptosis (Cario et al., 2007).  
 
1.1.2.2 Nod-like and RIG-1 like receptors 
Although not so extensively studied as TLRs, NLRs and RLRs are also shown to be 
important for the intestinal epithelial cell functions.  
Nucleotide-binding oligomerization domains 1 (NOD1) and 2 (NOD2) are 
intracellular sensors of bacterial peptidoglycan components. NOD1-deficient mice 
are highly susceptible to infections with Helicobacter pylori, a Gram-negative 
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bacterium found in the stomach and linked with the development of duodenal ulcer 
(Viala et al., 2004). NOD2 deficiency results in the abnormal development and 
function of Peyer’s patches, which are organised lymphoid nodules in the small 
intestine important in the immune surveillance. These mice exhibit high 
concentrations of pro-inflammatory cytokines, suggesting that NOD2 is important 
for Peyer’s patches homeostasis (Frédérick et al., 2007). Furthermore, both NOD1 
and NOD2 gene polymorphisms are associated with susceptibility to Crohn’s disease 
and ulcerative colitis (McGovern et al., 2005).   
RLRs recognise viral RNA and their expression is also connected with the function 
of Peyer’s patches. RIG-1 deficient mice have significantly lower numbers of 
Peyer’s patches and also severe damage and infiltration of inflammatory cells into 
the colonic mucosa (Wang et al., 2007).   
 
1.1.3 Intestinal epithelial cells and adaptations to the antigen-rich 
environment 
It is obvious that a tonic level of PRR signalling is necessary to maintain intestinal 
homeostasis. However, it is less clear how this signalling is regulated so that it does 
not initiate an unnecessary immune response to commensal bacteria. A few 
hypotheses have been proposed over time. It was thought that the thick layer of 
mucus is impermeable to commensal microbes, however, it is likely that a low 
number of commensal bacteria cross the epithelium under steady-state conditions, as 
gut flora-derived microorganisms can be cultured from the spleens of mice (Abreu, 
2010). Furthermore, it was though that epithelial cells serve only as a mechanical 
barrier and cannot sense their environment. However, it is now clear that intestinal 
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epithelial cells, and not just underlying immune cells, have PRRs and can therefore 
recognise microbial patterns (Artis, 2008). This means that there are other 
mechanisms in place to control the balance between homeostasis and the immune 
response of intestinal epithelial cells.  
  
1.1.3.1 Spatial distribution of PRRs 
The polarisation of intestinal epithelial cells seems to play a crucial role in avoiding 
chronic stimulation of PRRs by commensal bacteria. The epithelium is divided into 
an apical and basolateral domain with a distinct lipid and protein composition (Pott 
and Hornef, 2012). The apical membrane is exposed to the lumen and intestinal 
microbiota, while the basolateral side is protected from direct contact with 
commensals. The cellular localisation of innate immune receptors is also influenced 
by epithelial cell polarisation. For example, TLR5 is expressed exclusively on the 
basolateral side of the membrane (Gewirtz et al., 2001) and because of that it can 
only be activated when the epithelial barrier is disrupted. TLR9 is expressed both on 
the apical and basolateral side of the membrane, but ligation from the apical side 
dampens epithelial cell activation, while ligation from the basolateral side strongly 
stimulates pro-inflammatory chemokine secretion (Lee et al., 2006). Furthermore, 
TLR3, TLR7 and TLR8 are expressed in the intracellular endosomal organelles 
(Medzhitov, 2007) and NLRs and RLRs are found in the cytoplasm (Philpott and 
Girardin, 2004). These PRRs, therefore, only encounter pathogens when they invade 
the epithelial cell barrier.   
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1.1.3.2 Commensal bacteria – epithelial cell crosstalk 
In addition to their role in digestion, absorption and storage of nutrients that would 
otherwise be inaccessible to their host, commensal bacteria also play a key role in 
the maintenance of gut homeostasis. Commensal bacteria have been shown to up-
regulate tight junction proteins, change their expression and distribution and in that 
way control intestinal permeability (Ulluwishewa et al., 2011). Besides that, 
commensals have been shown to interfere with NF-κB signalling. NF-κB is 
sequestered in the cytoplasm by IκB. Following cell activation, IκB is 
phosphorylated which targets it for ubiquitylation and degradation. Once IκB is 
degraded, NF-κB can move to the nucleus where it activates the transcription of 
many pro-inflammatory genes (Karin and Ben-Neriah, 2000). Commensal bacteria 
can potentially inhibit the degradation of IκB and consequently stop the nuclear 
translocation of NF-κB (Neish et al., 2000). Furthermore, members of the 
Bacteroides species were shown to inhibit the NF-κB pathway by up-regulating the 
peroxisome-proliferation-activated receptor-γ (PPARγ) (Kelly et al., 2004). PPARγ 
is a member of the nuclear hormone receptor family which binds and diverts 
activated NF-κB from the nucleus back to the cytoplasm (Kelly et al., 2004).  
Furthermore, commensal bacteria were shown to up-regulate MHCII expression by 
intestinal epithelial cells (Hershberg and Mayer, 2000). MHCII, together with co-
stimulatory molecules CD80 and CD86 is needed for the activation of T-cells 
(Sharpe and Freeman, 2002). Since intestinal epithelial cells express only low levels 
of co-stimulatory molecules, it is speculated that MHCII up-regulation, in the 
absence of co-stimulation, leads to T cells tolerance, rather than activation. This way 
epithelial cells regulate the activation of the adaptive immune system (Hershberg and 
Mayer, 2000).  
11 
 
1.1.4 Immunomodulatory role of intestinal epithelial cells 
As mentioned, intestinal epithelial cells are in a close contact with commensal 
microbiota from the lumen. In addition to that, they are in a close contact with 
immune cells in the lamina propria. Thus, epithelial cell – immune cell crosstalk is 
also important for the maintenance of the gut homeostasis. Increasing evidence is 
showing that epithelial cells can modulate the phenotype and function of various 
immune cells through activation of receptors or secretion of cytokines (Rimoldi et 
al., 2005). 
Several studies have implicated an immunomodulatory role for intestinal epithelial 
cells on antigen presenting cells, such as dendritic cells (DCs). Conditioning of 
monocyte-derived DCs with Caco-2 intestinal epithelial supernatants induced the 
production of high amounts of IL-10 from DCs and switched off the production of 
IL-12 (Rimoldi et al., 2005). Furthermore, epithelial cell conditioned DCs were able 
to induce the differentiation of T-cells into more anti-inflammatory fates, such as 
Th2 or Treg (Rimoldi et al., 2005).   
The exact mechanism of this immunomodulation is still unclear; however it seems to 
be regulated by epithelial cell production of thymic stromal lymphopoietin (TSLP) 
and transforming growth factor-β (TGF-β). TSLP deletion in mice leads to over-
expression of IL-12 and inability of intestinal DCs to generate protective regulatory 
and Th2 responses (Zaph et al., 2007).  TGF-β can also convert DCs into a Treg-
promoting tolerogenic phenotype (Iliev et al., 2009). It has been shown to act in 
concert with TSLP to inhibit NF-κB-dependent gene expression and production of 
pro-inflammatory cytokines (Zeuthen et al., 2008). Mice with a DC-specific deletion 
of αvβ8 integrin, which is required for activation of latent TGF-β, develop severe 
colitis and have a reduced colonic Treg population (Travis et al., 2007). 
12 
 
Intestinal epithelial cells can also influence B-cells. It has been shown that epithelial 
cells produce APRIL, a B-cell proliferation-inducing ligand and BAFF, B-cell –
activating factor of the tumour necrosis factor family (He et al., 2007). APRIL and 
BAFF give the signal for class switch recombination of IgM-positive B-cells to IgA 
and support IgA production in vivo (Mora et al., 2006, He et al., 2007). IgA then 
recognises and opsonises bacteria in the lumen, preventing their access to the lamina 
propria.  
In addition to this, a new study has shown that semaphorin 7A, a glycoprotein 
expressed on the basolateral surface of intestinal epithelial cells, can stimulate IL-10 
production from intestinal macrophages and suppress inflammatory responses (Kang 
et al., 2012).   
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1.2 Intestinal macrophages 
The intestinal macrophages constitute the largest reservoir of macrophages in the 
body (Lee et al., 1985). They are most abundant in the colon, with slightly lower 
frequencies in the small intestine. Intestinal macrophages are characterised by the 
expression of the F4/80 antigen and the integrins CD11c and CD11b (Lee et al., 
1985). They also express CD64 (Tamoutounour et al., 2012) and, as shown in the 
last few years, they express high levels of the chemokine receptor CX3CR1 (Schulz 
et al., 2009). Although F4/80 still remains the most reliable marker of murine 
macrophages (Austyn and Gordon, 1981, Gordon et al., 2011), recent studies have 
shown that eosinophils in the gut can also express this marker (Mowat and Bain, 
2010). Furthermore, macrophages in the gut show significant heterogeneity (as 
described in details in section 1.2.2). The combination of markers such as F4/80, 
CX3CR1, Ly6C, MHCII, CD11b and CD11c should, therefore, be used when 
characterising macrophages populations in the gut to investigate these cells more 
precisely (Bain et al., 2013).  
 
1.2.1 The unique properties of intestinal macrophages 
Unlike other macrophages in the body, intestinal macrophages express only low 
levels of co-stimulatory molecules, such as CD80, CD86 and CD40 (Rogler et al., 
1998). They express all the TLRs at mRNA and protein level (Smith et al., 2011), 
however they are unresponsive to stimulation with TLR ligands and do not produce 
pro-inflammatory cytokines such as IL-12, IL-23, IL-6, IL-1 when stimulated with 
TLR ligands (Smith et al., 2005). This unresponsiveness is not only restricted to 
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TLR ligation, intestinal macrophages are also unresponsive to ligands for NOD-1, 
NOD-2 and C-type lectins, intact bacteria, apoptotic debris, IFN-γ and phorbol 12-
myristate 12-acetate (PMA) (Smith et al., 2011, Hirotani et al., 2005, Kamada et al., 
2005). They do produce anti-inflammatory IL-10 constitutively and in response to 
TLR ligation (Denning et al., 2007) and, as shown recently, they produce pro-
inflammatory TNF-α even in a steady state, but this does not lead to inflammation 
(Bain et al., 2013). Despite this anergy, intestinal macrophages exhibit strong 
phagocytic and bacteriocidal activity (Smythies et al., 2005). However, phagocytosis 
is not accompanied by cytokine release, as in other tissue, and bactericidal activity 
seems to be independent of the production of reactive oxygen species (ROS) 
(Rugtveit et al., 1995). In addition to low ROS production, intestinal macrophages 
also produce only low levels of other pro-inflammatory mediators, such as nitric-
oxide (NO) (Ikeda et al., 1997). The differences between intestinal macrophages and 
other macrophages are summarised in Table 1.1 
Property 
Intestinal 
macrophage 
Inflammatory 
macrophage 
Co-stimulatory molecules (CD80, CD86, CD40) - + 
Responsiveness to TLR stimulation - + 
Cytokine production (IL-12, IL-6, IL-23) - + 
Phagocytosis ++ + 
NO production - + 
ROS production - + 
IL-10 production + + 
TNF-α production + + 
 
Table 1.1 Phenotypic comparison of macrophage populations Difference between 
intestinal macrophages and conventional inflammatory macrophages  
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1.2.2 The origin of intestinal macrophages 
All tissue macrophages are derived from bone marrow stem cells through a highly 
regulated cascade of events. In the bone-marrow, a combination of cytokines that 
include IL-1, IL-3 and IL-6 together with granulocyte/macrophage colony 
stimulating factor (GM-CSF) and macrophage-colony stimulating factor (M-SCF) 
induce proliferation of a monocyte precursor into a monoblast, then a promonocyte 
and finally a monocyte (Smith et al., 2011). After leaving the bone marrow, 
monocytes enter the blood, where they circulate for days before migrating into tissue 
(Rees, 2010). It is believed that there are two different populations of monocytes; 
one that migrates and replenishes macrophages in the resting tissue and one that is 
recruited during inflammation (Geissmann et al., 2003). The first population was 
termed “resident” monocytes and characterised by the low expression of Ly6C 
glycoprotein. “Resident” monocytes are non-inflammatory and inert to stimuli 
(Geissmann et al., 2003). The second population are termed “inflammatory” 
monocytes or Ly6C
hi
 and unlike “resident” monocytes they are fully responsive to 
stimulation and home to inflamed tissue (Geissmann et al., 2003).  
Because of their distinctive, non-inflammatory features, intestinal macrophages were 
thought to derive from “resident” monocytes. Surprisingly, experiments combining 
resident cell ablation with precursor cell transfer have shown that resident intestinal 
macrophages, actually, derive from “inflammatory” monocytes (Jung et al., 2002, 
Varol et al., 2009). Once they arrive in the gut these “inflammatory” monocytes then 
adapt to the gut environment by acquiring a non-inflammatory gene expression 
signature (Bain et al., 2013). Bain et al. showed that the differentiation of adoptively 
transferred Ly6C
hi
 monocytes into resident gut macrophages happens through a 
number of transitional stages that they termed P1-P4 [Figure 1.2A]. The cells in the 
16 
 
P1 stage appear to be identical to “inflammatory” monocytes, with high expression 
of Ly6C. Moving from P1 to P4 cells gradually lose the expression of Ly6C and gain 
the expression of CX3CR1. They also gradually lose the expression of pro-
inflammatory genes (IL-6, iNOS) which were highly expressed on cells in P1 phase, 
but extinguished by P4 (Bain et al., 2013). In parallel, from P1 to P4, there was an 
increase in TGFβR2, IL-10 and other markers associated with anti-inflammatory 
macrophages (Bain et al., 2013). This progressive development of Ly6C
hi
 monocytes 
into CX3CR1
hi
Ly6C
-
 (P4) resident macrophages has also been proposed in a study 
by Tamoutounour et al, which they named “macrophage waterfall” (Tamoutounour 
et al., 2012).  
Interestingly, this “macrophage waterfall” was disrupted in murine model of disease. 
Both groups showed that inflammation disrupts full differentiation of 
“inflammatory” Ly6Chi monocytes into CX3CR1hi resident macrophages and causes 
the accumulation of cells in P1/P2 stage (Bain et al., 2013, Tamoutounour et al., 
2012) [Figure 1.2B].  
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Figure 1.2 Differentiation of inflammatory monocytes into intestinal 
macrophages under healthy and inflammatory conditions In a healthy intestine, 
inflammatory monocytes differentiate into anti-inflammatory intestinal macrophages 
through a number of transitional stages (A). Under inflammatory conditions 
maturation of inflammatory monocytes is disrupted and there is an accumulation of 
pro-inflammatory macrophages in the lamina propria (B). Adapted from (Bain et al., 
2013, Tamoutounour et al., 2012) 
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1.2.3 Mechanisms underlying the hypo-responsiveness of intestinal 
macrophages 
While the phenotype of colonic macrophages has been extensively studied, the 
mechanisms that regulate their specific properties are still largely unclear. However, 
a number of possibilities have been proposed.   
Intestinal macrophages express barely detectable levels of myeloid differentiation 
primary response gene 88 (MyD88) and Toll/IL-1 receptor (TIR) – domain 
(Smythies et al., 2010). As MyD88 is crucial for NF-κB activation of all TLRs 
except TLR3 and TIR mediates TLR3 signalling, down-regulation of these two 
molecules probably results in NF-κB inactivation in intestinal macrophages 
(Smythies et al., 2010). Consequently this stops pro-inflammatory cytokine and 
chemokine production. Furthermore, Hirotani et al. have found that colonic 
macrophages express IκBNS, which is a negative regulator of NF-κB signalling 
(Hirotani et al., 2005). Another negative regulator of the NF-κB pathway was found 
in intestinal macrophages, IκBα (Smythies et al., 2010). Intestinal macrophages do 
not phosphorylate IκBα or NF-κB which stops the translocation of NF-κB to the 
nucleus and induction of pro-inflammatory genes (Smythies et al., 2010). Besides 
the defects in the NF-κB pathway, intestinal macrophages also lack the expression of 
triggering receptor expressed on myeloid cells 1 (TREM-1) (Schenk et al., 2005). 
TREM-1 can be regarded as an amplifier of inflammation. The cross-linking of 
TREM-1 leads to a rapid and enhanced secretion of pro-inflammatory mediators 
(Schenk et al., 2005).  
TSLP and TGF-β, secreted by intestinal epithelial cells, have been proposed as 
possible candidates that suppress NF-κB and TREM-1 signalling (Artis, 2008, 
Schenk et al., 2005, Smythies et al., 2010). IL-10 is also a candidate, since the 
19 
 
inhibition of IL-10 production by intestinal macrophages reverses their TLR 
unresponsiveness in vitro (Denning et al., 2007). Another factor could be CX3CR1-
CX3CL1 interaction. While resident colonic macrophages have high expression of 
CX3CR1, the CX3CL1 chemokine is produced by intestinal epithelial cells in large 
quantities (Lucas et al., 2001). Furthermore, CX3CL1 has been shown to condition 
macrophages in the brain (Lyons et al., 2009).  
  
1.2.4 Intestinal macrophage functions 
Because of their hypo-responsiveness to stimuli and inability to mount an 
inflammatory response, the only role of intestinal macrophages was thought to be 
phagocytosis of apoptotic cells and debris. However, they have been shown to be 
important for intestinal homeostasis as depletion of macrophages leads to intestinal 
inflammation (Qualls et al., 2006). One of their homeostatic-inducing roles is the 
regulation of epithelial cell integrity. Intestinal macrophages produce prostaglandin 
E2 and promote MyD88-dependent survival and proliferation of epithelial progenitor 
cells during colonic wound healing (Pull et al., 2005). Also, they produce cyclo-
oxygenase 2 (COX2) which has been linked with anti-inflammatory effects as 
myeloid cell specific COX2 knockout mice have increased expression of pro-
inflammatory cytokines, such as IL-6, TNF-α and IFN-γ, compared to wild type 
(Watanabe et al., 2010).  
Rescigno et al. showed that CX3CR1
+
 cells are capable of extending processes 
across the epithelial layer into the intestinal lumen and sample bacteria (Rescigno et 
al., 2001). They called these cells dendritic cells, however Shulz et al. showed that 
these CX3CR1
+
 cells do not migrate to mesenteric lymph nodes and are, in fact, 
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macrophages (Schulz et al., 2009). As mentioned, these macrophages cannot migrate 
into the mesenteric lymph nodes and prime naϊve T-cells, however one of the 
possibilities is that these cells pass on the antigen to the migratory population of 
antigen presenting cells, such as dendritic cells (Persson et al., 2010). Another 
possibility is that by sampling the intestinal lumen, macrophages regulate adaptive 
immune responses within the lamina propria. Indeed, lamina propria macrophages 
seem to be specialised in the maintenance of regulatory T-cells (Treg). This is 
supported by the deficiency of CX3CR1 mutant mice to maintain their tissue Treg 
cells (Hadis et al., 2011). CX3CR1
hi 
macrophages are also shown to be crucial for 
the in vivo maintenance of Foxp3 (a master regulator of the development and 
function of regulatory T-cells) expression and suppressive activity of Treg cells 
during colitis (Murai et al., 2009). In vitro, CX3CR1
hi
 macrophages promote the 
differentiation of naive CD4
+
 T-cells into Foxp3
+
 Treg cells (Denning et al., 2007).  
 
1.3 Inflammatory bowel disease 
Inflammatory bowel disease (IBD) is an inflammatory disorder of the 
gastrointestinal tract characterised by an abnormal immune response to antigens of 
the intestinal content that leads to a persistent inflammatory state (Scaldaferri and 
Fiocchi, 2007). Two major forms of IBD are Crohn’s disease and ulcerative colitis, 
distinguished by the area they affect. While ulcerative colitis exclusively effects the 
colon, Crohn’s disease can affect the whole gastrointestinal tract, but is mainly 
localised to the colon and ileum (Podolsky, 2002). The exact cause of IBD remains 
poorly understood, however different environmental factors are considered risk 
factors for IBD, such as smoking, diet, drugs, stress and enteric flora (Loftus, 2004).  
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Furthermore, advances in DNA analysis and sequencing have indentified some IBD-
associated genetic mutations (Duerr, 2007). Whatever the cause may be, both 
ulcerative colitis and Crohn’s disease are characterised by the disruption of the 
epithelial cell barrier and the dysfunction of the immune system.  
 
1.3.1 The role of epithelial cells in IBD 
Over the last decade, evidence has mounted that intestinal barrier disruption may be 
the primary driver of IBD. Increased gut permeability is most likely genetically 
determined. It has been shown that up to 40% of healthy first-degree relatives of 
patients with Crohn’s disease exhibit increased intestinal permeability as measured 
by Cellobiosc/Mannitol test (Secondulfo et al., 2001). Furthermore, the International 
IBD Genetics Consortium have identified multiple risk loci for Crohn’s disease and 
ulcerative colitis, most of which are connected with epithelial barrier dysfunction 
(Hindryckx P, 2012). 
A polymorphism in the cytoplasmic peptidoglycan receptor NOD2 is associated with 
Crohn’s disease (Hugot et al., 2001). NOD2 is highly expressed by Paneth cells 
which provide host defence against microbes in the ileum by secreting defensins and 
lyzozyme. In patients with NOD2 mutations, expression of defensins is diminished 
which leads to an increased number of surface associated bacteria and consequently 
loss of barrier function and uncontrolled inflammation (Wehkamp et al., 2005). 
Furthermore, two other mutations of genes involved in Paneth cell and goblet cell 
function and development have been identified; XBP1 and Atg16L1. A Atg16L1 
mutation causes impaired exocytosis of Paneth cells secretory granules. This leads to 
inability to release antimicrobial peptides and therefore contributes to intestinal 
22 
 
inflammation (Cadwell et al., 2008). XBP1 is a transcriptional factor required for the 
normal development of Paneth cells and goblet cells (Kaser et al., 2008). Mice 
deficient in XBP1 have reduced numbers of goblet cells and develop spontaneous 
intestinal inflammation (Kaser et al., 2008). 
Some mutation have been linked with junctional complex genes, such as HNF4A 
and LAMB1 (Hindryckx P, 2012) and also in genes encoding mucin proteins 
(Gersemann et al., 2009). Mucin proteins are produced by goblet cells and mice that 
carry a mutation in MUC2, which is the most abundant mucin protein, develop 
chronic inflammation in the distal colon (Heazlewood et al., 2008). 
It is clear that the disruption of the intestinal cell barrier can be caused by different 
factors and inevitably leads to increased intestinal permeability for commensal 
bacteria and other antigens. This surge of antigens activates the underlying immune 
system which may lead to more intestinal damage.     
 
1.3.2 The role of macrophages in IBD 
As discussed previously, during IBD the intestinal epithelial barrier is disrupted 
which allows the invasion of commensal bacteria. This leads to influx of 
inflammatory cells and their constant activation. Indeed, patients with active IBD 
have an increased number of macrophages in the inflamed intestinal mucosa (Xavier 
and Podolsky, 2007) and these macrophages display a different phenotypic and 
functional profile than under homeostatic conditions. Macrophages in IBD patients 
display increased levels of co-stimulatory receptors, such as CD40, CD80 and CD86 
which enables the crosstalk and activation of T-cells (Rugtveit et al., 1997a). This is 
coupled with an increased production of pro-inflammatory cytokines, such as IL-12 
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and IL-23 (Kamada et al., 2005).  IL-12 drives IFN-γ production from T-cells, which 
then in turn increases macrophage activation and also increases epithelial cell 
permeability (Kamada et al., 2005). IL-23 promotes a development of a CD4
+
 
phenotype characterised by the production of IL-17, called Th17 cells, which are 
involved in the pathogenesis of IBD (Kamada et al., 2005).  
Macrophages in IBD are also a main source of TNF-α, which is considered to be a 
“master regulator” of pro-inflammatory cytokine production. It has a pivotal role in 
orchestrating the production of a pro-inflammatory cytokine cascade and therefore 
drives the disease (Parameswaran and Patial, 2010). Furthermore, macrophages in 
the IBD show increased expression of PRRs, such as TLR2 and TLR4 and also 
TREM-1 which triggers the synthesis and secretion of inflammatory factors (Smith 
et al., 2005, Schenk et al., 2005). Engagement of TREM-1 leads to increased 
secretion of IL-1β, IL-6 and IL-8 (Schenk et al., 2007). This pro-inflammatory 
response leads to epithelial apoptosis, necrosis, formation of granuloma and fibrosis 
(Heinsbroek and Gordon, 2009). Expression of tissue degrading cathepsins by 
intestinal macrophages has also been seen in IBD (Menzel et al., 2006), together 
with an increased release of nitric oxide and oxygen radicals that further contribute 
to macrophage-dependent tissue damage (Keshavarzian et al., 2003). 
While macrophages in the inflamed intestine show an enhanced pro-inflammatory 
phenotype, their ability to eradicate intracellular pathogens is decreased as their 
phagocytosis is significantly reduced (Caradonna et al., 2000). This probably 
accounts for recurrent infection in IBD patients with pathogens that directly target 
macrophages, such as Mycobacterium paratuberculosis (Weber et al., 2009).  
Some of the disruptions in macrophage signalling are also reported to contribute to 
intestinal inflammation. Selective disruption in STAT3 signalling in macrophages 
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leads to impaired production of anti-inflammatory IL-10 and spontaneous 
development of colitis in mice (Takeda et al., 1999). The mutant form of NOD2, 
associated with Crohn’s disease, is also expressed on macrophages and therefore 
may contribute to disease pathology (Hugot et al., 2001).  
  
25 
 
1.4 TNF-α and its receptors 
Tumour necrosis factor α (TNF-α) is a potent cytokine produced by many cell types, 
but mainly by monocytes and macrophages. It primarily occurs as a trans-membrane 
protein of 26 kDa, which can be cleaved by TNF-α-converting enzyme (TACE) to a 
17 kDa soluble protein (Wajant et al., 2003). TNF-α has an extremely complex role 
in the immune system. It is a regulatory cytokine that co-ordinates communication 
between immune cells and controls many of their functions, such as activation, 
apoptosis, survival, proliferation and differentiation (Parameswaran and Patial, 
2010). It also has a pivotal role in orchestrating the induction of pro-inflammatory 
signalling cascade and it is important for the normal response to infection (Wajant et 
al., 2003). Because of the central role in the regulation of immune system, 
inappropriate and excessive production of TNF-α can be harmful. Indeed, over-
production of TNF-α has been associated with the pathogenesis of many diseases, 
including rheumatoid arthritis, Crohn’s disease, atherosclerosis, psoriasis, sepsis, 
diabetes and obesity (Plevy et al., 1997, Brennan et al., 1992, Clark, 2007). Absence 
of TNF-α is equally detrimental. Mice lacking TNF-α show a high degree of 
susceptibility to infectious agents and impaired clearance of pathogens (Marino et 
al., 1997). Furthermore, in TNF-α deficient mice colonic injury during DSS-induced 
colitis was significantly aggravated and their survival rate was markedly lower 
(Naito et al., 2003).  Therefore, the levels of TNF-α have to be tightly regulated in 
order to exhibit optimal functions in both homeostasis and disease.   
Exposure of cells to TNF-α can lead to a variety of different responses. TNF 
signalling mainly activates NF-κB pathway leading to production of inflammatory 
proteins and anti-apoptotic proteins (Bradley, 2008). However, in some cases TNF 
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can trigger apoptosis and cell death pathway (Wang et al., 2008, Micheau and 
Tschopp, 2003). This paradoxical role of TNF-α is mediated by two distinct 
receptors, TNFR1 and TNFR2 (Peschon et al., 1998). While TNFR1 is expressed on 
almost all cell types, TNFR2 expression is restricted to endothelial cells and immune 
cells, especially monocytes, macrophages and T-cells (Tartaglia and Goeddel, 1992, 
Aggarwal, 2003). Both receptors are activated by membrane-bound (mTNF) and 
soluble TNF-α (sTNF), with mTNF being a stronger inducer of the TNFR2 pathway 
(Wajant et al., 2003).   
 
1.4.1 TNFR1 signalling 
The extracellular domain of TNFR1 consists of three cysteine-rich domains that 
characterise the TNF receptor superfamily and a fourth which resides within a 
membrane. The intracellular part contains a protein-protein interaction region called 
the death domain (DD) (Chan et al., 2000). In an unstimulated receptor the DD is 
pre-associated with a cytoplasmic protein designated silencer of death domain 
(SODD) (Jiang et al., 1999). After ligand binding of TNFR1, SODD dissociates 
from the intracellular DD which then allows binding of different cytoplasmic 
proteins.  
 
1.4.1.1 The inflammatory pathway 
Intracellular DD of TNFR1 recruits a membrane-associated complex, named 
complex I, which comprises of the adaptor protein TNFR1-associated death domain 
protein (TRADD), the death domain containing protein kinase receptor – interacting 
protein 1 (RIP1) and several ubiquitin E3 ligases,  such as TNFR-associated factor 2 
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(TRAF-2) and cellular inhibitor of apoptosis protein 1 and/or 2 (cIAP1, cIAP2) 
(Micheau and Tschopp, 2003). TRAF-2 from the TRADD-RIP-TRAF-2 complex 
recruits inhibitor of cellular apoptosis proteins cIAP-1 and cIAP-2, and binds to the 
inhibitor of κB complex (IKK). IKK then phosphorylates IκB proteins and this leads 
to the release of NF-κB subunits that are bound to IκB under unstimulated 
conditions. The free NF-κB subunits translocate into the nucleus and initiate gene 
transcription (Varfolomeev et al., 2008) [Figure 1.3A]. 
In complex I, RIP1 is rapidly polyubiquitylated which mediates the recruitment and 
activation of transforming growth factor-β (TGF-β)-activated kinase (TAK1) which, 
in turn, activates the IKK complex (Ea et al., 2006). This leads to NF-κB activation 
and translocation [Figure 1.3B]. NF-κB is composed of dimers derived from five 
different subunits, p65 (RelA), RelB, cRel, p50 and p52. Signalling through TNFR1 
activates the so-called classical pathway, with the p65-p50 heterodimer being a most 
important set of subunits for transcription. Target genes include cytokines, 
chemokines, receptors that regulate the adhesion and migration of cells and anti-
apoptotic molecules (Vallabhapurapu and Karin, 2009). 
TAK1 can also phosphorylate and activate the mitogen-activated protein kinase 
(MAPK) pathway (Wang et al., 2001). MAPK kinase 4 and MAPK kinase 6 then 
activate c-Jun N-terminal kinases (JNKs) and p38 MAPK. JNK and p38 MAPK 
subsequently activate transcription of genes via AP-1 [Figure 1.3C]. AP-1 controls 
many processes including apoptosis, differentiation and proliferation (Nishitoh et al., 
1998).   
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1.4.1.2 The pro-apoptotic pathway 
In addition to mediating cell survival and pro-inflammatory signals through NF-κB, 
TNFR1 can also initiate the death signalling pathway. This decision between cell 
survival or cell death seem to be regulated by RIP1 (O'Donnell and Ting, 2011). The 
activity of RIP1 is determined by its ubiquitylation status. Ubiquitylated RIP1 
interacts with different ubiquitin-binding receptors that mediate cell survival in NF-
κB dependent and independent manner (as explained in section 1.4.1.1) (Li et al., 
2006). However, when RIP1 fails to be ubiquitylated, it becomes pro-apoptotic 
signalling molecule by engaging caspase-8. This seems to be mediated by the 
negative regulators of NF-κB, such as the ubiquitin–editing enzyme A20 and the 
deubiquitylating enzyme cylindromatosis (CYLD). A20 and CYLD disassemble 
complex I by deubiquitylating RIP1 and TRAF-2. This leads to formation of the 
alternative cytosolic complexes, complex IIa and complex IIb (Ofengeim and Yuan, 
2013). Complex IIa includes Fas-associated death domain protein (FADD), caspase 
8 and RIP1 and mediates activation of caspase-8 and caspase-3 which leads to 
apoptosis [Figure 1.3D]. If caspase-8 activation is inhibited, RIP1 kinase binds to 
RIP3 to form complex IIb. Complex IIb mediates necroptosis (Ofengeim and Yuan, 
2013).  
Complex IIa and IIb can be negatively regulated by activation of NF-κB that initiate 
transcription of anti-apoptotic target genes, such as c-IAP1/2, TRAF-2 and FLICE-
inhibitory protein (FLIP) [Figure 1.3]. These pro-apoptotic genes inhibit the 
association of RIP1 with complex II components (Naude et al., 2011).    
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Figure 1.3 TNFR1 signalling pathway Activation of NF-κB transcription factor (A, 
B), activation of AP-1 transcription factor (C), activation of pro-apoptotic pathway 
(D); DD, death domain; TRADD, TNF receptor associated death domain; TRAF, 
TNF receptor associate factor; RIP, receptor interacting protein; cIAP, cellular 
inhibitor of apoptosis; TAK1, (TGF-β)-activated kinase; IKK, IκB kinase; IκB, 
inhibitor of kappa B; FADD, Fas-associated death domain protein; MAPK, mitogen-
activated protein kinase; JNK, c-Jun N-terminal kinase; AP-1, transcription factor 
activator protein 1; NF-κB, nuclear factor kappa B; FLIP, caspase-8 homologue 
FLICE-inhibitory protein   
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1.4.2 TNFR2 signalling 
The signalling pathways initiated by TNFR2 are less clearly defined. This is due to 
the fact that most experiments use sTNF which does not fully activate the TNFR2 
pathway (Wajant et al., 2003). However, it does contribute to TNFR2 signalling as 
only sTNF and not mTNF triggers the expression of monocyte chemoattractant 
protein-1 (MCP-1) in alveolar epithelial cells via TNFR2 (Liu et al., 2005). This 
adds more complexity to the TNFR2 signalling.  
TNFR2 can activate the NF-κB pathway independently of TNFR1, through classical 
and alternative pathways. TNF-α binding leads to trimerization of the TNFR2 
receptor, binding to TRAF-2 and recruitment of TRAF-2 associated proteins, TRAF-
1, cIAP1 and cIAP2. The classical pathway then activates the phosphatidylinositol 3-
kinase (PI3K) and protein kinase B/serine-threonine kinase (PKB/Akt) pathway that 
lead to IKK activation and subsequent IκB phosphorylation and degradation [Figure 
1.4A]. The NF-κB p50/p65 complex then translocates to the nucleus and initiates 
gene transcription (Al-Lamki et al., 2005).  
In unstimulated cells the TRAF-2-cIAP1/2 complex interacts with a complex of 
TRAF-3 and NF-κB inducing kinase (NIK) which leads to ubiqitination and 
degradation of NIK. When TNFR2 is stimulated, TRAF-3 can be degraded which 
leads to accumulation, rather than degradation of NIK. This leads to activation of the 
alternative NF-κB pathway. NIK stimulates IKKα and phosphorylates the NF-κB 
precursor p100, thus triggering its proteolysis to p52 (Rauert et al., 2010). The 
p52/RelB complex then translocates into the nucleus [Figure 1.4B].  
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Figure 1.4 TNFR2 signalling pathway Classical NF-κB pathway (A) and 
alternative NF-κB pathway (B). TRAF, TNF receptor associated factor; cIAP, 
cellular inhibitor of apoptosis; PI3K, phosphoinositide 3-kinases; PKB/Akt, protein 
kinase B/serine-threonine kinase; IκB, inhibitor of kappa B; NIK, NF-κB inducing 
kinase; IKK, IκB kinase;   
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1.4.3 Crosstalk between TNFR1 and TNFR2  
The intracellular part of TNFR2, unlike TNFR1, lacks a death domain and cannot 
bind FADD. However, it can still, in some cases, activate apoptosis, but the 
mechanisms behind that have not been completely elucidated. Several studies have 
pointed to the existence of a functional crosstalk between TNFR1 and TNFR2. It has 
been proposed that TNFR2 can bind and hold TNF-α and increase its concentration 
in the vicinity of TNFR1. TNFR1 receptor then accepts the TNF-α from TNFR2 and 
activates its own apoptotic signalling. This mechanism is called “ligand-passing” 
(Tartaglia et al., 1993).  
Furthermore, TNFR2 signalling can induce TRAF-2 degradation and depletion. This 
stops anti-apoptotic TNFR2 signalling, but also prevents the formation of TRADD-
RIP-TRAF-2 complex with TNFR1. Consequently TNFR1 favours TRADD- RIP-
FADD association and activation of pro-apoptotic pathway (Fotin-Mleczek et al., 
2002). TNFR2 can also dampen signals produced by TNFR1 activation. It has been 
shown that TNFR2 activation can lead to ASK-1 degradation which terminates the 
activation of MAPK pathway and AP-1 induced gene transcription (Zhao et al., 
2007). Therefore, it seems that TNFR1-TNFR2 crosstalk can serve as a feedback 
mechanism that either enhances or dampens signals generated by TNFR1.  
 
1.4.4 TNFR1 and TNFR2 in disease 
TNFR1 signalling usually activates pro-apoptotic and pro-inflammatory pathways, 
while TNFR2 is responsible for cell proliferation and pro-survival functions 
(Bradley, 2008). However, as mentioned previously, there is a degree of overlap 
between TNFR1 and TNFR2 pathways and they can both exhibit protective or 
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harmful effects in disease states. This seems to depend on certain factors, such as cell 
type, cell activation state, intracellular and extracellular environment and, in the case 
of infectious diseases, pathogens itself (Faustman and Davis, 2010).  
 
1.4.4.1 Infectious diseases 
TNF receptors have a strong influence on the outcome of infectious diseases. TNFR1 
signalling is crucially involved in the immune response to Listeria monocytogene 
and in the absence of TNFR1, phagocytosis and breakdown of bacteria are 
significantly impaired, resulting in increased bacterial growth and early death due to 
failure of the innate immune system (Pfeffer et al., 1993). The immune response to 
infections with mycobacteria, such as Mycobacterium tuberculosis, seems to be 
dependent on both receptors, with TNFR1 having a more important role. The TNF-
mediated macrophage activation and bactericidal activity to Mycobacterium 
tuberculosis are dependent on TNFR1 and TNFR1 mutant mice die from bacterial 
overgrowth and necrosis (Flynn et al., 1995b). Lack of TNFR2 also leads to 
increased sensitivity to bacteria, but it is not as extensive as in TNFR1 deficient mice 
(Jacobs et al., 2000). TNFR2, however, proved to be protective in a model of 
polymicrobial sepsis with TNFR2 signalling attenuating the toxic effects of TNF-α 
in this model, while all the detrimental effects of TNF-α are conferred via TNFR1 
(Ebach et al., 2005). 
TNFR2 has been shown to be more important than TNFR1 for viral control. TNFR2 
seems to be crucial for the generation of antigen-specific cytotoxic T-cells for 
antiviral immune responses, as CD4
+
 and CD8
+
 T-cells were shown to depend on 
TNFR2 for survival during clonal expansion in response to adenovirus infections 
(Kim et al., 2006, Kafrouni et al., 2003). 
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TNFR1 also plays a role in protozoal infections. In murine toxoplasmosis TNFR1
-/-
 
mice are highly susceptible to infection and succumb to the infection within three 
weeks (Deckert-Schluter et al., 1998). TNFR1 is also important for parasite control 
in infection with Trypanosoma cruzi and TNFR1 deficient mice have an increased 
parasitemia compared to wild type mice (Castanos-Velez et al., 1998). 
 
1.4.4.2 Autoimmune diseases 
TNF-α has a dominant role in autoimmunity and inhibiting its biological activity 
substantially improves the outcome of patients suffering from autoimmune diseases, 
such as IBD and rheumatoid arthritis (RA) (Yapali and Hamzaoglu, 2007, Majithia 
and Geraci, 2007). Information about the role of TNF receptors in these diseases is 
limited, but they are proving to be important for the initiation and maintenance of the 
disease.  
Rheumatoid arthritis is a chronic autoimmune inflammatory disorder characterised 
by inflammation of synovial tissue, leading to bone damage and erosion (Majithia 
and Geraci, 2007). Using animal models of inflammatory arthritis, TNFR1 has been 
identified as a driving force in arthritis development, enhancing the generation of 
osteoclasts and local bone destruction (Kobayashi et al., 2000). Moreover, TNFR1 
deficient mice show reduced development of collagen-induced arthritis (Tada et al., 
2001). On the other hand, TNFR2-deficient mice develop aggravated arthritis, joint 
destruction and increased osteoclastogenesis (Bluml et al., 2010), indicating a 
protective role of TNFR2 signalling.  
TNFR2 was also shown to have an anti-inflammatory role in experimental 
autoimmune encephalitis (EAE), which is a mouse model of multiple sclerosis (MS). 
MS is a chronic relapsing inflammatory disease of the central nervous system, 
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caused by abnormal T-cell reactivity to myelin antigens (Hafler and Weiner, 1989). 
TNFR1 seems to be necessary for the detrimental effects of TNF-α, which occur in 
the acute phase of the disease (Kassiotis and Kollias, 2001). TNFR2 signalling, 
however, promotes proliferation of oligodendrocyte progenitors and remyelination in 
the later stage (Kassiotis and Kollias, 2001).  
In experimental colitis, a mouse model of IBD, TNFR2 also seems to be protective 
as the absence of TNFR2, especially on CD4
+
 T-cells, leads to an accelerated onset 
of disease and more severe signs of inflammation (Dayer Schneider et al., 2009). 
Furthermore, a polymorphism in TNFR2 has been found in some patients with 
Crohn’s disease (Sashio et al., 2002) and ulcerative colitis (Pierik et al., 2004). The 
consequences of this polymorphism may be altered binding kinetics between TNF 
and TNFR2 and reduced activation through NF-κB, which in turn deregulates 
proliferative and anti-apoptotic effects of TNFR2 pathway (Till et al., 2005).  
However, the exact role of TNFR1 and TNFR2 in colitis is still unclear as the up-
regulation of TNFR2 on intestinal epithelial cells during colitis has also been 
connected with intestinal epithelial damage (Mizoguchi et al., 2002) and some 
differences in TNF receptor signalling have been observed in acute and chronic stage 
of colitis (Chen et al., 2007).  
 
1.4.4.3 Other diseases  
Circulating levels of TNF-α are independent predictors of mortality in patients with 
heart failure (Mann, 2002). However, anti-TNF therapy in humans failed to induce 
any clinical improvement (Mann, 2002). This could be due to divergent effects of 
TNF-α signalling through TNFR1 or TNFR2. Research has shown that ablation of 
the TNFR2 gene exacerbates heart failure and reduces survival, while ablation of 
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TNFR1 blunts heart failure and improves survival (Higuchi et al., 2004, Hamid et 
al., 2009). Therefore, TNF-α signalling through TNFR2 is cardioprotective and 
needed to ameliorate chamber remodelling and hypertrophy (Hamid et al., 2009).  
In retinal ischemia, which is a frequent complication in diabetic patients, TNFR1 and 
TNFR2 have also shown opposing effects. TNFR1 deficiency leads to a strong 
reduction in neurodegeneration, while lack of TNFR2 leads to enhancement of 
neurodegeneration. In this model TNF/TNFR2 signalling proved to be 
neuroprotective via the PKB/Akt anti-apoptotic pathway (Fontaine et al., 2002).  
TNF-α has also been implicated in the pathogenesis of many renal diseases, 
including ischaemic renal injury and glomerulonephritis. Ischaemic renal injury is 
acute kidney injury with an abrupt decrease in kidney function (Devarajan, 2006). 
Glomerulonephritis is a term for several renal diseases characterised by 
inflammation of the glomeruli or small blood vessels in the kidney and can lead to 
kidney failure (Chadban and Atkins, 2005). While TNFR2-mediated cell 
proliferation seems to be important for tubular regeneration in acute renal injury (Al-
Lamki et al., 2005), in proliferative forms of glomerulonephritis inhibition of 
TNFR2 proliferation may be more desirable (Vielhauer et al., 2005).  
Increased TNF-α levels also underlie the pathology of other inflammatory diseases, 
such as therapy-resistant sarcoidosis, inflammatory myopathies, inflammatory eye 
disease, systemic lupus erythematosus (Faustman and Davis, 2010) and the 
contribution of TNF/TNFR1 and TNF/TNFR2 pathways in these diseases also 
warrants further investigation.  
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1.5 AIMS AND OBJECTIVES 
The intestinal immune system is exposed to more antigens than any other part of the 
body. In order to cope with the antigen exposure it has evolved into a highly 
specialised and tightly regulated system. Normal immunology “rules” often do not 
apply here and the immune cells of the intestine present a population of its own, 
distinct from their counterparts in other tissue. The mechanisms that guide their 
specialised roles are still unclear, mostly because the isolation of these cells presents 
a challenge.  
Interestingly, resident intestinal macrophages have the same origin as 
“inflammatory” monocytes and they only lose their inflammatory properties once 
they arrive in the gut. With this in mind, our hypothesis was that the intestinal 
epithelial environment guides the phenotypic and functional changes of newly 
arrived monocytes in order to adapt them to an antigen-rich environment.  
 
To test our hypothesis the aims of this thesis were: 
 to isolate a viable and functional population of colonic macrophages  
 to address the question of their origin and explore whether the intestinal 
environment, especially intestinal epithelial cells, shape their function 
 to investigate the way in which intestinal macrophages contribute to 
homeostasis and disease and identify a potential link between epithelial cells 
and macrophages that regulates their function 
 
As we have mentioned, intestinal macrophages are a major contributor in the 
maintenance of intestinal homeostasis. However, they are also a major driver of 
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disease, when homeostasis is disturbed. Better understanding of macrophage 
functions could reveal potential therapeutic targets which will restore their protective 
role and help attenuate acute and chronic intestinal diseases.  
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CHAPTER 2 
2 MATERIALS AND METHODS 
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2.1 MATERIALS 
 
CELL CULTURE MATERIALS/REAGENTS 
Material Source 
  
Tissue culture flasks T-75cm
2 
Nunc 
Tissue culture flask T-25cm
2 
Nunc 
Sterile Petri dishes Nunc 
6, 26, 96-well tissue culture plates Nunc 
96-well round bottom plate Starstedt 
Trypan blue (0.4% w/v) Sigma-Aldrich 
Foetal Calf Serum Gibco 
RPMI-1640 Gibco 
DMEM Sigma-Aldrich 
Penicillin Streptomycin/Glutamine Gibco 
LPS Enzo Lifesciences 
DPBS Gibco 
Sterile dH2O Sigma-Aldrich 
PAM3CSK4 Invivogen 
Flagellin Invivogen 
CpG Invivogen 
Trypsin/EDTA Sigma-Aldrich 
CellTiter 96™ Aqueos One Solution Promega 
Griess reagent Promega 
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TNFR1 antagonist R&D 
TNFR2 antagonist Biolegend 
TNFR2 isotype control Biolegend 
TGF-β neutralising antibody R&D 
TSLP neutralising antibody R&D 
rmTGF-β R&D 
Table 2.1 Cell culture materials All cell culture materials/reagents used and 
corresponding sources 
 
 
ELISA REAGENTS 
Material Source 
96-well microtiter plate Nunc 
TMB BD 
Tween 20 Sigma-Aldrich 
Bovine serum albumin Sigma-Aldrich 
ELISA Duoset kits R&D Systems 
DPBS Gibco 
Table 2.2 ELISA reagents All ELISA reagents used and corresponding sources 
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FLOW CYTOMETRY REAGENTS 
Material Source 
FACS flow BD 
FACS Rinse BD 
FACS Clean BD 
Sodium azide Sigma-Aldrich 
EDTA Sigma-Aldrich 
Propidium Iodide solution Miltenyi Biotec 
Anti-F4/80 antibody Biolegend 
Anti-CD86 antibody BD 
Anti-CD80 antibody BD 
Anti-TLR2 antibody eBioscience 
Anti-TLR4 antibody eBioscience 
Anti-MHCII antibody eBioscience 
Anti-CD40 antibody BD 
Anti-TNFR1 antibody Biolegend 
Anti-TNFR2 antibody Biolegend 
DCFDA Abcam 
CellEvent
™
 Caspase 3/7 assay Life Technologies 
Table 2.3 Flow cytometry materials All flow cytometry materials/reagents used 
and corresponding sources 
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IMMUNOHISTOCHEMISTRY REAGENTS 
Material Source 
Acetone Sigma-Aldrich 
HCl Sigma-Aldrich 
Sodium bicarbonate Sigma-Aldrich 
Ethanol Merck 
Harris Haematoxylin Sigma-Aldrich 
Eosin Sigma-Aldrich 
Histo-clear National Diagnostics 
OCT solution TissueTek 
Histobond microscope slides RA Lamb 
Table 2.4 Immunohistochemistry reagents All immunohistochemistry reagents 
used and corresponding sources 
 
 
 
RNA ISOLATION AND cDNA SYNTHESIS 
Material Source 
Nucleospin RNA II Columns Macherey-Nagel 
DEPC treated water Invitrogen 
High Capacity cDNA Reverse 
Transcription kit 
Applied Biosystems 
Molecular grade ethanol  Sigma-Aldrich 
Table 2.5 RNA isolation materials All reagents used for RNA isolation and cDNA 
synthesis and corresponding sources 
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qRT-PCR REAGENTS 
Material Source 
SYBR
®
 Green Mastermix Roche 
Taqman
®
 Gene Expression Mastermix Applied Biosystems 
MicroAmp
®
 Optical 96-well plate Applied Biosystems 
MicroAmp
®
 Optical Adhesive Film Applied Biosystems 
IL-12p40 PrimeTime qRT-PCR Primers IDT 
TNF-α PrimeTime qRT-PCR Primers IDT 
IL-6 PrimeTime qRT-PCR Primers IDT 
IL-10 PrimeTime qRT-PCR Primers IDT 
Foxp3 PrimeTime qRT-PCR Primers IDT 
TGF-β PrimeTime qRT-PCR Primers IDT 
TNFR1 PrimeTime qRT-PCR Assay IDT 
TNFR2 PrimeTime qRT-PCR Assay IDT 
Occludin PrimeTime qRT-PCR Assay IDT 
Rps18 PrimeTime qRT-PCR Primers IDT 
Rps18 PrimeTime qRT-PCR Assay IDT 
Table 2.6 Quantitative PCR reagents All qRT-PCR reagents used and 
corresponding sources 
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PRIMARY CELL ISOLATION REAGENTS 
Material Source 
HBSS Sigma-Aldrich 
CMF-HBSS Gibco 
EDTA Sigma-Aldrich 
Collagenase II Gibco 
Collagenase IV Gibco 
Collagenase V Sigma-Aldrich 
Collagenase D Roche 
Dispase Gibco 
DNase Roche 
Percoll GE Healthcare 
Sodium chloride Sigma-Aldrich 
Anti-APC MicroBeads Miltenyi Biotec 
LS MACS
®
 columns Miltenyi Biotec 
MACS
®
 DeadCell Removal Kit Miltenyi Biotec 
M-CSF eBioscience 
Table 2.7 Primary cell isolation reagents All reagents used for primary cell 
isolation and corresponding sources 
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2.2 Flow cytometry 
 
2.2.1 Basic principles of flow cytometry 
Flow cytometry is a technology that allows the individual measurement of physical 
and chemical characteristics of particles as they pass one by one through a light 
source. A ﬂow cytometer is made up of three main systems: ﬂuidics, optics, and 
electronics. The fluidics system transports particles in a stream to the laser beam for 
interrogation.  The optical system consists of excitation optics and collection optics. 
The excitation optics are lasers and lenses that shape and focus the laser beam onto a 
particle. The collection optics then collect the light emitted from the particle and 
direct that light, through optical mirrors and filters, to the appropriate detectors. The 
electronics system converts the detected light signals into electronic signals that can 
be processed by the computer [Figure 2.1]. 
When a particle or a cell passes through a laser beam, laser light is scattered in all 
directions. Light that scatters axial to the laser beam is called forward scatter (FSC); 
light that scatters perpendicular to the laser beam is called side scatter (SSC). FSC 
and SSC are related to certain physical properties of cells. FSC is proportional to the 
cell-surface area or size, while SSC is proportional to cell granularity or internal 
complexity.  
Fluorescent probes can also be added to the cell for detecting specific molecules in 
or on the cell. These probes are typically antibodies to cellular antigens with a 
covalently attached fluorochrome. The fluorochrome, excited by the laser light, will 
emit light which is collected, measured and analysed (Ormerod, 2008).  
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Figure 2.1 A schematic of fluorescence detection by a flow cytometer (adapted 
from “The Science Creative Quarterly”, scq.ubc.ca, Jane Wang) 
 
2.2.2 Cell surface marker staining 
For the staining of cell surface markers in this thesis, the following protocols were 
used. Cells were removed from the tissue culture plates using a cell scraper and 
placed into a 96-well round bottom plate or 1.5ml eppendorf tubes in a concentration 
of 200,000-400,000 cells/well or tube. An equal amount of foetal bovine serum 
(FBS) was then added, to block the unspecific binding of antibodies, for 15min at 
RT. Cells were then washed twice with FACS buffer [see Appendix A] and 
incubated with appropriate fluorochrome-conjugated antibodies [Table 2.3] for 
30min at 4ºC protected from light. Cells were then washed three times to remove the 
unbound antibodies and analysed using a FACSAria I (BD). Dead cells exclusion 
was performed by adding the propidium-iodide staining (PI; Miltenyi Biotec) at a 
final concentration of 1µg/ml, immediately prior to the acquisition. All the flow 
cytometry data was analysed using FlowJo software (Treestar).  
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2.2.3 Fluorescence activated cell sorting (FACS) 
Fluorescence-activated cell sorting is a specialised type of flow cytometry that 
provides a method for the physical separation of cells of particular interest from the 
heterogeneous mixture, depending on their light scattering and fluorescent 
properties. The sample is aspirated from the reservoir and hydrodynamically focused 
so that cells pass one by one through the light source where they are investigated. 
After the signal is detected and measured, the stream that carries the cells breaks up 
into droplets. Individual drops, as they break away, can be charged depending on 
whether they contain the cell of interest or not. Drops then pass through an electrical 
field created by two charged plates and they are deflected into collection vessels 
(Davies, 2007.). In order to sort a pure population, it is important to ensure that the 
cell of interest is contained in a drop that does not also contain a non-target 
(unwanted) cell. Therefore, usually only the drop that contains the target cell is 
charged. However, sometimes the target cell falls near the edge of the drop and it 
may appear in the preceding or the following drop. In this case, to avoid cell loss, 
more than one drop can be charged. Thus, how the sort is going to be performed is 
determined by choosing the appropriate sort precision mode. 
Each sort precision mode on the BD FACSAria I is made up of a set of masks: Yield 
mask, Purity mask and Phase mask, that are divided in 1/32-drop increments 
(Gautho, 2003). Mask settings determine whether a drop is going to be sorted or not, 
depending on the location of the target cell within a drop and the location of the non-
target cell in the preceding or the following drop. For achieving the highest purity 
two precision modes were tested: 0-32-0 and 16-16-0. In the first mode, the Purity 
mask was set on maximum so a drop will only be sorted if the leading and the 
trailing drops do not contain unwanted cell [Figure 2.2].  
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Figure 2.2 Precision mode 0-32-0 Purity mask is set on 32, which means that the 
drop will only be sorted if there is no unwanted particle in a trailing or a leading drop 
 
 
In the second mode the Purity mask is set to 16 meaning that the drop is going to be 
sorted if a non-target cell falls outside the Purity mask (in other words, if the non-
target cell is far enough from the target cell) [Figure 2.3]. The Yield mask was also 
set to 16 meaning that additional drop (preceding or following) will be sorted if the 
target cell falls within the Yield mask (additional drop will be sorted if target cell 
falls near the edge of the drop) [Figure 2.4].  
 
Figure 2.3 Precision mode 16-16-0 Purity is set to 16, which means that the drop 
will only be sorted if unwanted particle falls outside the purity mask 
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Figure 2.4 Precision mode 16-16-0 Yield is set to 16, which means that the 
additional drop will be sorted if a wanted particle falls within the yield mask 
 
 
2.3 Cell culture 
 
All cell culture was carried out using aseptic technique in a class II laminar airflow 
unit (Holten 2010 – ThermoElectron Corporation, OH, USA). Cell cultures were 
maintained in a 37 C incubator with 5 % CO2 and 95 % humidified air (Model 381 - 
Thermo Electron Corporation OH USA). Cells were grown in complete DMEM 
medium (DMEM Sigma-Aldrich, supplemented with 10% FBS and 2% penicillin -
streptomycin/glutamine).  FCS was heat-inactivated (56C for 30 min) to inactivate 
complement and aliquoted for storage at -20 C. Supplemented medium was stored 
at 4 C for no longer than one month.  
 
2.3.1 Murine monocyte-derived macrophage cell line, J774A.1 
The J774A.1 cell line was purchased from the European Collection of Cell Cultures 
(ECACC) and maintained in complete DMEM in 75 cm
2
 flasks. Cell monolayers 
were passaged at a confluency of 80% (every 3 to 4 days). Cells were detached using 
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a cell scraper and transferred into a 50 ml falcon. Cells were centrifuged at 250g for 
5 min and resuspended in complete DMEM. For subculture, cells were plated at 1x106 
or 2x106/25ml DMEM in a fresh 75cm
2
 flask.  
 
2.3.2 Murine colonic epithelial cell line, CMT-93 
The CMT-93 cell line was purchased from the ECACC and maintained in complete 
DMEM in 75 cm
2
 flasks. Cell monolayers were passaged at a confluency of 80% 
(every 4 to 5 days). Cells were detached by adding 2ml of 0.25% trypsin, 0.02% 
EDTA solution (Sigma-Aldrich). Trypsin/EDTA solution was left on the cells at 
37ºC until the cells detached (5-10min). Fresh culture medium was then added, cells 
centrifuged at 250g at 5min, resuspended and subcultured in a ratio 1:10, in a fresh 
75cm
2
 flask.  
 
2.4 Conditioning experiments 
 
CMT-93 cells were grown until they were approx. 80% confluent after which fresh 
media was added, left on the cells for 24h and then collected, centrifuged and stored 
at -20ºC for conditioning experiments. This is referred to as CMT-93 conditioned 
media. 
J774A.1 macrophages were plated in 6-wells or 24-wells tissue culture plates at a 
concentration of 1x10
6
 cells/ml and incubated for 2h, 6h or 24h with DMEM 
medium alone (unconditioned) or CMT-93 conditioned medium. After incubation, 
cells and supernatants were collected for further analysis. To determine the 
macrophage response to stimuli, macrophages were pre-conditioned for 2h, 6h or 
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24h in the presence or absence of CMT-93 conditioned medium before being 
stimulated with LPS (100ng/ml, Enzo Life Sciences), PAM3CSK4 (1µg/ml; 
InvivoGen),  Flagellin (5µg/ml; InvivoGen) or CpG (2µM; InvivoGen) for 24h.  
 
2.5 Assessment of phagocytosis 
 
Macrophages were cultured in a 6-well plate at 5x10
5
 cells in a total volume of 
2ml/well. To assess phagocytosis, macrophages were incubated with 1µm 
fluorescent latex beads (Sigma-Aldrich), at a concentration of 20 beads per cell, for 
1h at 37ºC (Seyrantepe et al., 2010). Cells were then washed with PBS/2% FCS and 
the uptake of beads (λex ~470 nm; λem ~505 nm) was measured by flow cytometry. 
For the analysis of phagocytosis after stimulation, cells were treated with 100ng/ml 
LPS for 24h prior the addition of latex beads. As a negative control, the same 
experiment was repeated with CMT-93 cells which do not phagocytose (see 
Appendix B). Additionally, macrophages were incubated with 10µg/ml 
Cytochalasin D (Sigma-Aldrich) for 30min prior to the addition of latex beads (see 
Appendix B). Phagocytosis is sensitive to treatment with cytochalasin, a drug that 
disrupts actin polymerization, but endocytosis is cytochalasine insensitive (DeFife et 
al., 1999).  
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2.6  Enzyme-linked immunosorbent assay (ELISA) 
 
2.6.1 Basic principles of ELISA 
ELISA is a sensitive and robust method which measures the antigen concentration in 
an unknown sample. In all of our studies we used a sandwich ELISA to measure the 
amount of cytokines and chemokines in cell supernatants. In a sandwich ELISA the 
antigen of interest is quantified between two layers of antibodies: the capture and the 
detection antibody. These antibodies must bind to non-overlapping epitopes on the 
antigen. The detection antibody is usually conjugated with biotin which then allows 
for the detection reagent (streptavidin-HRP) to bind to it. The streptavidin and biotin 
bind with high affinity and the amount of horseradish-peroxidase (HRP) is 
proportional to the amount of target antigen in the sample. Substrate solution is then 
added (tetramethylbenzidine, TMB) and the HRP enzyme catalyses the oxidation of 
the TMB into a coloured product. The intensity of the colour is proportional to the 
concentration of antigen in the sample. Colour development is stopped by adding an 
acidic solution and the optical density (O.D.) of the colour is measured on a 
microplate reader. For each set of samples, a standard curve is generated and the 
values of unknown samples are calculated from the standard curve (Sandhu 
Premjeet1, 2012).  
 
2.6.2 Cytokine ELISA 
The concentration of cytokines IL-12p40, TNF-α, IL-6, IL-10 and IL-27 in cell 
supernatants was determined using ELISA Duoset kits from R&D Systems in 
accordance with the manufacturers’ instructions. Briefly, 100µl/well of capture 
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antibody (diluted to the appropriate concentration in PBS) was added to an ELISA 
plate (Nunc) and incubated overnight at room temperature. Plates were then washed 
three times with Wash Buffer (PBS + 0.05% Tween-20) and blocked by adding 
300µl of Blocking buffer (1% (w/v) BSA/PBS) for a minimum of 1h at room 
temperature. The washing step was repeated and 100µl of samples and standards 
(diluted to appropriate concentrations) were added per well, in triplicate. Plates were 
then incubated at 4ºC overnight. The next day, plates were washed again and 100µl 
of the biotinylated detection antibody was added to each well and incubated for 2h at 
RT. 100µl of Streptavidin-HRP (R&D) was then added to each well, following 
another wash step. Plates were incubated for 20min at RT. After the last washing 
step, 100µl of TMB (BD Biosciences) was added to each well and plates were left in 
dark for 20min or until the blue colour develops. Colour development was stopped 
by adding 50µl of 1M sulphuric acid (Sigma-Aldrich) to the wells. The optical 
density was determined at 450nm, using a VersaMax™ microplate reader 
(Molecular Devices). 
 
2.6.3 Chemokine ELISA 
The concentration of chemokines MIP-1α, MIP-2 and MCP-1 in cell supernatants 
was determined using ELISA Duoset kits from R&D Systems in accordance with the 
manufacturers’ instructions. The protocol is as described in the last section 2.6.2.  
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2.7 Measurement of nitric oxide (NO) formation 
 
NO levels were detected in the cell supernatants by measuring the production of 
nitrite (NO2
-
) which is a stable breakdown product of NO. The production of nitrite 
was measured using the Griess Reagent System (Promega). The Griess Reagent 
system uses sulfanilamide and N-1-napthylethylenediamine dihydrochloride (NED), 
under acidic (phosphoric acid) conditions, which form the coloured azo-compound 
in the presence of nitrite. The intensity of the colour is proportional to the 
concentration of nitrite in the sample. The nitrite concentration is then determined 
using sodium nitrite as a standard. This method was originally described by Griess 
(Griess, 1879).  
Briefly, 50µl of samples and standards were added to the 96-well plate in triplicates. 
50µl of the Sulfanilamide Solution (Promega) was then added to each well and plate 
was incubated for 10min at RT, protected from light. In the next step, 50µl of the 
NED solution (Promega) was added to all wells and incubated for another 10min at 
RT, protected from light. A purple/magenta colour develops and the absorbance was 
measured at 543nm using a VersaMax™ microplate reader (Molecular Devices). 
. 
2.8  Measurement of reactive oxygen species (ROS) 
 
To measure the intracellular ROS production, 0.5x10
6
 cells/ml were incubated with 
20µM of the cell permeant reagent 2’,7’ –dichlorofluorescein diacetate (DCFDA; 
Abcam) for 30 min at 37ºC in the dark, according to manufacturer’s instructions. 
DCFDA is a fluorogenic dye that measures hydroxyl, peroxyl and other ROS activity 
within the cell. After diffusion into the cell, DCFDA is deacetylated by cellular 
esterases to a non-fluorescent compound, which is later oxidized by ROS into 2’, 7’ 
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–dichlorofluorescin (DCF) (Eruslanov and Kusmartsev, 2010). DCF is a highly 
fluorescent compound which can be detected by fluorescence spectroscopy with 
maximum excitation and emission spectra of 495nm and 529nm respectively. The 
fluorescence intensity of DCF was measured by flow cytometry.  
 
2.9  MTS viability assay 
 
To determine the number of viable cells, The CellTiter 96® AQueous One Solution 
Cell Proliferation Assay (Promega) was used. This assay uses the MTS tetrazolium 
compound (Owen’s reagent) which is bioreduced by cells into a coloured formazan 
product that is soluble in tissue culture medium (Malich et al., 1997). The quantity of 
formazan product is then measured by the absorbance at 490nm and it is directly 
proportional to the number of living cells in culture. Briefly, cells were plated on a 
96-well plate at 100,000 cells/well in a total volume of 100µl. 20µl of MTS 
compound was added to each well and the plate was incubated at 37ºC for 1h, in a 
humidified, 5% CO2 atmosphere. Absorbance was then recorded at 490nm using a 
96-well plate reader. Results are expressed as a percentage of untreated cells. 
 
2.10 Caspase 3/7 assay 
 
CellEvent® Caspase-3/7 Green Detection Reagent (Life Technologies) consist of 
cell permeant reagent with a four amino acid peptide (DEVD) conjugated to a 
nucleic acid binding dye. During apoptosis, caspase-3 and caspase-7 proteins are 
activated and able to cleave the DEVD sequence. Cleavage of the DEVD sequence 
and binding of DNA labels apoptotic cells with a bright, fluorescent signal (Belloc et 
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al., 2000). The absorption and emission wavelengths of the CellEvent® reagent are 
511nm/533nm. The assay was performed according to manufacturer’s instructions. 
Briefly, 0.5x10
6
 cells/ml were stained with 500nM CellEvent® Caspase-3/7 Green 
Detection Reagent for 30min at 37ºC. Samples were then analysed, without washing 
or fixing, on FACSAria I flow cytometer.  
 
2.11 RNA Analysis 
 
2.11.1 Total RNA isolation 
Colonic tissue (20-30mg) was homogenised in Lysis buffer RA1 (Macherey-Nagel) 
using Qiagen TissueLyser LT for 5min at 50Hz. Total RNA was then isolated using 
a Nucleospin RNA II kit (Macherey-Nagel) according to manufacturer’s instructions. 
Briefly, the viscosity of the lysate was first cleared by filtration through a 
NucleoSpin® filter and centrifuging for 1min at 11000g. 70% ethanol was added to 
the homogenised lysate to adjust RNA binding conditions. The NucleoSpin® RNA 
II column was then used to bind RNA, with the addition of Membrane Desalting 
Buffer to remove salt and improve the efficiency of rDNase digestion. DNA was 
digested using a DNase reaction mixture at RT for 15min. After 15min Buffer RA2 
and RA3 were added to inactivate rDNase and wash the column. The NucleoSpin® 
RNA II column was then placed into a nuclease free collection tube and RNA was 
eluted in RNase-free H2O. The concentration of RNA was then measured using the 
Nanodrop® ND-1000 (Thermo-Fisher Scientific). The purity of the RNA was 
determined using 260nm and 280nm absorption wavelengths. All the RNA used in 
this study had a A280/A260 ratio between 1.8 and 2.1 (Ralph Rapley, 1998).   
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2.11.2 cDNA synthesis 
Complementary DNA (cDNA) is generated from mRNA using the High Capacity 
cDNA Reverse Transcriptase Kit (Applied Biosystems, USA). The kit contains a 
master mix of dNTP, random primers and the enzyme reverse transcriptase. Reverse 
transcriptase synthesises single strain cDNA using the mRNA strands as a template. 
This is then used as the template for the subsequent qRT-PCR experiments. 1µg of 
mRNA was used in each cDNA synthesis reaction. The settings in Table 2.8 are 
used in the reaction on a PTC-200 PCR thermal cycler (MJ Research). 
 
 Step 1 Step 2 Step 3 Step 4 
Temperature (ºC) 25 37 85 4 
Time (min) 10 120 5 ∞ 
Table 2.8 Thermal cycling conditions 
 
 
2.11.3 Basic principles of quantitative real time PCR (qRT-PCR) 
The principle of polymerase chain reaction (PCR) is to specifically increase a target 
from an undetectable amount of starting material. This is done by using a cDNA 
template that we want to amplify, sequence specific oligonucleotides, heat stable 
DNA polymerase and thermal cycling. In classical PCR, at the end of the 
amplification, the product can be run on a gel for detection of the specific product. 
Real time PCR, however, combines the DNA amplification with the immediate 
detection of the product. This is done by using a fluorescent reporters and PCR 
instruments that are able to measure fluorescence while performing the thermal 
cycling needed for the PCR reaction. The amount of DNA is measured after each 
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cycle via fluorescent reagents that yield an increasing fluorescent signal which is 
proportional to the increase in target (Kolmodin and Birch, 2002). 
These fluorescent reagents can be sequence specific or non-sequence specific. In this 
thesis both types of reagents were used, Taqman® assay and SYBR® green dye. 
 
2.11.3.1 Taqman® assay 
Taqman® assays contain two primers and a probe. A Taqman probe has a gene-
specific sequence and binds the target between the two PCR primers. At the 5’ end 
of the probe is a reporter, which is a fluorescent dye. On the 3’ end of the probe is a 
quencher, which quenches fluorescence from the reporter in an intact probe. During 
PCR, the primers and probe anneal to the target and if they bind to the correct target 
sequence the DNA polymerase cleaves the probe, releasing the fragment with the 
reporter dye. Once cleaved, the reporter dye is no longer in close proximity to the 
quencher and therefore it can emit its full signal. Eventually, cleaved probes will 
accumulate and produce a signal that can be measured by the PCR instrument.  
 
2.11.3.2 SYBR® green dye 
SYBR® green is a fluorescent dye that binds to the minor groove of double-stranded 
DNA. During the PCR reaction, the primers will amplify the target sequence, more 
molecules of the dye will bind to the double-stranded product and will fluoresce. 
SYBR® green dye is non-sequence specific, which means it can bind to any double-
stranded sequence such as primer-dimer artifacts or non-target sequence. To assess 
the specificity of the SYBR® green assay we, therefore, performed the dissociation 
analysis for each product. The dissociation step was added after the final PCR cycle. 
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If there is only one product present in the tube it should have one specific melting 
temperature, Tm. The PCR software transforms the melt profile into a peak. If there 
is more than one peak present that usually signals the amplification of non-target 
products. Presence of one pure peak shows that one target amplified, but to further 
evaluate this we also ran the products on the gel [see Appendix C].  
 
2.11.4 qRT-PCR assay optimisation  
Before analysis of gene expression, we first evaluated the assay performance by 
assessing the standard curve and PCR efficiency [see Appendix C]. A standard 
curve was created by carrying out a serial dilution of the PCR product. When a 
standard curve correlation coefficient was close to 1, the PCR efficiency was 
determined using the following formula: 
     
 
 
               
A well performing assay will have efficiency between 90-100%, which correlates to 
slope values of 3.1-3.3. Non template controls (NTC) were included in all 
experiments. Samples with a NTC within 5 cycles of the sample Ct value were 
disregarded (Raymaekers et al., 2009). 
Premade primers and Taqman® assay primer/probes were ordered from IDT [Table 
2.6 and Appendix C] and used as recommended by manufacturer. Where DNA 
binding dye (SYBR® green) was used, the dissociation step was added, after the 
final PCR cycle, in order to assess primer specificity as explained in the section 
2.11.3.2 [Appendix C]. In order to further ensure that the primers are only 
amplifying the product of interest, PCR product was ran on the gel (details in the 
61 
 
section 2.11.7) [Appendix C]. If assay efficiency or primer specificity was not 
satisfactory, new sets of primers were ordered.  
 
2.11.5 qRT-PCR protocol 
PCR was prepared in triplicate for each sample by adding cDNA, master mix and 
RNase free water. In experiments with Taqman® primer/probes Taqman® Gene 
Expression Mastermix (Applied Biosystems) was used. In other experiments we 
used SYBR Green Mastermix (Roche). All the primers and primer/probes were 
ordered from IDT and are listed in Table 2.6 and Appendix C. ROX dye was used 
as a passive reference to normalise the well to well differences that may occur due to 
artefacts such as pipetting errors or instrument limitations. Samples were added to a 
96-well reaction plate (Applied Biosystems) and sealed with optically clear film 
(Applied Biosystems). Plates were centrifuged for 1min at 1000g and run on the ABI 
Prism 7500 under the conditions shown in Table 2.9. The results were analysed 
using the ABI Prism sequence detection software (Applied Biosystems) and Excel 
Software (Microsoft).   
 
 Step 1 Step 2 Step 3a Step 3b 
Temperature (ºC) 50 95 95 60 
Time 2min 10min 15sec
* 
15sec
* 
   *Repeat for 40 cycles 
Table 2.9 Thermal cycling conditions 
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2.11.6 qRT-PCR data analysis 
For gene expression analysis we used a relative quantification method in which the 
gene levels are expressed as a fold difference between a sample and a calibrator 
(such as untreated/healthy tissue). Samples were first normalised to an endogenous 
control which is a gene that maintains consistent expression levels despite treatment. 
Several endogenous controls were tested and the most suitable one (in our case 18S) 
was selected [see Appendix C]. Normalised samples were then compared to the 
calibrator (healthy control) using ∆∆Ct method: 
                                
Where ∆Ct sample = Ct sample – Ct endogenous control and ∆Ct calibrator = Ct 
calibrator – Ct endogenous control.  
 
2.11.7 DNA product analysis by gel electrophoresis 
Gel electrophoresis was used to check DNA products following qRT-PCR [see 
Appendix C]. Samples were run on a 2% agarose gel. The gel was prepared by 
dissolving 2g of agarose (Termo-Fisher Scientific) in 100ml 1x TAE buffer [see 
Appendix A] and heating to boiling point. After cooling, 10µl of SYBR® safe DNA 
gel stain (Applied Biosystems) was added to the gel mix before pouring into a gel 
mould and setting the well comb. DNA samples were mixed with loading buffer 
(Fermentas) and loaded straight onto the gel, together with GeneRuler 100bp DNA 
ladder (Termo-Fisher Scientific). Gels were run for 1h in 1x TAE buffer at 100V and 
visualised using the G-box imaging system (Syngene).  
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2.12 Primary cell isolation 
 
2.12.1 Mice 
BALB/c mice, 6-8 weeks old, were purchased from Charles River. Mice were kept 
under specific pathogen-free conditions at the Bioresource Unit, Faculty of Health 
and Science, Dublin City University, Ireland. All mice were maintained according to 
the guidelines of the Irish Department of Children and Health.  
 
2.12.2 Isolation of colonic lamina propria cells 
The large intestines of mice were excised and soaked in PBS. Fat and faecal matter 
were removed and the tissue was washed in Hank’s balanced salt solution (HBSS, 
Gibco) with 2% fetal bovine serum (FBS, Gibco) and cut into approx. 0.5cm 
sections. To remove the epithelial layer, tissue was incubated with 2mM EDTA 
(ethylene diamine tetraacetic acid, Sigma) in calcium, magnesium free (CMF) HBSS 
(Gibco), in a shaking water bath for 15min at 37°C. The supernatant was then 
discarded and tissue was washed with fresh CMF HBSS, following a second 
incubation with 2mM EDTA in CMF HBSS. The remaining tissue was washed and 
digested with a pre-warmed combination of enzymes in complete RPMI (Gibco) 
medium. Three different combinations of enzymes were used, the first contained 
240U/ml Collagenase II (Gibco) and 290U/ml Collagenase IV (Gibco). The second 
contained 1mg/ml Collagenase D (Roche), 1mg/ml Dispase (Gibco) and 50U/ml 
DNase I (Roche). The third contained 1.25mg/ml Collagenase D, 0.85mg/ml 
Collagenase V (Sigma), 0.03mg/ml Dispase and 30U/ml DNase I. The tissue was 
incubated in the digestion solution, in the shaking water bath at 37°C, for either 
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2x20min (digestion solution was changed after 20min), 2x30min (digestion solution 
was changed every 30min) or 40min with or without vigorously shaking every 5-
10min. Finally, the supernatant containing lamina propria cells was removed and 
passed through a 70µm filter (BD Bioscience). Cells were centrifuged for 5min at 
300g, resuspended in complete RMPI medium, filtered again and kept on ice until 
used.   
 
2.12.2.1 Separation of dead cells and debris using Percoll gradient 
In this study a discontinuous (step) gradient was used. To form a discontinuous 
gradient, Percoll (GE Healthcare) medium was diluted to a series of different 
densities. First an isotonic stock solution was prepared by adding 9 parts of Percoll 
to one part of 1.5M NaCl. The isotonic solution was then diluted to lower densities 
by adding 0.15M NaCl. The solutions of different densities were then carefully 
layered one on top of another, starting with the most dense at the bottom of the tube. 
The suspension of the cells in medium was added on top of the layers and 
centrifuged at 300g for 30min. After centrifugation a sharp band of cells that 
occurred at an interface was carefully collected into a sterile 50ml tube. Dead cells 
and debris usually end up at the bottom of the tube or floating on the top. Collected 
cells were then washed in HBSS and centrifuged three times for 5min at 300g to 
remove Percoll.   
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2.12.3 Purification of colonic macrophages 
2.12.3.1  Cell purification using magnetic beads 
Cells isolated from mouse colons were resuspended in 90µl buffer (PBS containing 
0.5% bovine serum albumin and 2mM EDTA) per 10
7
 cells and incubated with 10µl 
of FcR Blocking Reagent (Miltenyi) for 10min at 4°C. After blocking, cells were 
stained with 0.2µg of allophycocyanin (APC) - conjugated anti-mouse F4/80 
antibody (BioLegend) per 10
7
 cells in 100µl of buffer and incubated for 30min at 
4°C in the dark. Cells were then washed twice to remove unbound antibody and 
magnetically labelled with Anti-APC MicroBeads (Miltenyi), according to 
manufacturer’s instructions. Briefly, the cell pellet was resuspended in 80µl of buffer 
and incubated with 20µl of Anti-APC Microbeads per 10
7
 of total cells, for 15min in 
the refrigerator. Cells were then washed, resuspended in 500µl of buffer and loaded 
onto an LS MACS
® 
column and placed in the magnetic field of the MACS 
Separator. The magnetically labelled cells were retained within the column (positive 
fraction) while unlabelled cells (negative fraction) ran through. To remove all 
unlabelled cells the column was washed three times with 3ml of buffer. After 
separation, the column was removed from the magnetic field and the positive 
fraction was eluted by firmly pushing the plunger into the column. The cell purity 
and viability of both fractions were measured by flow cytometry.  
 
2.12.3.2 Removal of dead cells using MACS® Dead Cell Removal Kit (Miltenyi) 
Cells were magnetically labelled with Dead Cell Removal MicroBeads (Miltenyi), 
according to manufacturer’s instruction. Briefly, the cell pellet was resuspended in 
100µl of Dead Cell Removal MicroBeads per 10
7
 of total cells and incubated for 
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15min at room temperature. The cell suspension was then diluted with 1ml of 
Binding Buffer (Miltenyi) per 10
7
 cells and applied onto an LS MACS
® 
column and 
placed in the magnetic field of the MACS Separator. The magnetically labelled dead 
cells were retained in the column while the unlabelled living cells passed through. 
The fraction that passed through was then collected and the viability was determined 
by flow cytometry.  
 
2.12.3.3 Cell purification using fluorescence-activated cell sorting (FACS) 
The isolated lamina propria cells were incubated with 1:1 solution of RPMI and FBS 
for 15min at room temperature, to prevent non-specific binding. Cells were then 
washed by centrifugation at 300g for 5min and stained with 0.2µg APC-conjugated 
anti-mouse F4/80 antibody (BioLegend) per 10
7
 cells in 100µl of sterile buffer (PBS 
with 2% FBS), for 30min at 4°C in the dark. After staining cells were washed two 
times to remove unbound antibody and resuspended in the sterile sorting buffer. Two 
different sorting buffers were used, the first one contained PBS with 1mM EDTA 
(Sigma), 25mM HEPES (Gibco) and 1% FBS (Gibco), and the second one PBS 
without EDTA and HEPES. Cells were kept on ice until sorting. Propidium-iodide 
(PI) solution (Miltenyi) was added to the cells a few minutes before sorting, at a final 
concentration of 1µg/ml, to enable exclusion of dead cells. Sorting was performed on 
the BD FACSAria I cell sorter. The day before sorting, the internal sheath path of the 
sorter was decontaminated with bleach or ethanol and the lines were then rinsed with 
DI water. Cells were sorted into polystyrene FACS tubes half filled with complete 
RPMI medium. Sorting was performed at two different temperatures, 4°C and room 
temperature and also using either slower (<10000 cells/s) or faster (>10000 cells/s) 
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sorting speed. In order to achieve the highest purity two precision modes were tested: 
0-32-0 and 16-16-0. 
After sorting cells were re-analysed on the FACS Aria I for purity and used in 
further experiments. Schematic of the optimised cell isolation procedure is shown in 
Appendix D.  
 
2.12.4 Isolation and differentiation of bone marrow-derived macrophages 
The bone marrow was flushed out of the femurs and tibias of adult mice. Cells were 
then centrifuged at 250g for 5min and resuspended in complete RPMI (Gibco) 
supplemented with 10% FBS (Gibco) and 2% penicillin streptomycin/glutamine 
(Gibco). 50ng/ml M-CSF (eBioscience) was added to generate macrophages (Sweet 
and Hume, 2003). Cells were plated on petri dishes (4 petri dishes/mouse; 10ml/petri 
dish) and placed in a CO2 incubator at 37ºC.  After 3 days, 10ml of fresh media with 
50ng/ml M-CSF was added to each plate. At day 6 non-adherent cells were removed 
by washing with RPMI and the adherent cells were displaced using a cell scraper 
(Sarstedt) and collected for further experiments (Zhang et al., 2008). The purity of 
harvested bone marrow-derived macrophages was assessed by flow cytometry and 
was typically >95% F4/80
+
.  
 
2.12.5 Isolation of peritoneal macrophages 
To obtain peritoneal macrophages, euthanized mice were injected intraperitoneally 
with 10ml ice cold, sterile PBS (Gibco) and resident peritoneal cells were collected 
by harvesting the solution from the peritoneal cavity. Cells were then centrifuged at 
250g for 5min, resuspended in complete RPMI and placed on a 6-well tissue culture 
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plates (Nunc). After 2h non-adherent cells were removed by washing with RPMI and 
the adherent cells were displaced using a cell scraper and collected for further 
experiments. Collected cells were typically >90% F4/80
+
.  
 
2.13 Mouse models of disease 
 
2.13.1 Dextran sulfate sodium (DSS) induced model of colitis 
The DSS model work was carried out in collaboration with Dr. Silvia Melgar in the 
Alimentary Pharmabiotic Centre, University College Cork (UCC). 25 C57BL/6 
female mice, weight 18-20g at arrival, were housed in the Biological Service Unit 
(BSU) at UCC. DSS was administered to the mice in drinking water at a final 
concentration of 3% (Okayasu et al., 1990b). Fresh DSS was prepared daily in 
normal tap water and administered ad libitum. Mice were split into 4 groups for the 
study: 
1. Control 
No DSS was administered to the control mice 
2. Early acute 
Mice were administered DSS for 5 days (day 0 – day 4) followed by 2 days 
on water and sacrificed for sample and tissue processing on day 7 
3. Late acute 
Mice were administered DSS for 5 days (day 0 – day 4) followed by 7 days 
on water and sacrificed for sample and tissue processing on day 12 
 
 
69 
 
4. Chronic 
Mice were administered DSS for 5 days (day 0 – day 4) followed by 21 days 
on water and sacrificed for sample and tissue processing on day 26 
 
The clinical symptoms recorded in the DSS-treated and the control mice were body 
weight, fur texture/posture and stool consistency on day 0 and 2 times/week from 
day 4. These were used to generate a daily disease activity index (DAI). At the end 
point of each group the length and weight of each colon were also measured and 
used as an indicator of colitis. 0.5cm sections of distal colon were collected for RNA 
purification and histology.  
 
2.13.2 Clostridium difficile infection 
C. difficile spores from two strains, ribotypes 001 and 027, frozen in DMEM were 
acquired from the Sir Patrick Dunne Laboratory at St. James's Hospital, Dublin. The 
C. difficile infection model was carried out in collaboration with Pat Casey and Colin 
Hill in the Alimentary Pharmabiotic Centre & Microbiology Department, University 
College Cork.  
C57BL/6J mice were infected with C. difficile using an antibiotic-induced model of 
mouse infection (Chen et al., 2008a). Mice were treated for 3 days with an antibiotic 
mixture of kanamycin (400 μg/ml), gentamicin (35 μg/ml), colistin (850 U/ml), 
metronidazole (215 μg/ml) and vancomycin (45 μg/ml) in the drinking water. Mice 
were subsequently given autoclaved water. On day 5, mice were injected i.p. with 
clindamycin (10 mg/kg).  Mice were infected with 10
3
 C. difficile spores on day 6 by 
oral gavage. Mice that were not treated with antibiotics were also challenged with C. 
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difficile. Animals were weighed daily and monitored for overt disease, including 
diarrhoea. The caecum was harvested from uninfected (day 0) and infected mice at 
days 3 and 7 and the contents were removed for CFU counts. 0.5cm section of distal 
colon was collected for tissue homogenisation and RNA purification.    
The contents of the cecum were recovered from infected and uninfected mice, 
weighed and homogenised in 1 ml PBS by vortex mixing in a 1.5 ml microcentrifuge 
tube.  The suspension was serially diluted (10
-1
 to 10
-4
) and 50 l of each dilution 
was spread in duplicate onto quadrants of Brazier’s CCEY plates (Lab M).  Plates 
were incubated under anaerobic conditions at 37ºC for 30h.  Colonies were counted 
and CFU/g
 
determined for each sample. 
 
2.13.3 Tissue sectioning and histochemistry 
Tissue sections of 0.5cm were removed from the distal part of the washed colon and 
embedded in optimum cutting temperature (OCT) solution (Tissue-Tek), followed 
by freezing in liquid nitrogen and preserved at -80ºC. The sections were cut in a 
controlled temperature cryostat (Leica Cryocut 1800) at -20ºC and mounted onto 
microscope slides (RA Lamb). Slides were left overnight at room temperature. 
Sections were then fixed in acetone/alcohol mix for 5min at RT and washed in PBS. 
Slides were stained with Harris haematoxylin (Sigma-Aldrich) for 10 minutes and 
washed again under running tap water for 5min. The slides were differentiated in 1% 
acid/alcohol for 30s 3 times and then washed under a tap for 1min. After washing 
slides were placed in 0.1% sodium bicarbonate (Sigma-Aldrich) for 1min followed 
by washing under a tap for 5min. The slides were then rinsed in 95% ethanol 
(Merck) for 10 dips before counterstaining with eosin (Sigma-Aldrich) for 1min by 
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dipping up and down. Finally the slides were dehydrated by dipping in 75% ethanol 
for 3min, 95% ethanol for 3min (x2), followed by 100% ethanol for 3min and 3min 
in Histo-clear (National Diagnostics). Slides were then mounted with mounting 
medium and the cover slips pushed firmly to remove bubbles.  
 
2.14 Statistical analysis 
 
Results are presented as mean ± standard error of the mean (SEM) and groups were 
compared using an unpaired Student’s t-test or for multiple groups, a one-way 
ANOVA followed by a Newman-Keuls post test. All data were analysed using Prism 
Software (GraphPad Software, Inc.). Values of less than p<0.05 were considered 
statistically significant. 
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3 CHAPTER 3 
ISOLATION AND CHARACTERISATION 
OF COLONIC MACROPHAGES 
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3.1 INTRODUCTION 
 
The gastrointestinal mucosa is the largest reservoir of macrophages in the body (Lee 
et al., 1985). The macrophages are found in both the small and large intestine, 
strategically positioned in the lamina propria which underlies the surface epithelium. 
The intestinal immune system is continually exposed to different environmental and 
dietary antigens in the presence of commensal bacteria. Furthermore, the intestinal 
tract is a major site of pathogen exposure. To cope with these challenges, intestinal 
macrophages have evolved into a specialised type of mononuclear cells that differ 
from other macrophage populations in the body. The most important difference is 
their anti-inflammatory phenotype (Smith et al., 2005, Smythies et al., 2005).  
 
Unlike other tissue macrophages intestinal macrophages are in a state of hypo-
responsiveness. They do not express high levels of co-stimulatory molecules such as 
CD80 and CD86 (Smith et al., 2011). Furthermore, they do not produce pro-
inflammatory cytokines or chemokines in response to stimuli; neither do they up-
regulate co-stimulatory molecules or antigen-presenting receptors (Smith et al., 
2005, Schenk and Mueller, 2007). However, they do produce the anti-inflammatory 
cytokine, IL-10, in response to Toll-like receptor ligation and retain phagocytic 
abilities (Smith et al., 2005, Hadis et al., 2011). An anti-inflammatory phenotype is 
not the only feature of intestinal macrophages. Studies have implicated their role in 
the regulation of epithelial cell renewal and integrity (Pull et al., 2005). Furthermore, 
they have been shown to support the induction and survival of Treg cells in the 
mucosa (Denning et al., 2007, Hadis et al., 2011). All of these properties make them 
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crucial cells for maintenance of gut homeostasis. Indeed, depletion of macrophages 
leads to increased susceptibility to intestinal inflammation (Qualls et al., 2006).  
 
Despite the importance of this macrophage population, the molecular mechanisms 
underlying their specific properties still remain unclear. One of the main reasons for 
this is the fact that they are notoriously difficult to isolate. A typical isolation 
involves extensive enzymatic digestion that affects both macrophage viability and 
number. Also they cannot be cultured as they progressively die once removed from 
their natural environment.   
 
The aim of this study was to find the best method for isolation of colonic 
macrophages. This involves optimising the type and amount of enzymes required for 
tissue digestion and optimising the time of digestion. We wanted to establish a 
method that would yield the highest cell number and best viability. We also wanted 
to purify the macrophage population from other resident cells in the lamina propria 
(dendritic cells, eosinophils, mast cells, T-cells, etc) using their distinguishing 
feature of expression of the F4/80 marker. F4/80 is a member of the epidermal 
growth factor – transmembrane 7 family and has been widely used as a murine 
macrophage marker (Austyn and Gordon, 1981, MartinezPomares et al., 1996). 
During our optimisation studies it has become clear that colonic eosinophils can also 
expresses F4/80 marker (Mowat and Bain, 2010). Furthermore, the expression of 
chemokine receptor, CX3CR1 has proven to be a more reliable way to distinguish 
between colonic macrophages and other intestinal populations (Pabst and Bernhardt, 
2010). Because of the inability to find a good CX3CR1 antibody, we continued using 
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F4/80 as a macrophage marker, but we have adapted a revised method of gating in 
the attempt to exclude eosinophils (as described later in the result section). 
 
For cell purification we wanted to compare two methods, namely cell separation 
using magnetic beads and fluorescence activated cell sorting.  Finally, we wanted to 
characterise the isolated colonic macrophages and compare them to other 
macrophage populations in order to validate our model.  
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3.2 RESULTS 
3.2.1 Optimisation of tissue digestion 
Cell isolation from tissue is a complex process that depends on many factors such as 
combination and concentration of enzymes and the digestion time. In order to 
determine the method that yields the highest viability and cell number, we tested 
several different variables [Table 3.1]. The first digestion solution contained a 
combination of two enzymes, Collagenase II and Collagenase IV and the tissue was 
allowed to digest for 40min in the shaking water bath at 37°C. The cell suspension 
obtained after digestion contained a high amount of dead cells and debris. We then 
used Percoll medium to enrich the viable cell population. Percoll medium is based 
on colloidal silica particles that are coated with polyvinylpyrrolidone. When a 
solution of Percoll is centrifuged, coated silica particles begin to sediment and, since 
Percoll is polydisperse colloid, these particles sediment at different rates creating a 
gradient. This can be utilised to separate cells, viruses, organelles and other particles 
depending on their size and granularity. To determine the best gradient to separate 
viable cells from debris, we prepared a few different discontinuous gradients, 20% 
Percoll over 40%, 20%/50%, 30%/50% and 40%/80%. The cell suspension was 
layered on top of these gradients. After 30min centrifugation a thin layer of cells was 
collected from the interface between gradients. Cells were counted and viability was 
determined using Trypan blue staining. The 20%/40% gradient yielded 1x10
6
 cells, 
20%/50% yielded 2.1x10
6
, 30%/50% yielded 2.3x10
6
 and 40%/80% yielded 3x10
6
 
cells. Viability of those cells were 29%, 43%, 69% and 66% respectively [Table 
3.1]. Since the 40%/80% Percoll gradient yielded the highest cell number (3x10
6
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cells) with relatively high percentage of viable cells (66%), we decided to use that 
gradient for further tissue digestions.     
The second digestion solution that was tested contained three different enzymes, 
Collagenase D, Dispase and DNase I. The digestion time was split into 2x20min or 
3x20min. After each 20min fresh digestion solution was added. The viable 
population was enriched using a 40%/80% Percoll gradient and it contained 74% 
viable cells; however the cell number was still low (2x10
6
). In order to determine 
whether the cells were lost during digestion or during Percoll gradient separation, the 
Percoll step was left out. The number of cells markedly increased to 37x10
6
 cells and 
viability was still high (70%). Therefore Percoll gradient was not used in the further 
digestions. 
The third digestion solution also contained Collagenase D, Dispase and DNase I with 
the addition of Collagenase V. The tissue was digested for 40min. After digestion, 
the cell suspension contained 70x10
6
 cells with 85% viability. This combination of 
enzymes and digestion time was then used throughout the study.  
 
3.2.2 Optimisation of cell purification 
In order to purify macrophages from the suspension of lamina propria cells we tested 
two different purification methods. The first method was magnetic separation using 
Miltenyi MACS
® 
columns and the second method was fluorescence-activated cell 
sorting on BD FACSAria I. Macrophages isolated from the mouse colon were 
purified based on their expression of F4/80 marker which has been widely used as a 
murine macrophage marker (MartinezPomares et al., 1996). 
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3.2.2.1 Cell purification using Miltenyi MACS® columns 
Cells isolated from the colon were stained with allophycocyanin (APC) - conjugated 
anti-mouse F4/80 antibody and F4/80
+
 macrophages were purified using the Miltenyi 
MACS column as described in the Materials and methods section 2.12.3.1. The 
positive fraction obtained after purification was stained with Propidium Iodide (PI) 
solution to determine the cell viability. PI is a commonly used fluorescent dye for 
identifying dead cells as it can penetrate cell membranes of dead and dying cells and 
bind to DNA. Fluorescence can then be detected in the red or yellow fluorescence 
channel. Cell purity and viability were measured using flow cytometry. 
Cells were first gated based on their size (forward scatter, FSC) and granularity (side 
scatter, SSC) in order to exclude debris which are smaller and less granular than the 
cells. Secondly, cells were gated based on their expression of F4/80 or PI. Cell 
purity, before and after magnetic separation, is shown by the contour plot [Figure 
3.1A] with the F4/80 expression on the y-axis. F4/80
+
 cells shift up on the y-axis 
relative to the intensity of their fluorescent staining. Cell viability is shown as a dot 
plot [Figure 3.1B] with PI expression on the y-axis. Viable cells do not shift on the 
y-axis because they cannot take up propidium iodide dye and therefore lack 
fluorescence.  
The lamina propria cell suspension contained 11% F4/80+ cells before magnetic 
separation. Following separation, purity increased to 63% F4/80+ cells [Figure 
3.1A]. On the other hand viability of the freshly isolated cells was 89% which 
decreased after the isolation to 54% of viable cells [Figure 3.1B].  
One possible explanation of the decreased cell viability was unspecific binding of 
anti-APC beads to dead cells. To examine this, the purified sample was double-
stained with PI and F4/80 antibody and analysed further. The dot plot [Figure 3.2], 
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with F4/80 expression on the x-axis and PI expression on the y-axis, was divided 
into quadrants showing the percentages of dead F4/80
-
 cells, dead F4/80
+
 cells, 
unstained cells and live F4/80
+
 cells in the sample. The sample contained 34% dead 
F4/80- cells (upper right quadrant) indicating that anti-APC beads un-specifically 
bind dead non-macrophage cells, decreasing the purity of the sample.   
To remove dead cells from the sample we used MACS
®
 Dead Cell Removal Kit 
(Miltenyi) as described in Materials and methods section 2.12.3.2. The percentage of 
viable cells was then determined by flow cytometry using PI staining. Viability of 
the sample is shown as a dot plot [Figure 3.3] with PI fluorescence on the y-axis. 
Following the use of Dead Cell Removal Kit, dead cells were enriched instead of 
removed from the sample (97% dead cells after the use of kit). This technique was 
not used any further.  
 
3.2.2.2 Cell purification using fluorescence-activated cell sorting  
Cells isolated from the colonic lamina propria were sorted on the FACS Aria I cell 
sorter as described in Material and methods section 2.12.3.3.  
In order to achieve the highest purity and viability of sorted cells, a number of 
parameters that can affect sorting efficiency, were tested [Table 3.2]. Firstly, cells 
for sorting were kept in two different sorting buffers, one containing EDTA (Sigma) 
and HEPES buffer (Gibco), and one without EDTA/HEPES. The first buffer 
increased the cell viability and it was used for further sorting experiments [Table 
3.2]. Secondly, cell sorting was performed at different temperatures, which also had 
an effect on cell viability. Viability of the cells sorted at 4°C was higher than of 
those sorted at room temperature. Also higher viability and purity was achieved if 
the speed of sorting was slower (less than 10000 events per second). 
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In order to sort a pure population, it is important to ensure that the cell of interest is 
contained in a drop that does not also contain a non-target (contaminating) cell. 
Therefore, usually only the drop that contains target cell is charged. However, 
sometimes the target cell falls near the edge of the drop and it may appear in the 
preceding or the following drop. In this case, to avoid the cell loss, more than one 
drop can be charged. Thus, how the sort is going to be performed is determined by 
choosing the appropriate sort precision mode (sort precision mode is described in 
more details in Material and methods section 2.2.3).  
For achieving the highest purity, two precision modes were tested: 0-32-0 and 16-16-
0. Although sort precision in the first mode is stricter, the second mode yielded 
higher cell number and purity and it was used throughout the study.  
Figure 3.4 shows the gating strategy that was used for all the sorting experiments. 
The sample was first gated based on the size (FSC) and granularity (SSC) to exclude 
debris [Figure 3.4A]. The acquired population was then further gated based on the 
FSC-area vs. FSC-height to remove single cells from doublets. Doublets occur when 
two cells are stuck together and are seen by the flow cytometer as a single, larger 
particle. They appear differently in a graphical display and can therefore be gated out 
since they fall off the primary axis of population [Figure 3.4B]. It was important to 
sort only live cells that can be put into culture following sorting; therefore dead cells 
were gated out using PI staining [Figure 3.4C]. Finally, live cells were gated based 
on their F4/80 expression [Figure 3.4D]. Only live, F4/80
+
 cells were sorted.  
To confirm that the required population was collected, sorted cells were re-analysed 
on the flow cytometer. Contour plots and dot plots [Figure 3.5] show purity and 
viability of cells before and after sorting. Before sorting lamina propria cells 
contained 12% F4/80
+
 cells which were 81% viable [Figure 3.5A]. Sorted cells were 
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93% F4/80
+
 and viability was 96% [Figure 3.5B]. To check for the actual purity, 
since some of the cells can lose the antibody during sorting, sorted cells were re-
stained with F4/80 antibody which increased the purity to 96% [Figure 3.5C]. 
Fluorescence-activated cell sorting was shown to be a more efficient method for 
purification of colonic macrophages when compared to magnetic separation [Table 
3.3]; therefore this method was used throughout the study.  
 
3.2.3 Isolation and differentiation of bone marrow-derived macrophages 
In order to assess the phenotypic and functional characteristics of colonic 
macrophages and compare them with another macrophage population, bone marrow-
derived macrophages (BMMØ) were generated. Bone marrow cells were isolated 
from the femurs and tibias of BALB/c mice and differentiated into BMMØ in vitro 
in the presence of the macrophage colony-stimulating factor (eBioscience) for 6 
days. The macrophage colony-stimulating factor (M-CSF) is a lineage-specific 
growth factor responsible for differentiation and proliferation of myeloid progenitors 
into cells of macrophage lineage (Sweet and Hume, 2003). Purity of the 
differentiated macrophages was determined by flow cytometry using the F4/80 
macrophage marker and it was regularly higher than 95%. The histogram in Figure 
3.6 shows the percentage of BMMØ that express F4/80 marker.  
 
3.2.4 Colonic macrophages are hypo-responsive to Toll-like receptor 
stimulation 
Both colonic macrophages (colonic MØ) and bone marrow-derived macrophages 
(BMMØ) were cultured in the presence of LPS (100ng/ml; Enzo Life Sciences) or 
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PAM3CSK4 (1µg/ml; InvivoGen) for 24h. Unstimulated cells were used as a control. 
After 24h supernatants were harvested and stored at -20°C, while cells were analysed 
for the expression of CD80, CD86, MHC class II and CD14 by flow cytometry. 
Expression of surface markers, before and after LPS or PAM stimulation, is shown 
as histograms and compares BMMØ and colonic MØ.  
Unstimulated BMMØ expressed basal levels of CD80, CD86, MHC class II and 
CD14 and as expected they were all up-regulated following LPS stimulation [Figure 
3.7]. However, that was not the case for the colonic MØ. Expression of CD80 and 
CD86 on colonic MØ was low or almost absent, however there was expression of 
CD14 and MHC class II but it was lower compared to BMMØ. More importantly 
there was no up-regulation of these markers following LPS stimulation [Figure 3.7]. 
The same trend was observed after PAM3CSK4 stimulation [Figure 3.9].  
We also assessed expression of the Toll-like receptors, TLR2 and TLR4 on both 
macrophage populations using flow cytometry. Untreated BMMØ expressed both 
TLR2 and TLR4 receptors and they were both up-regulated after LPS stimulation 
[Figure 3.8]. However, expression of TLR2 and TLR4 on colonic MØ was very low 
and did not change following LPS stimulation [Figure 3.8]. Similar expression 
profiles were observed after PAM3CSK4 stimulation [Figure 3.10]. 
Another hallmark of macrophage activation is the production of a wide range of 
cytokines following encounters with pathogens. After stimulation with LPS and 
PAM3CSK4, for 24h, supernatants were collected from the BMMØ and colonic MØ 
and cytokine levels were measured by ELISA, including IL-12p40, TNF-α, IL-6, IL-
10 and IL-27. LPS stimulation of BMMØ resulted in increased production of all 
cytokines measured. However, while colonic MØ secreted low levels of TNF-α, IL-
6, IL-10 and IL-27, these levels did not change in response to LPS [Figure 3.11]. A 
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similar profile was observed following PAM3CSK4 stimulation, although production 
of IL-10 was slightly higher in PAM-stimulated colonic MØ than unstimulated 
colonic MØ [Figure 3.12]. 
 
3.2.5  Colonic MØ retain phagocytic abilities 
So far in this study we have shown that colonic macrophages fail to up-regulate co-
stimulatory molecules when stimulated with TLR ligands and also fail to produce 
pro-inflammatory cytokines which are characteristics of colonic macrophages. We 
next wanted to measure their ability to phagocytose and compare it to BMMØ, as 
colonic macrophages have been reported to maintain phagocytic ability.     
Both BMMØ and colonic MØ were cultured with 1µm fluorescent latex beads 
(Sigma) at 37°C. After 1h cells were washed and analysed by flow cytometry for the 
uptake of beads. Beads show green fluorescence which can be measured in the FITC 
channel (475-700nm). Cells that took up the beads show fluorescence, which is then 
seen on the histogram as a shift to the right [Figure 3.13]. Colonic MØ showed high 
uptake of beads (32.9% phagocytosing cells) without prior activation indicating that 
their phagocytic ability is retained. Phagocytosis of BMMØ was lower with 23.2% 
phagoytosing cells.  
 
3.2.6 Colonic macrophages become pro-inflammatory in the disease 
While colonic macrophages seem unresponsive to inflammatory stimuli, it has been 
shown that during intestinal inflammation phenotype of colonic macrophages 
becomes pro-inflammatory, with the up-regulation of co-stimulatory molecules, such 
as CD80 and Toll-like receptors (TLR), such as TLR4 (Rugtveit et al., 1997a, 
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Hausmann et al., 2002). They also produce pro-inflammatory cytokines (Rugtveit et 
al., 1997b). In order to confirm this phenotype switch, we isolated colonic MØ from 
the colons of mice following induction of colitis using dextran sodium sulfate (DSS), 
as described in Materials and methods section 2.13.1. Colonic MØ from healthy 
controls and DSS mice were sorted, as previously described, and left in culture for 
24h. After 24h supernatants were collected and stored at -20ºC and cells were stained 
with fluorescently labelled antibodies against CD86 and TLR4 and analysed by flow 
cytometry. The revised method of colonic macrophage gating was used in this 
experiment. Live, single cells were gated based on their high expression of F4/80 
(F4/80
low
 cells were not gated) and then subgated based on their FSC and SSC 
properties [Appendix E]. Eosinophils have the forward and side scatter properties of 
granulocytes (Mowat and Bain, 2010) and can be distinguished from macrophages. 
Colonic MØ from the diseased mouse show much higher expression of CD86 and 
TLR4 when compared to healthy controls [Figure 3.14A]. Secretion of pro-
inflammatory cytokines was measured in the collected supernatants by ELISA and 
colonic MØ from the DSS mice produced significantly higher amounts of IL-12p40 
(p<0.001), TNF-α (p<0.05) and IL-6 (p<0.001) [Figure 3.14B].  
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3.3 FIGURES  
 
 
Table 3.1 Optimisation of tissue digestion. Different combinations and 
concentrations of enzymes in the digestion solution, Percoll gradients and times of 
digestion were tested in order to achieve the highest number and viability of cells in 
the single cell suspension. 
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Figure 3.1 Cell purity and viability before and after magnetic separation using 
Miltenyi MACS® columns After tissue digestion cells were stained with APC anti-
mouse F4/80 antibody (BioLegend), magnetically labelled with Anti-APC 
Microbeads (Miltenyi Biotec) and the cell suspension was loaded onto a MACS
®
 
column, according to manufacturer’s instructions. Cells were then analysed using a 
BD FACSAria I cytometer. Contour plot and dot plot represent cells stained with 
APC F4/80 antibody (BioLegend) and Propidium Iodide stain (Miltenyi), 
respectively. Cell purity (A) and viability (B) was measured before and after 
magnetic separation. Data are representative of three independent experiments.  
 
(A) 
BEFORE 
(B) 
AFTER 
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Figure 3.2 Magnetic beads bind the cells in an unspecific manner After magnetic 
separation, the positive fraction was analysed based on the expression of F4/80 vs. 
Propidium Iodide fluorescence. The dot plot is divided into quadrants showing the 
percentages of dead F4/80
-
 cells, dead F4/80
+
 cells, unstained cells and live F4/80
+
 
cells in the sample. Sample contains 34 % dead F4/80
-
 cells. Data are representative 
of three independent experiments.  
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Figure 3.3 Dead cells are enriched instead of removed using Dead Cell Removal 
Kit (Miltenyi). After tissue digestion, the Dead Cell Removal Kit was used 
according to manufacturer’s instruction to eliminate dead cells from the sample. 
Cells were then analysed on FACSAria I based on their Propidium Iodide 
fluorescence. Dot plots show the percentage of viable cells before and after the use 
of the kit. Data are representative of three independent experiments.  
 
  
BEFORE 
 
 
AFTER 
89 
 
 
Parameters 
tested 
 
Effect on cell 
viability 
Effect on cell 
purity 
Sorting buffer 
(PBS + 1% FCS) 
+ EDTA, HEPES  - 
-  EDTA, HEPES  - 
Temperature of 
sorting 
+4°C  - 
RT  - 
Sort precision 
mode 
0-32-0 -  
16-16-0 -  
Speed of sorting 
<10000 events/s   
>10000 events/s   
 
Table 3.2 Optimisation of fluorescence-activated cell sorting Different parameters 
were tested in order to find optimal conditions for sorting of colonic macrophages on 
a BD FACSAria I cells sorter. 
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Figure 3.4 Gating strategies for sorting Cells were gated according to their size 
(FSC) and granularity (SSC) (A), doublets were excluded (B) and to assess viability 
dead cells were gated out based on the Propidium Iodide stain (C). Live-gated singe 
cells were then further gated based on their F4/80 expression (D). Data are 
representative of three independent experiments.  
 
(C) 
(A) 
(D) 
(B) 
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Figure 3.5 Cell purity and viability after fluorescence-activated cell sorting 
After tissue digestion, cells were stained with APC F4/80 antibody (BioLegend) and 
Propidium Iodide (Miltenyi) and sorted using BD FACSAria I cell sorter. Cells were 
gated based on their size (FSC) and granularity (SSC) and doublets were excluded. 
Furthermore cells were gated based on their expression of F4/80 and Propidium 
Iodide. Only live F4/80
+
 cells were sorted. Purity and viability of cells is shown 
before (A) and after sorting (B). Some of the cells lose the antibody during sorting; 
therefore cells were re-stained with F4/80 antibody following sorting to show the 
actual purity (C). Data are representative of three independent experiments.  
 
  
PURITY VIABILITY 
(C) 
(A) 
(B) 
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Method used Purity 
% viable cells after 
purification 
Number of cells after 
purification 
MACS
® 
column 60-70% 50-60 2.2±0.5x10
6
 
Cell sorting 93-97% 95-97 1±0.5x10
6
 
 
Table 3.3 Summary of the tested purification methods Purity, viability and 
number of colonic macrophages following two different purification methods  
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Figure 3.6 Purity of bone marrow - derived macrophages Macrophages derived 
from mouse bone marrow were stained with an F4/80 marker and purity was 
analysed on FACSAria I. The histogram shows the percentage of cells that express 
the F4/80 macrophage marker. Data are representative of three independent 
experiments.  
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Figure 3.7 Expression of cell surface markers following LPS stimulation, 
comparing colonic and bone marrow-derived macrophages Bone marrow-
derived macrophages (BMMØ) and colonic macrophages (colonic MØ) were stained 
with fluorescently labelled antibodies after 24h stimulation with LPS (100ng/ml) and 
surface expression was analysed on FACSAria I. Cells were gated on F4/80 positive 
population. The histograms show marker expression on unstimulated cells (black 
line) compared to LPS-stimulated cells (dashed line). Filled histograms represent 
unstained cells. Data are representative of three independent experiments.  
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Figure 3.8 Expression of Toll-like receptors following LPS stimulation, 
comparing colonic and bone marrow-derived macrophages Bone marrow-
derived macrophages (BMMØ) and colonic macrophages (colonic MØ) were stained 
with fluorescently labelled antibodies after 24h stimulation with LPS (100ng/ml) and 
surface expression was analysed on FACSAria I. Cells were gated on F4/80 positive 
population. The histograms show marker expression on unstimulated cells (black 
line) compared to LPS-stimulated cells (dashed line). Filled histograms represent 
unstained cells. Data are representative of three independent experiments.  
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Figure 3.9 Expression of cell surface markers following PAM3CSK4 stimulation, 
comparing colonic and bone marrow-derived macrophages Bone marrow-
derived macrophages (BMMØ) and colonic macrophages (colonic MØ) were stained 
with fluorescently labelled antibodies after 24h stimulation with PAM3CSK4 
(1µg/ml) and surface expression was analysed on FACSAria I. Cells were gated on 
F4/80 positive population. The histograms show marker expression of unstimulated 
cells (black line) compared to PAM3CSK4- stimulated cells (dashed line). Filled 
histograms represent unstained cells. Data are representative of three independent 
experiments.  
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Figure 3.10 Expression of Toll-like receptors following PAM3CSK4 stimulation, 
comparing colonic and bone marrow-derived macrophages Bone marrow-
derived macrophages (BMMØ) and colonic macrophages (colonic MØ) were stained 
with fluorescently labelled antibodies after 24h stimulation with PAM3CSK4 
(1µg/ml) and surface expression was analysed on FACSAria I. Cells were gated on 
F4/80 positive population. The histograms show marker expression of unstimulated 
cells (black line) compared to PAM3CSK4- stimulated cells (dashed line). Filled 
histograms represent unstained cells. Data are representative of three independent 
experiments.  
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Figure 3.11 Cytokine secretion by colonic and bone marrow-derived 
macrophages following LPS stimulation Bone marrow-derived (BMMØ) and 
colonic macrophages (colonic MØ) were stimulated with LPS (100ng/ml) and after 
24h supernatants were collected. Secretion of cytokines was measured by ELISA 
(R&D), according to manufacturer’s instruction. Data are presented as mean ± SEM 
of three replicates and are representative of three independent experiments. 
***P<0.001 vs. unstimulated BMMØ by unpaired t-test 
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Figure 3.12 Cytokine secretion by colonic and bone marrow-derived 
macrophages following PAM3CSK4 stimulation Bone marrow-derived (BMMØ) 
and colonic macrophages (colonic MØ) were stimulated with PAM3CSK4 (1µg/ml) 
and after 24h supernatants were collected. Secretion of cytokines was measured by 
ELISA (R&D), according to manufacturer’s instruction. Data are presented as mean 
± SEM of three replicates and are representative of three independent experiments. 
***P<0.001 vs. unstimulated BMMØ by unpaired t-test 
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Figure 3.13 Phagocytosis of colonic and bone marrow-derived macrophages 
Bone marrow-derived (BMMØ) and colonic macrophages (colonic MØ) were 
cultured with 1µm fluorescent latex beads (Sigma) for 1h. Cells were washed and 
analysed by flow cytometry for uptake of beads. Gates on histograms show 
percentage of cells that contain beads (phagocytes) or do not contain beads (non-
phagocytes). Data are representative of three independent experiments.  
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Figure 3.14 Colonic MØ have altered phenotype in inflammatory disease Mice 
were administered 3% DSS in drinking water for 5 days, followed by two days of 
water only. On day 7 mice were sacrificed and lamina propria cells were isolated 
from the colon. Expression of surface markers was measured on live, F4/80
+
 cells 
and compared between a healthy control (black histogram) and diseased mouse 
(dashed histogram) (A). Live, F4/80
+
 cells were sorted using FACSAria I cell sorter 
(BD) and the production of cytokines was measured by ELISA (R&D) following 
24h in the culture. Data are presented as mean ± SEM (B). n=2 mice/control and 5 
mice/DSS group. Statistical analysis was performed using unpaired t-test. *P<0.05, 
***P<0.001 vs. control.  
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3.4 DISCUSSION 
 
The aim of this study was to optimise a method for the isolation and purification of 
colonic macrophages. Firstly, we wanted to establish a method for the digestion of 
tissue that would give us a single cell suspension with the highest cell number and 
viability. Secondly, we wanted to find the best way to purify the cells of interest 
from the obtained suspension with no risk to the achieved viability. Lastly, we 
wanted to characterise the purified cells to confirm that we have the appropriate 
population and that the cell phenotype and function was not affected during the harsh 
isolation procedure.  
 
The intestinal immune system is comprised of three main lymphoid areas: the lamina 
propria which is located just underneath the epithelium, the intraepithelial 
compartment and the lymphoid nodules. The majority of macrophages are located in 
the lamina propria (Mahida et al., 1989a). There are a variety of protocols published 
in the literature for the isolation of intestinal cells. The first protocols that were 
established attempted to isolate lymphoid cells with particular interest in 
lymphocytes (Bull and Bookman, 1977, Vanderheijden and Stok, 1987). While all 
the protocols vary in terms of the type and concentration of enzymes used and the 
time of the incubation and temperature, they all use collagenases as the main 
enzymes. Collagenases are enzymes that break down the native collagen that holds 
the animal tissue together. They are used for the isolation of a wide variety of cell 
types, mostly because they generally have little effect on the cell function and 
phenotype (Gibson et al., 1985, Holt et al., 1986). The first enzyme solution we used 
contained a mixture of collagenase type II and collagenase type IV. Although 
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Lefrancois and Lycke reported that the use of collagenases, without other additional 
enzymes, gives the best final yield of live lamina propria lymphocytes (Lefrancois 
and Lycke, 2001), our sample which was digested in just collagenases contained the 
highest number of dead cells and undigested tissue. This indicated that the enzyme 
concentration was not high enough to digest all the tissue and also that the enzyme 
combination was toxic to the cells. Other researchers (Pavli, 2001, Weigmann et al., 
2007) suggested the use of collagenase D as an enzyme of choice, together with 
dispase and DNase. Collagenase D has high collagenase activity and very low tryptic 
activity while dispase is a neutral protease suitable for a gentle dissociation of tissue 
while preventing unwanted cell clumping. DNase is also reported to reduce cell 
clumping. In our hands this enzyme combination reduced the number of dead cells; 
however the digestion was still incomplete with the highest amount of undigested 
tissue. This may be due to the low concentration of enzymes used or the short 
incubation time. Since our cell viability increased using this combination we did not 
want to increase the concentration of enzymes and therefore risk the viability. 
Instead, we incubated the tissue for 40min or 60min and replaced the digestion 
solution with a fresh one every 20min. This, however, did not improve tissue 
digestion. Platt et al. used a similar combination of enzymes with the addition of 
collagenase V and were able to obtain a higher cell number than with the use of only 
dispase and DNase. Addition of the collagenase V to our digestion solution also 
improved the tissue digestion without a decrease in the cell viability. Therefore the 
digestion solution which contained collagenase D, dispase and Dnase, with the 
addition of collagenase V was used throughout the study.  
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In order to improve the removal of dead cell and debris we utilised the property of 
Percoll medium to form a gradient during centrifugation and separate cells based on 
their size and granularity. In agreement with others (Weigmann et al., 2007) we 
found a 40% over 80% Percoll gradient to be the best in the enrichment of a viable 
population, however it was at the expense of cell numbers. When we left out the 
Percoll step the cell number markedly increased. Lefrancois and Lycke also reported 
that a Percoll gradient purification usually resulted in the loss of approx 50% cells 
(Lefrancois and Lycke, 2001). This may be due to cell clumping in the Percoll 
medium resulting in the sedimentation of cells at the bottom of the tube where they 
are mistaken for debris. Also, in some cases, thin layer of cells between gradients 
were almost invisible making it difficult to extract all the cells from the layer. 
Although the Percoll step had a benefit in the early stages of the optimisation, when 
our sample contained high amount of cell debris and undigested tissue, the improved 
digestion solution resulted in a single cell suspension with the highest viability and 
the Percoll gradient centrifugation could be left out. Furthermore leaving out the 
Percoll step shortened the isolation procedure which, in turn, also increased the cell 
viability.   
 
Once we optimised the digestion procedure, we next assessed two different 
techniques for cell purification; magnetic separation and fluorescence-activated cell 
sorting. Both techniques are widely used and rely on the labelling of cells of interest 
with antibodies in order for them to be purified. In the first method the appropriate 
cells are magnetically labelled and retained in the magnetic field to be separated 
from the rest of the population. The second method is separation of cells based on 
their fluorescent marker using a specialised flow cytometer. We experienced 
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difficulties using the magnetic separation method as the separated fraction 
consistently had low purity and viability. Flow cytometric analysis showed high 
numbers of dead, non-macrophage cells present in the sample after the purification. 
We demonstrated that this was most likely due to unspecific binding of the magnetic 
beads to dead cells since they tend to be quite sticky. In order to remove the dead 
cells from the sample we used the Miltenyi Dead Cell Removal MicroBeads which 
recognise the antigen in the plasma membrane of apoptotic and dead cells and bind 
to it. Although magnetically labelled dead cells were supposed to be retained in the 
magnetic column and depleted in that way, we found that after the use of the kit the 
purified sampled contained only dead cells. It is possible that the amount of dead 
cells after the tissue digestion was too high and quickly saturated the column, 
resulting in the majority of dead cells passing through instead of being retained in the 
column. However, our sample contained only 10-15% dead cells after the digestion. 
It is more likely that the Miltenyi beads were not appropriate for use in the intestinal 
cell preparations since those cells tend to be much stickier than the cells obtained 
after the digestion of other tissue such as spleen, increasing the potential for 
unspecific binding of the beads. Other research groups we consulted experienced the 
same problem (personal communication). A cheaper and more user friendly method 
would be negative selection using magnetic beads, where everything but the cells of 
interest would be magnetically labelled and depleted from the sample; however there 
were currently no negative selection kits for the intestine on the market at the time of 
this study.    
 
The fluorescence-activated cell sorting proved to be a better method to purify 
intestinal macrophages, although the technique was more difficult to optimise.  Our 
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initial problem was low cell viability which we improved by using a specialised 
sorting solution with the addition of EDTA and HEPES. This decreased cell 
clumping and increased cell viability by keeping the pH in the optimal range. Based 
on the fluorescent properties and light scatter, we were able to visualise the 
population of interest on the flow cytometer, which was not an option while using 
magnetic separation. Also, we were able to distinguish between dead and live cells. 
Although the cell sorting was time consuming, better control of a population we 
wanted to collect, yielded samples with high cell purity and viability.  
  
Following the optimisation of the method for isolation and purification of colonic 
macrophages, we next characterised their phenotype and function. In agreement with 
previous studies (Rogler et al., 1998, Hirotani et al., 2005, Smith et al., 2011) our 
colonic macrophages showed low expression of the co-stimulatory molecules CD80 
and CD86, but high expression of MHC class II. Furthermore, we were able to detect 
low expression of TLR2 and TLR4, which concurs with findings from Platt et al. 
(Platt et al., 2010). Although it has been widely accepted that human intestinal 
macrophages do not express CD14 (Smith et al., 2001), it has been shown that CD14 
may be expressed at low levels intracellularly in murine colonic macrophages 
(Nakata et al., 2006b).  We however observed relatively high surface expression of 
CD14 on the colonic macrophages we isolated which is supported by a recent study 
of Mowat et al. who also reported that most mouse intestinal macrophages express 
high levels of this molecule (Bain and Mowat, 2011). We also examined the 
response of the colonic macrophages to stimulation with TLR ligands and showed 
that they do not respond to the TLR stimuli by producing pro-inflammatory 
cytokines or by up-regulating the expression of co-stimulatory molecules and other 
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innate immune receptors which are characteristics of these cells (Rogler et al., 1998, 
Hirotani et al., 2005, Smith et al., 2011). Furthermore, our colonic macrophages 
maintained avid phagocytic ability which has been previously reported (Smythies et 
al., 2005).  
 
During the study presented in this chapter, it has become obvious that F4/80 marker 
does not stain only macrophages in the colon, but also eosinophils (Mowat and Bain, 
2010). Since we did not include eosinophil marker, Siglec-F, or other newly 
described colonic macrophage markers (Bain et al., 2013) in our experiments, we 
adapted a new gating strategy in the attempt to define macrophage population more 
precisely. In our lamina propria suspension, F4/80
+
 cells were further gated based on 
their FSC and SSC properties to exclude eosinophils that have the forward and side 
scatter properties of granulocytes (Mowat and Bain, 2010). Although our samples 
still might contain some non-macrophage cells, we believe that the revised gating 
strategy improves the authenticity of our colonic macrophage population. This 
revised gating strategy was also employed later in the chapter 5.  
 
While colonic macrophages do not appear to respond to inflammatory stimuli their 
phenotype is significantly altered during the intestinal inflammation. It is not clear 
whether this is due to the loss of homeostatic factors that are usually present in the 
healthy intestine or due to the effects of newly produced inflammatory factors (Bain 
et al., 2013, Tamoutounour et al., 2012). However, during inflammation, intestinal 
macrophages display a pro-inflammatory phenotype with higher expression of co-
stimulatory molecules (Rugtveit et al., 1997a) and Toll-like receptors (Hausmann et 
al., 2002) as well as higher production of IL-12, TNF-α, IL-6 and other pro-
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inflammatory cytokines (Rugtveit et al., 1997b, Platt et al., 2010). To confirm that 
we also see these changes as well as to confirm again that we are isolating the correct 
population, we sorted and characterised colonic macrophages from mice from a 
dextran sulphate sodium (DSS) induced colitis model. DSS-induced colitis is a well-
established animal model of mucosal inflammation with similarities to human 
inflammatory bowel disease (Wirtz and Neurath, 2007). It is induced by the addition 
of DSS to drinking water and it is characterised by the weight loss, diarrhea, blood in 
stools, epithelial cell degeneration and infiltiration of immune cells into lamina 
propria and submucosa (Kullmann et al., 2001). As anticipated, colonic macrophages 
that we isolated from mice with DSS colitis showed higher expression of CD80 and 
TLR4 as well as increased production of pro-inflammatory cytokines.  
 
Taken together, the results from our phenotypic analysis demonstrate that we have 
isolated the cells from a mouse colon that resemble colonic macrophage population 
in phenotypic and functional characteristics as reported by other groups. The 
optimised isolation procedure can, therefore, be used to obtain colonic macrophages 
for future experiments.   
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4 CHAPTER 4 
CROSSTALK BETWEEN INTESTINAL 
EPITHELIAL CELLS AND 
MACROPHAGES 
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4.1 INTRODUCTION 
 
It is clear that macrophages in the intestine represent a unique population distinct 
from their counterparts in other tissues. All of their properties have developed in 
order to keep the balance between protective immunity and tolerance in the antigen-
rich environment of the gut. Although we now know that macrophages are critical 
for the maintenance of gut homeostasis (Qualls et al., 2006), it is still unclear how 
and when they acquire these homeostatic abilities.   
 
It has been speculated that intestinal macrophages originate from a special lineage of 
blood monocytes termed “resident” monocytes, which have homeostatic properties 
and home to noninflamed tissue, unlike “inflammatory” monocytes that home to 
inflamed tissue (Geissmann et al., 2003). However Varol et al showed that, in a 
mouse depleted of mononuclear phagocytes, adoptively transferred “resident” 
monocytes fail to replenish intestinal macrophages (Varol et al., 2009). On the 
contrary, they showed that intestinal macrophages are replenished by 
“inflammatory” monocytes. This was confirmed in the recent study by Bain et al. 
where they demonstrate that inflammatory blood monocytes migrate to the intestine, 
where they then differentiate into anti-inflammatory macrophages through a number 
of transitional stages (Bain et al., 2013). Since this plasticity happens only in the 
intestine, it is probable that the intestinal environment itself is responsible for 
altering the phenotype of inflammatory monocytes upon their arrival in the gut. 
 
Intestinal epithelial cells were once thought to be just a physical barrier that 
separates the luminal contents from the lamina propria. However, in addition to this 
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barrier function, there is increasing evidence to show that the intestinal epithelium 
has an immunomodulatory role, influencing underlying immune cells and shaping 
their function (Shale and Ghosh, 2009). This led to the characterisation of many 
pattern recognition receptors that are expressed by intestinal epithelium. Almost all 
Toll-like receptors (TLR) have been shown to be expressed at the mRNA level in the 
colon and small intestine (Wells et al., 2011). However signalling through these TLR 
in the healthy intestine does not promote inflammation. Rather TLR signalling in 
epithelial cells seems to be necessary for maintaining the intestinal homeostasis 
(Rakoff-Nahoum et al., 2004). In addition to that, epithelial cells also secrete various 
factors that can modulate the immune response in the intestine, such as antimicrobial 
peptides and chemokines (Wells et al., 2011). Furthermore, intestinal epithelial cells 
are capable of processing and presenting antigens through major histocompatibility 
complex (MHC) which enables their interactions with T cells, even in the healthy gut 
(Shale and Ghosh, 2009).  
 
Considering the above mentioned properties of intestinal epithelial cells and a 
strategic position of intestinal macrophages, just underneath the epithelium (Hume et 
al., 1984), we hypothesised that epithelial cells may play an important role in 
monocyte differentiation into intestinal macrophages. It has been shown already that 
the mucosal environment can change the ability of dendritic cells to mount an 
immune response. Culture of human monocyte-derived dendritic cells with epithelial 
cell supernatants resulted in the induction of non-inflammatory dendritic cells that 
favour the generation of a Th2 response (Rimoldi et al., 2005). Furthermore, co-
culture of monocyte-derived dendritic cells with Caco-2 intestinal epithelial 
monolayers resulted in dendritic cells with reduced expression of MHC class II, 
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CD86 and CD80 and reduced levels of inflammatory cytokine production (Butler et 
al., 2006). 
 
To test our hypothesis we wanted to establish a model which would partially mimic 
the environment to which monocytes are exposed, once they arrive in the gut. Since 
mouse epithelial cells are difficult to obtain and culture in vitro, we used a colonic 
epithelial cell line, CMT-93, which has an epithelial morphology and form junctional 
complexes and microvilli with attached glycoproteins (Franks and Hemmings, 
1978). We then exposed monocyte-derived macrophages J774A.1 to CMT-93 
supernatants in order to investigate whether the soluble factors secreted by colonic 
epithelial cells can induce differentiation of monocyte-derived macrophage into a 
tolerogenic phenotype resembling intestinal macrophages.  
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4.2 RESULTS 
4.2.1 Characterisation of a mouse colonic epithelial cell line, CMT-93 
In the in vitro system we established, we wanted to expose J774A.1 monocyte-
derived macrophages to soluble factors secreted by CMT-93 colonic epithelial cells. 
After this conditioning, we wanted to measure cytokine and chemokine production 
from those conditioned macrophages and compare them to the unconditioned 
macrophages. To ensure that any cytokine and chemokine levels detected are not 
present in CMT-93 supernatants itself, we measured the levels of cytokines and 
chemokines produced by this cell line in response to a panel of TLR ligands.   
 
4.2.1.1 CMT-93 cells do not produce cytokines in response to stimuli 
CMT-93 cells were plated on a 6-well plate, at 0.25x10
6
 cells/2ml, and left until they 
were confluent. Media was then discarded, fresh media added and the cells were 
stimulated with PAM3CSK4 (1 µg/ml), LPS (100ng/ml), Flagellin (5μg/ml), CpG 
(2μM) or medium alone as a control. After 24h supernatants were collected and the 
production of cytokines was measured by ELISA. 
We did not detect any TNF-α or IL-10 production from the control cells and the 
levels of other cytokines were low (<40pg/ml). There was no significant up-
regulation of cytokine production even after stimulation with a range of TLR ligands 
[Figure 4.1].  
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4.2.1.2 CMT-93 cells secrete MIP-2 and MCP-1 
The supernatants from the previous experiments were also used to measure the 
production of chemokines by CMT-93 cells. Production of MIP-1 was low and did 
not change following TLR stimulation, however there was a significant up-
regulation in the production of MIP-2 (p<0.001) and MCP-1 (p<0.001) in response 
to TLR2 (PAM) and TLR4 (LPS) ligation, but not in a response to TLR5 (Flagellin) 
or TLR9 (CpG) [Figure 4.2].  
 
4.2.1.3 CMT-93 cells express MHCII, TLR2 and TLR4 but do not up-regulate 
their expression following stimulation 
Epithelial cells throughout the intestine constitutively express major 
histocompatibility complex (MHC) class II (Hershberg et al., 1998) and TLRs 
(Abreu, 2010). We used flow cytometry in order to confirm the expression of these 
receptors on the CMT-93 cell line. 
CMT-93 cells were plated on a 6-well plate, at 0.25x10
6
 cells/2ml, and left until they 
were confluent. Media was then discarded, fresh media added and the cells were 
stimulated with PAM3CSK4 (1 µg/ml), LPS (100ng/ml), Flagellin (5μg/ml), CpG 
(2μM) or medium alone as a control. After 24h cells were collected and stained with 
fluorescently labelled antibodies against MHC class II, TLR2 and TLR4 and the 
expression of these markers was measured by flow cytometry. 
CMT-93 cells do express MHCII, TLR2 and TLR4, however the expression of these 
markers was unaffected by stimulation with a range of TLR ligands [Figure 4.3].  
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4.2.2 Conditioning with epithelial cell supernatants does not have a 
strong effect on surface marker expression, but modulates the 
production of TNF-α, MIP-1α and MIP-2 
In order to assess the effect of epithelial cell conditioning on macrophages, we 
started with a short 2h exposure of J774A.1 macrophages to CMT-93 supernatants.  
For flow cytometry studies macrophages were cultured for 2h in the unconditioned 
medium or CMT-93 conditioned medium. After 2 hours cells were stained with 
fluorescent antibodies against CD80, CD86, CD40, MHC class II, TLR2 and TLR4 
and their expression was measured on FACS Aria I flow cytometer. The histograms 
in Figure 4.4 show surface expression of each marker comparing macrophages in 
unconditioned and CMT-93 conditioned media. Conditioning for 2h did not have a 
strong effect on surface marker expression. There was only a slight down-regulation 
of MHC class II and TLR4 and no change in the expression of other surface markers 
we investigated.  
Supernatants from the same experiment were used to measure the production of 
cytokines and chemokines by J774A.1 macrophages. Conditioned macrophages 
produced significantly higher levels of TNF-α (p<0.01) with no change in production 
of IL-12p40, IL-6, IL-10 and IL-27 [Figure 4.5]. Conditioning also resulted in 
increased production of MIP-1α (p<0.01) and a decrease in MIP-2 (p<0.01) [Figure 
4.6].  
 
116 
 
4.2.3 CMT-93 conditioning alters the macrophage ability to mount the 
immune response to LPS 
When exposed to stimuli, such as lipopolysaccharide (LPS) from the outer 
membrane of Gram negative bacteria, macrophages elicit a strong inflammatory 
response (Adams and Hamilton, 1984). To explore whether the exposure to epithelial 
cell media has an effect on the ability of macrophages to mount such a response, we 
pre-conditioned J774A.1 macrophages with CMT-93 conditioned media for 2h 
before stimulating with LPS (100ng/ml). After 24h supernatants were collected to 
measure the production of cytokines and chemokines and the cells were stained with 
fluorescently labelled antibodies to measure the expression of surface markers by 
flow cytometry. 
In Figure 4.7 we demonstrate that the expression of CD86, CD80, CD40, MHCII, 
TLR2 and TLR4 surface markers is up-regulated following LPS activation, as 
expected. However, pre-conditioning of macrophages with epithelial cell media, 
resulted in a marked down-regulation of CD40, MHCII and TLR4 (dashed 
histograms). There was also a slight down-regulation of CD80 expression. 
Additional controls showing histograms of conditioned vs. conditioned LPS-
stimulated cells are added in Appendix F.  
The epithelial cell pre-conditioning also had an effect on the production of cytokines 
and chemokines by macrophages. LPS up-regulated the production of IL-12p40, 
TNF-α, IL-6, IL-10 and IL-27 cytokines [Figure 4.8] and MIP-1α, MIP-2 and MCP-
1 chemokines [Figure 4.9] from unconditioned cells, as expected. The conditioned 
macrophages, however, produced significantly lower amounts of IL-12p40 (p<0.01), 
IL-6 (p<0.001), IL-10 (p<0.001) and IL-27 (p<0.01), when exposed to LPS, but 
higher amounts of TNF-α (p<0.001) [Figure 4.8]. The production of MCP-1 was 
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also significantly down-regulated (p<0.01), however conditioning did not have any 
effect on the production of MIP-1α or MIP-2 [Figure 4.9].    
 
4.2.4 CMT-93 conditioning alters the macrophage ability to mount the 
immune response to different TLR ligands 
We have shown so far that epithelial cell conditioning alters the macrophage 
response to LPS, which is a TLR4 ligand. The strongest effect was the decrease in 
CD40, MHCII and TLR4 expression and the decrease in the production of pro-
inflammatory cytokines, except TNF-α which was increased [Figure 4.7 and Figure 
4.8]. We next wanted to investigate whether these effects are restricted solely to 
TLR4 ligation or if conditioning also affects the macrophage response to other TLR 
ligands. J774A.1 macrophages were, therefore, exposed to CMT-93 supernatants for 
2h before being stimulated with PAM3CSK4 (PAM; TLR2 ligand), Flagellin (TLR5 
ligand) or CpG (TLR9) ligand. After 24h, expression of surface markers and 
cytokine production were measured by flow cytometry and ELISA respectively.  
As shown in Figure 4.10 stimulation with PAM, Flagellin and CpG up-regulated the 
expression of CD40, CD80 and MHCII on unconditioned cells, as expected. This up-
regulation was suppressed on conditioned macrophages (dashed histograms), similar 
to the effects observed on conditioned LPS-stimulated macrophages [Figure 4.7]. 
The effects of conditioning on cytokine production were also similar to that observed 
from conditioned LPS-stimulated macrophages. Pre-conditioning with epithelial cell 
media significantly down-regulated the production of IL-12p40 (p<0.001) in 
response to PAM, Flagellin and Cpg and IL-6 (p<0.001) in response to PAM and 
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CpG. Pre-conditioning also significantly up-regulated the production of TNF-α 
(p<0.001) in response to PAM, Flagellin and CpG [Figure 4.11].  
 
4.2.5 Longer conditioning has a more potent effect on macrophage 
phenotype  
In order to investigate whether the length of time of conditioning further affects 
macrophage phenotype, we cultured J774A.1 macrophages with CMT-93 
supernatants for 2h, 6h and 24h. While 2h conditioning did not have a strong effect 
on the expression of CD80, CD40, MHCII and TLR4, these surface markers were 
markedly down-regulated following 24h conditioning [Figure 4.12]. Down-
regulation of CD40 was observed as early as the 6h time point. The longer 
conditioning time did not change the expression of CD86 and TLR2 [Figure 4.12].  
2h conditioning up-regulated the production of TNF-α and this effect was maintained 
after 6h and 24h conditioning (p<0.001) [Figure 4.13]. After 24h, conditioned 
macrophages showed reduced secretion of IL-12p40 (p<0.01), IL-6 (p<0.05) and IL-
27 (p<0.05), while the secretion of IL-10 was unaffected [Figure 4.13].  
The effect of conditioning on chemokine secretion was the same after 2h and 24h, 
with conditioned macrophages secreting more MIP-1α (p<0.01) and less MIP-2 
(p<0.01) [Figure 4.14].  
 
4.2.6 Longer conditioning affects macrophage response to stimuli 
Since the longer conditioning time resulted in a more potent effect on macrophage 
phenotype in a steady state, we next examined its effect on the macrophage response 
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to LPS. The LPS-induced expression of MHCII and TLR4 was decreased even after 
2h pre-conditioning and this was maintained after 24h. The LPS-induced increase of 
CD80 was decreased at 2h and more pronounced after 6h and 24h pre-conditioning. 
The LPS-induced CD40, however, was down-regulated after 2h pre-conditioning, 
but at the 6h and 24h time point it expression was similar to that of unconditioned 
cells [Figure 4.15]. Longer pre-conditioning did not affect the expression of CD86 
and TLR2 in response to LPS. Furthermore, a longer pre-conditioning time did not 
have a stronger effect on cytokine and chemokine production and profiles remained 
the same after 2h, 6h or 24h pre-conditioning, except for the production of IL-27 and 
MCP-1 [Figure 4.16 and 4.17]. IL-27 production, in response to LPS, was the same 
as that of unconditioned cells after 24h pre-conditioning [Figure 4.16]. On the other 
hand, cells that were pre-conditioned for 24h secreted more MCP-1 in response to 
LPS (p<0.05) [Figure 4.17]. 
 
4.2.7 Conditioned macrophages display enhanced phagocytic activity 
Phagocytosis and clearance of pathogens is a hallmark of macrophage function and 
while colonic macrophages are hypo-responsive, they maintain a strong phagocytic 
capacity (Smythies et al., 2005). Therefore we investigated the effect of CMT-93 
conditioning on macrophages’ ability to phagocytose.  
J774A.1 macrophages were cultured in the presence of conditioned or unconditioned 
media for 24h before we assessed their ability to phagocytose. When the 
phagocytosis was measured in response to stimuli, LPS was added for 24h following 
24h pre-conditioning. To measure phagocytosis fluorescent latex beads were added 
to the culture and macrophages were left to phagocytose for 2h. Cells were then 
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washed and the uptake of beads was measured by flow cytometry.  Cells that took up 
the beads showed green fluorescence which can be measured in the FITC channel of 
the flow cytometer and expressed as a percentage of phagocytosing cells. 
Conditioned macrophages show higher uptake rate than unconditioned macrophages, 
both in a steady state (49.2% phagocytes vs. 65.6% phagocytes after 2h 
conditioning, 49.2% vs. 61.5% after 6h conditioning and 49.2% vs. 59.5% after 24h 
conditioning) [Figure 4.18A] and in a response to LPS stimulation (58.8% 
phagocytes vs. 78.9% phagocytes after 2h pre-conditioning, 58.8% vs. 78.5% after 
6h pre-conditioning and 58.8% vs. 80.1% after 24h pre-conditioning [Figure 4.18B]. 
The rate of phagocytosis did not depend on the time of conditioning.  
 
4.2.8 Conditioned macrophages produce lower amounts of nitrite and 
reactive oxygen species  
Classically activated macrophages produce large quantities of inflammatory 
mediators such as nitric oxide (NO) and reactive oxygen species (ROS) in response 
to bacterial endotoxins. However, colonic macrophages do not generate a significant 
respiratory burst and nitric oxide production under the same conditions (Ikeda et al., 
1997, Mahida et al., 1989b). Therefore we measured the levels of NO and ROS on 
conditioned macrophages to investigate whether epithelial cell soluble factor also 
affect these parameters.  
To measure the NO levels, J774A.1 macrophages were cultured with conditioned or 
unconditioned media for 24h before being stimulated with LPS for another 24h. NO 
levels were then detected in the supernatants by measuring the production of nitrite 
(NO2
-
) which is a stable breakdown product of NO. Levels of nitrite from 
121 
 
unstimulated macrophages were undetectable, but following stimulation with LPS, 
macrophages produced high amounts of nitrite, as expected [Figure 4.19]. 
Conditioned macrophages produced significantly lower levels of nitrite in response 
to LPS, both after 6h (p<0.01) and 24h pre-conditioning (p<0.05) [Figure 4.19]. 
ROS levels were measured using the cell permeant reagent 2’,7’ – 
dichlorofluorescein diacetate (DCFDA), a fluorogenic dye that measures hydroxyl, 
peroxyl and other ROS activity within the cell. J774A.1 macrophages were 
conditioned as previously described and the fluorescent signal relative to 
intracellular ROS generation was then measured by flow cytometry and compared 
between unconditioned (black histograms) and conditioned cells (dashed 
histograms). Conditioning for 2h, 6h and 24h decreased the basal levels of ROS in 
unstimulated macrophages [Figure 4.20A]. The levels of ROS were also down-
regulated in conditioned macrophages in response to LPS [Figure 4.20B], however, 
while 6h conditioning was enough to decrease the ROS production from 
unstimulated macrophages, 24h pre-conditioning was necessary to detect the 
decrease of ROS in LPS-stimulated conditioned macrophages [Figure 4.20B].  
 
4.2.9 CMT-93 conditioning does not affect macrophage viability 
In order to show that conditioning with CMT-93 cell supernatants is not affecting 
macrophage viability and consequently their response to stimuli, J774A.1 
macrophages were incubated with either unconditioned media or CMT-93 
conditioned media for 24h. After 24h cells were stained with PI viability stain and 
the percentage of viable cells was determined by flow cytometry. Macrophages 
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conditioned with CMT-93 media showed the same viability as unconditioned 
macrophages [Figure 4.21A].  
Cell viability was also determined by the MTS assay that measures the bioreduction 
of MTS tetrazolium compound into a coloured formazan product. This reduction will 
happen only in the metabolically active cells and the quantity of formazan is directly 
proportional to the number of living cells in the culture. As shown in Figure 4.21B, 
conditioned macrophages did not exhibit reduced viability when compared to 
unconditioned macrophages.     
 
4.2.10  Conditioned macrophages do not exhibit increased caspase 
activity in response to TNF-α 
So far we have shown that macrophages conditioned with colonic epithelial cells 
media exhibit an anti-inflammatory phenotype. However, these macrophages 
produced significantly higher amounts of TNF-α than unconditioned controls, both 
in a steady state and in a response to TLR ligation [Figure 4.11, 4.13, 4.16]. The 
treatment of cells with TNF-α can lead to activation of caspase cascade involving 
caspase-8 and caspase-3, which can then induce apoptosis (Bradley, 2008) . To 
determine whether TNF-α has a same effect on conditioned and unconditioned cells, 
we incubated these cells with recombinant TNF-α (10ng/ml) for 24h and measured 
the activity of caspase-3. Caspase-3 activity was measured using the CellEvent 
Caspase-3/7 Green Detection reagent (Invitrogen) as described in Materials and 
methods section 2.10. The percentage of cells positive for active caspase-3/7 was 
determined by flow cytometry and expressed relative to control (unstimulated cells). 
Incubation of unconditioned cells with TNF-α led to an increased caspase-3/7 
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activity, as expected (p<0.05) [Figure 4.22]. Conditioning of cells protected against 
this with the activity of caspase-3/7 in conditioned cells similar to the control cells 
[Figure 4.22].  
 
4.2.11 Conditioned macrophages show higher expression of TNFR2 
The activities of TNF-α are mediated by two receptors, TNFR1 (p55) and TNFR2 
(p75) (Peschon et al., 1998). While signalling through TNFR1 usually activates pro-
inflammatory and apoptotic pathways, TNFR2 signalling is associated with more 
anti-inflammatory and immunoprotective effects of TNF-α (Bradley, 2008). 
Considering that TNF-α stimulation did not induce caspase-3 activation in 
conditioned cells, we wanted to investigate and compare the expression of TNF 
receptors on unconditioned and conditioned macrophages.  
J774A.1 macrophages were incubated with either unconditioned media or CMT-93 
conditioned media for 24h. After 24h macrophages were labelled with fluorescent 
antibodies against TNFR1 and TNFR2 and their expression was investigated by flow 
cytometry. Macrophages conditioned with CMT-93 cell media showed higher 
expression of TNFR2, but not TNFR1 (dashed histograms), compared to 
unconditioned control (black histograms) [Figure 4.23].  
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4.3 FIGURES 
 
 
Figure 4.1 Cytokine production from CMT-93 cells in response to stimulation 
with different TLR ligands CMT-93 cells were stimulated with PAM3CSK4 (1 
µg/ml), LPS (100ng/ml), Flagellin (5μg/ml), CpG (2μM) or medium alone as a 
control. After 24h supernatants were collected and cytokine secretion was measured 
by ELISA (R&D) according to manufacturer’s instruction. Data are representative of 
three independent experiments. Statistical significance for multiple comparisons was 
determined by one-way ANOVA followed by Newman-Keuls analysis. 
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Figure 4.2 Chemokine production from CMT-93 cells in response to stimulation 
with different TLR ligands CMT-93 cells were stimulated with PAM3CSK4 (1 
µg/ml), LPS (100ng/ml), Flagellin (5μg/ml), CpG (2μM) or medium alone as a 
control. After 24h supernatants were collected and chemokine secretion was 
measured by ELISA (R&D) according to manufacturer’s instruction. Data are 
presented as mean ± SEM of three replicates and are representative of three 
independent experiments. Statistical significance for multiple comparisons was 
determined by one-way ANOVA followed by Newman-Keuls analysis. ***P<0.001 
vs. control 
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Figure 4.3 Expression of surface markers on CMT-93 cells in response to stimulation with different TLR ligands CMT-93 cells were 
stimulated with PAM3CSK4 (1µg/ml), LPS (100ng/ml), Flagellin (5μg/ml), CpG (2μM) or medium alone as a control. After 24h cells were 
stained with fluorescently labelled antibodies and the expression of surface markers was measured by flow cytometry. Histograms show surface 
marker expression of unstimulated control cells (black line) compared to TLR-ligand stimulated cells (dashed line). Filled histograms represent 
fluorescence of unstained cells. Data are representative of three independent experiments. 
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Figure 4.4 Expression of surface markers on CMT-93 conditioned 
macrophages. J774A.1 macrophages were incubated with unconditioned medium or 
CMT-93 conditioned medium for 2h. After 2h conditioning cells were stained with 
fluorescently labelled antibodies for CD86, CD80, CD40, MHCII, TLR2 and TLR4 
and expression was measured by flow cytometry. Histograms show surface marker 
expression of conditioned cells (dashed line) compared to unconditioned control 
cells (black line). Filled histograms represent fluorescence of unstained cells. Data 
are representative of three independent experiments.  
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Figure 4.5 Cytokine secretion from CMT-93-conditioned macrophages. J774A.1 
macrophages were incubated with unconditioned medium or CMT-93 conditioned 
medium for 2h. After 2h supernatants were collected and cytokine secretion was 
measured by ELISA (R&D) according to manufacturer’s instruction. Data are 
presented as mean ± SEM of three replicates and are representative of three 
independent experiments. **P<0.01 vs. control, by unpaired t-test.  
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Figure 4.6 Chemokine secretion from CMT-93-conditioned macrophages. 
J774A.1 macrophages were incubated with unconditioned medium or CMT-93 
conditioned medium for 2h. After 2h supernatants were collected and chemokine 
secretion was measured by ELISA (R&D) according to manufacturer’s instruction. 
Data are presented as mean ± SEM of three replicates and are representative of three 
independent experiments. **P<0.01 vs. control, by unpaired t-test.  
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Figure 4.7 Expression of surface markers on CMT-93-conditioned macrophages 
following TLR4 ligation. J774A.1 macrophages were incubated with unconditioned 
medium or CMT-93 conditioned medium for 2h before adding LPS (100ng/ml). 
After 24h cells were stained with fluorescently labelled antibodies for CD86, CD80, 
CD40, MHCII, TLR2 and TLR4 and the expression was measured by flow 
cytometry. Histograms show the expression of a particular surface marker on 
unconditioned LPS-stimulated cells (black line) compared to conditioned LPS-
stimulated cells (dashed line). Unconditioned, unstimulated cells were used as a 
control (gray line) and filled histograms represent fluorescence of unstained cells. 
Data are representative of three independent experiments. 
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Figure 4.8 Cytokine secretion from CMT-93-conditioned macrophages 
following TLR4 ligation. J774A.1 macrophages were incubated with unconditioned 
medium or CMT-93 conditioned medium for 2h before adding LPS (100ng/ml). 
Unconditioned and conditioned, unstimulated cells were used as a control. After 24h 
supernatants were collected and cytokine secretion was measured by ELISA (R&D) 
according to manufacturer’s instruction. Data are presented as mean ± SEM of three 
replicates and are representative of three independent experiments. Statistical 
significance for multiple comparisons was determined by one-way ANOVA 
followed by Newman-Keuls analysis. ***P<0.001, **P<0.01 vs. 
unconditioned+LPS 
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Figure 4.9 Chemokine secretion from CMT-93-conditioned macrophages 
following TLR4 ligation. J774A.1 macrophages were incubated with unconditioned 
medium or CMT-93 conditioned medium for 2h before adding LPS (100ng/ml). 
Unconditioned, unstimulated cells were used as a control. After 24h supernatants 
were collected and chemokine secretion was measured by ELISA (R&D) according 
to manufacturer’s instruction. Data are presented as mean ± SEM of three replicates 
and are representative of three independent experiments. Statistical significance for 
multiple comparisons was determined by one-way ANOVA followed by Newman-
Keuls analysis. **P<0.01 vs. unconditioned+LPS 
133 
 
 
 
Figure 4.10 CMT-93 conditioning impairs up-regulation of surface markers on 
macrophages in response to different TLR ligands J774A.1 macrophages were 
incubated with unconditioned medium or CMT-93 conditioned medium for 2h 
before adding PAM3CSK4 (1µg/ml),  Flagellin (5µg/ml) or CpG (2µM) for 24h. 
Cells were then stained with fluorescently labelled antibodies for CD80, CD40 and 
MHCII and the expression was measured by flow cytometry. Histograms show the 
expression of surface marker on unconditioned cells stimulated with the appropriate 
TLR ligand (black line) compared to conditioned TLR ligand-stimulated cells 
(dashed line). Unconditioned, unstimulated cells were used as a control (gray line) 
and filled histograms represent fluorescence of unstained cells. Data are 
representative of three independent experiments. 
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Figure 4.11 CMT-93 conditioned macrophages have similar cytokine profile 
following ligation with different TLR ligands J774A.1 macrophages were 
incubated with unconditioned medium or CMT-93 conditioned medium for 2h 
before adding PAM3CSK4 (1µg/ml) (A), Flagellin (5µg/ml) (B) or CpG (2µM) (C) 
for 24h. 24h supernatants were collected and cytokine secretion was measured by 
ELISA (R&D) according to manufacturer’s instruction. Data are presented as mean 
± SEM of three replicates and are representative of three independent experiments. 
Statistical significance was determined by unpaired t-test. ***P<0.001 vs. 
unconditioned TLR ligand-stimulated cells.   
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Figure 4.12 Effects of longer conditioning on macrophage phenotype. J774A.1 macrophages were incubated for 2h, 6h or 24h with 
unconditioned media as a control or CMT-93 supernatants (conditioned) and analysed for the expression of surface markers by flow cytometry. 
Histograms show surface marker expression on unconditioned cells (black line) and conditioned cells (dashed line). Filled histograms represent 
fluorescence of unstained cells. Data are representative of three independent experiments. 
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Figure 4.13 Effects of longer conditioning on cytokine production J774A.1 
macrophages were incubated with unconditioned medium or CMT-93 conditioned 
medium for 2h, 6h or 24h. At the end of each time point supernatants were collected 
and cytokine secretion was measured by ELISA (R&D) according to manufacturer’s 
instruction. Data are presented as mean ± SEM of three replicates and are 
representative of three independent experiments. *P<0.05, **P<0.01, 
***P<0.001control vs. conditioned, determined by unpaired t-test.  
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Figure 4.14 Effects of longer conditioning on chemokine production J774A.1 
macrophages were incubated with unconditioned medium or CMT-93 conditioned 
medium for 2h, 6h or 24h. At the end of each time point supernatants were collected 
and chemokine production was measured by ELISA (R&D) according to 
manufacturer’s instruction. Data are presented as mean ± SEM of three replicates 
and are representative of three independent experiments. *P<0.05, **P<0.01 control 
vs. conditioned, determined by unpaired t-test.  
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Figure 4.15 Effects of longer conditioning on macrophage response to stimuli J774A.1 macrophages were incubated for 2h, 6h or 24h with 
unconditioned media or CMT-93 supernatants before being stimulated with LPS (100ng/ml) for 24h. Expression of surface markers was 
analysed by flow cytometry. Histograms show surface marker expression on unconditioned cells (black line) compared to conditioned cells 
(dashed line) following LPS stimulation. Grey line represents the expression on unstimulated controls. Filled histograms represent fluorescence 
of unstained cells. Data are representative of three independent experiments. 
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Figure 4.16 Effects of longer conditioning on cytokine production following 
TLR4 ligation J774A.1 macrophages were incubated for 2h, 6h or 24h with 
unconditioned media or CMT-93 supernatants before being stimulated with LPS 
(100ng/ml) for 24h. Supernatants were then collected and cytokine production was 
measured by ELISA (R&D) according to manufacturer’s instruction. Data are 
presented as mean ± SEM of three replicates and are representative of three 
independent experiments. **P<0.01, ***P<0.001 determined by unpaired t-test.  
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Figure 4.17 Effects of longer conditioning on chemokine production following 
TLR4 ligation J774A.1 macrophages were incubated for 2h, 6h or 24h with 
unconditioned media or CMT-93 supernatants before being stimulated with LPS 
(100ng/ml) for 24h. Supernatants were then collected and chemokine production was 
measured by ELISA (R&D) according to manufacturer’s instruction. Data are 
presented as mean ± SEM of three replicates and are representative of three 
independent experiments. *P<0.05 determined by unpaired t-test.  
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Figure 4.18 Conditioned macrophages display enhanced phagocytic activity. 
J774A.1 macrophages were incubated with unconditioned media or colonic epithelial 
cell supernatants for 2h, 6h or 24h (A). Pre-conditioned cells were stimulated with 
LPS (100ng/ml) for 24h (B). To assess phagocytic ability of cells, 1µm fluorescent 
latex beads (Sigma) were added to the culture and macrophages were left to 
phagocytose for 2h. Cells were then washed and analysed by flow cytometry for the 
uptake of beads. Histograms show the percentages of cells that contain beads 
(phagocytes) or do not contain beads (non-phagocytes). Percentage of cells 
containing beads is additionally highlighted on each histogram. Data are 
representative of three independent experiments. 
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Figure 4.19 Conditioned macrophages produce lower amounts of nitrite in 
response to LPS stimulation J774A.1 macrophages were pre-conditioned with 
colonic epithelial cell media for 2h, 6h or 24h before being stimulated with LPS 
(100ng/ml) for 24h. The concentration of nitrite in supernatants was determined 
spectrophotometrically using Griess reagent. Data are presented as mean ± SEM of 
three replicates and are representative of three independent experiments. *p<0.05, 
**p<0.01 determined by unpaired t-test. 
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Figure 4.20 Conditioned macrophages produce lower levels of reactive oxygen 
species (ROS) in a steady state and in response to LPS stimulation. J774A.1 
macrophages were incubated with unconditioned media or CMT-93 supernatants for 
2h, 6h or 24h (A). After pre-conditioning, cells were stimulated with LPS 
(100ng/ml) for 24h (B). To measure the production of reactive oxygen species, cell 
were labelled with DCFDA (Abcam), acording to manufacturer’s instructions, and 
the fluorescent signal relative to intracellular ROS generation was then measured by 
flow cytometry and compared between unconditioned cells (black line) and 
conditioned cells (dashed line). Data are representative of three independent 
experiments. 
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Figure 4.21 CMT-93 conditioning does not affect macrophage viability J774A.1 
macrophages were incubated with unconditioned or CMT-93 conditioned media. 
After 24h cells were labelled with Propidium-iodide (Miltenyi) staining and the 
percentage of viable cells was determined by flow cytometry (A). Cell viability was 
also measured using the MTS assay (Promega) and is expressed as a percentage of 
the control (unconditioned) cells (B). Data are representative of three independent 
experiments. 
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Figure 4.22 Conditioned macrophages do not exhibit increased caspase activity 
in response to TNF-α. J774A.1 macrophages were incubated with conditioned or 
unconditioned media for 24h and then stimulated with the recombinant TNF-α 
(10ng/ml) for another 24h. Cells were then labelled with CellEvent Caspase-3/7 
Green Detection Reagent (Invitrogen), according to manufacturer’s instructions. The 
percentage of cells positive for active caspase-3/7 was determined by flow cytometry 
and expressed relative to control (unstimulated cells). Data are presented as mean ± 
SEM of three replicates and are representative of two independent experiments. 
*p<0.05 vs. control, determined by unpaired t-test.  
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Figure 4.23 Epithelial cell conditioning is increasing the expression of TNFR2. 
J774A.1 macrophages were incubated with conditioned or unconditioned media for 
24h. After 24h the cell were stained with fluorescent antibodies against TNF-
receptor 1 (TNFR1) and TNF-receptor 2 (TNFR2) and their expression was analysed 
by flow cytometry. Histograms show the expression of receptors on unconditioned 
cells (black line) compared to conditioned macrophages (dashed line). Data are 
representative of three independent experiments. 
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4.4 DISCUSSION 
 
Macrophages in the intestine are continuously replenished from inflammatory blood 
monocytes which change their phenotype upon the arrival in the gut (Varol et al., 
2009, Bogunovic et al., 2009). Through a number of differentiation stages, 
inflammatory monocytes lose their pro-inflammatory features and develop into a 
non-inflammatory subset that helps to maintain gut homeostasis (Bain et al., 2013). 
It is still unclear what is driving these changes; however, given its importance as a 
first line of defence between the gut microbiota and immune cells, it is most likely 
that the epithelium has a major role in this process. The main goal of this chapter 
was, therefore, to investigate whether the soluble factor secreted from colonic 
epithelial cells can alter macrophage phenotype into a phenotype resembling colonic 
macrophages.  
 
Macrophages conditioned with epithelial cell media showed altered expression of 
cell surface receptors involved in the immune response. We observed decreased 
expression of CD40 and CD80 co-stimulatory molecules, as well as MHCII and 
TLR4, on steady-state macrophages following conditioning. Conditioned 
macrophages also showed impaired sensitivity to LPS with a decrease in expression 
of TLR4 in response to this ligand. Furthermore, they almost completely switched 
off the TLR-induced up-regulation of CD80 and MHC class II. Development of a 
hypo-responsive phenotype following conditioning was also observed when we 
examined the production of cytokines. Conditioned macrophages, in a steady-state 
and in response to LPS, showed significantly lower production of pro-inflammatory 
IL-12p40 and IL-6. Low expression of co-stimulatory molecules, low cytokine 
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secretion, as well as the inability to mount an immune response to bacterial ligand, 
are all characteristics of colonic macrophages as we discussed and demonstrated in 
chapter 3. Interestingly, although some changes occurred even after a short 2h 
exposure to epithelial cell supernatants, longer conditioning had a more potent 
modulatory effect and macrophages developed a more pronounced anti-
inflammatory phenotype when exposed to the epithelial cell media for longer. This 
gradual transition into an anti-inflammatory macrophage is also observed in vivo. 
Bain et al. showed that inflammatory monocytes, once they arrive in the gut, slowly 
lose their inflammatory characteristics and become TLR hypo-responsive resident 
macrophages over a period of 24-48h (Bain et al., 2013).  
 
Reduced production of IL-12p40 has also been observed by other groups after they 
exposed monocyte-derived dendritic cells to human intestinal epithelial cell line, 
Caco-2, supernatants (Rimoldi et al., 2005, Butler et al., 2006). The same groups 
reported down-regulation of co-stimulatory molecules on dendritic cells following 
conditioning, which correlates with our findings. However, while other groups 
concentrated only on these parameters, we also investigated the effects of epithelial 
cells on chemokine production and macrophage function, such as phagocytosis. 
Conditioning with epithelial cell media significantly increased the production of 
MIP-1α chemokine from unstimulated macrophages and MCP-1 from LPS-
stimulated macrophages. Intestinal macrophages also produce MCP-1 as has been 
shown by Takada et al. The same study showed that intestinal macrophages from 
MCP
-/- 
mice produce lower amounts of IL-10 compared to WT mice (Takada et al., 
2010) which supports the homeostatic role of this chemoattractant in the intestinal 
environment. MIP-1α is important for the recruitment of eosinophils and neutrophils 
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(Cook, 1996), but also regulates various aspects of tissue homeostasis, such as stem 
cell development and angiogenesis (Menten et al., 2002). Contrary to our previous 
understanding that eosinophils appear in the intestine only in a rare parasitic 
infections, recent studies show unexpectedly large amounts of eosinophils in 
preparations from healthy small intestine and colon (Mowat and Bain, 2010). It is 
speculated that they may contribute to epithelial renewal and barrier integrity in the 
gut or may even be a source of the conditioning factors that maintain local 
macrophage hypo-responsiveness (Blanchard and Rothenberg, 2009, Mowat and 
Bain, 2010). If that is the case, the up-regulated production of eosinophil-recruiting 
chemokines that we report after epithelial cell conditioning may suggest a 
mechanism that supports intestinal homeostasis.  
 
Phagocytosis is the hallmark of macrophage function. It is vital for the clearance of 
infectious pathogens as well as apoptotic cells (Aderem and Underhill, 1999). 
Colonic macrophages have been shown to be highly phagocytic even though they do 
not activate an immune response following phagocytosis (Smythies et al., 2005). 
Here we show that the phagocytic ability of macrophages is enhanced following 
conditioning with epithelial cell supernatant. Macrophages cultured in the presence 
of epithelial cell media increased their intake of fluorescent beads, both in a steady-
state and after LPS stimulation. However, although our conditioned macrophages 
became highly phagocytic they did not demonstrate any increase in their respiratory 
burst capacity and nitric oxide production, which would typically accompany 
phagocytic activity. This further suggests that conditioning the macrophages with 
epithelial cell media induces a similar phenotype to that of a colonic macrophage, as 
intestinal macrophages isolated from normal, non-inflamed human colonic mucosa 
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do not show significant respiratory burst (Mahida et al., 1989b) neither do they 
express inducible nitric-oxide synthase (Ikeda et al., 1997).  
 
It has been shown in several studies that intestinal macrophages produce the anti-
inflammatory cytokine IL-10 (Denning et al., 2007, Hadis et al., 2011). However, 
we failed to observe induction of IL-10 following conditioning. Increased IL-10 
production was also not observed in the study by Rimoldi et al. where they 
conditioned dendritic cells with Caco-2 supernatants (Rimoldi et al., 2005), therefore 
it is possible that IL-10 production depends on different factors and it is not induced 
by epithelial cell priming. A study by Ueda et al. showed that IL-10 production is 
dependent on the presence of commensal microbiota and that colonic macrophages 
isolated from germ-free mice produce lower levels of IL-10 (Ueda et al., 2010). 
Zeuthen et al. also investigated the effects of Gram positive (G+) and Gram negative 
(G-) commensals on Caco-2 conditioned dendritic cells and showed that IL-10 is 
increased following encounter will G+ bacteria, but decreased upon encountering G- 
bacteria (Zeuthen et al., 2008). Use of LPS in our study, which is a major component 
of the outer membrane of G- bacteria, may therefore explain a decrease of IL-10 
following conditioning. This is supported by our finding that epithelial cell 
conditioning did not alter IL-10 expression from unstimulated macrophages.  
 
Considering that conditioned macrophages exhibited primarily anti-inflammatory 
properties, we were surprised with the finding that both unstimulated and LPS-
stimulated conditioned macrophages had significantly increased production of TNF-
α. TNF-α is usually seen as a potent pro-inflammatory cytokine implicated in various 
autoimmune and inflammatory diseases, such as rheumatoid arthritis, psoriasis, 
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Crohn’s disease, sepsis, diabetes and obesity (Plevy et al., 1997, Brennan et al., 
1992, Clark, 2007). Binding of TNF-α to its receptors can, in some conditions, 
initiate a caspase cascade, involving caspase-8 and caspase-3 activation, which leads 
to apoptosis and cell death (Bradley, 2008, Rath and Aggarwal, 1999). Interestingly, 
while activation of unconditioned macrophages with recombinant TNF-α did induce 
caspase-3 activation, our conditioned cells had the same levels of active caspase-3 as 
unstimulated controls. Additional controls are needed to investigate whether this 
protects the cell against apoptosis. Pro-survival effects of TNF-α have been 
documented before. TNF-α actually shows a remarkable functional duality, being 
engaged both in tissue regeneration and destruction (Wajant et al., 2003). For 
example, in tuberculosis TNF-α is responsible for the extensive tissue destruction, 
fibrosis and the formation of cavities (Mootoo et al., 2009). On the other hand, TNF-
α has been found to stimulate proliferation of gastric epithelial cells during ulcer 
repair (Luo et al., 2005). A dual role for TNF-α has also been implicated during 
experimental autoimmune encephalomyelitis (EAE), a murine model of multiple 
sclerosis. In the acute phase of the disease TNF-α has a detrimental activity, while in 
the later phase it is actually responsible for a spontaneous regression of EAE 
(Kassiotis and Kollias, 2001). 
  
This dual role of TNF-α seems to be dependent on the specific TNF receptor 
signalling. The activities of TNF-α are mediated by two receptors, TNF-R1 (p55) 
and TNF-R2 (p75) (Peschon et al., 1998). TNFR1 is constitutively expressed in most 
tissue, whereas TNFR2 is usually found in cells of the immune system (Wajant et 
al., 2003). Although their mechanisms have not been completely elucidated, it seems 
that they have opposing effects. The pro-inflammatory and apoptotic pathways of 
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TNF-α are largely mediated through TNFR1, while TNFR2 has been shown to 
mediate signals that promote proliferation and tissue repair (Bradley, 2008). In a 
mouse model of retinal ischemia TNFR2 protected against ischemic tissue 
destruction (Fontaine et al., 2002) and it also proved to be cardioprotective in an in 
vivo heart failure model in mice (Hamid et al., 2009). In the same studies, signalling 
through the TNF-R1 showed opposite effects, supporting the disease progression. 
With this in mind, we hypothesised that TNF-α does not activate caspase in 
conditioned macrophages because it somehow favours the protective TNFR2 
pathway. In order to explore that, we investigated the expression of TNF receptors 
on unconditioned and conditioned cells. Indeed, macrophages conditioned with 
colonic epithelial cell media showed higher expression of TNFR2.  
 
Recent studies show that, contrary to popular belief, colonic macrophages do 
produce TNF-α in a steady-state (Bain et al., 2013, Mowat, 2011). This production, 
however, does not lead to inflammation. It has been speculated that it is counteracted 
by the secretion of IL-10 from the same macrophages or maybe it is “extinguished” 
by some other anti-inflammatory products secreted from the surrounding cells 
(Mowat, 2011). So far, our data show that exposure to epithelial cell-derived factors 
results in the development of an anti-inflammatory macrophage that resembles the 
intestinal macrophage phenotype. Also, conditioning up-regulates the expression of 
TNFR2. Taken this into account, we hypothesise that maybe there is a high 
expression of TNFR2 on colonic macrophages, which has a role in limiting the pro-
inflammatory effect of TNF-α while potentiating its homeostatic function, such as 
organogenesis of secondary lymphoid tissue of the intestine (Kuprash et al., 1999) 
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or/and macrophage proliferation and differentiation (Guilbert et al., 1993, Witsell 
and Schook, 1992).  
 
Taken together, our data suggests that colonic epithelial cell-derived factors play a 
key role in monocyte differentiation into intestinal macrophages. It also implicates 
the role of TNFR2 as a possible mechanism by which macrophages maintain gut 
homeostasis. It is important to note that intestinal epithelial cells in vivo exist in a 
polarised state, divided into an apical and basolateral domain with a distinct protein 
and lipid composition (Pott and Hornef, 2012). The secretion of soluble factors 
produced by epithelial cells can vary between the apical and the basolateral side, 
with some factors being predominantly trafficked just to the one side (Yakovich et 
al., 2010). In our model we have not grown CMT-93 cells in polarising conditions, 
therefore this vectorial nature of soluble factor release was not taken into account. In 
order to fully elucidate the effect of epithelial cell soluble factors on macrophage 
phenotype CMT-93 cells should be grown on transwell plates, as described by Iliev 
et al, and conditioning experiments should be repeated with apical and basolateral 
secretions separately (Iliev et al., 2009).  
 
In the next chapter we move into the in vivo models of gut inflammation and 
infection, in order to confirm the hypothesis of the importance of TNFR2 on colonic 
macrophages and to attempt to elucidate the role of TNFR2 on colonic macrophages 
in homeostasis and disease.   
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5 CHAPTER 5 
THE ROLE OF MACROPHAGE TNFR2 IN 
THE GUT 
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5.1 INTRODUCTION 
 
In the previous chapter we show the development of an anti-inflammatory phenotype 
in macrophages, induced by colonic epithelial cell soluble factors. With low 
production of pro-inflammatory cytokines and other pro-inflammatory mediators, 
inertia when exposed to stimuli, but with high phagocytosis, these macrophages 
resemble colonic macrophages. However, even though they display an anti-
inflammatory phenotype, conditioned macrophages still produce TNF-α. This was 
confusing as TNF-α is usually seen as a pro-inflammatory cytokine involved in 
disease induction (Clark, 2007). Furthermore, these macrophages also seem to have 
decreased caspase-3 activity following TNF stimulation and have higher expression 
of TNFR2 than control macrophages. This data, together with the fact that colonic 
macrophages also produce TNF-α (which was speculated before (Nakata et al., 
2006a), and confirmed recently (Bain et al., 2013)) lead us to believe that there 
might be a non-inflammatory role for TNF-α in intestinal homeostasis and that it 
might be regulated by TNFR2.  
 
TNF-α is a pleiotropic cytokine produced by many different cell types, but mostly 
monocytes and macrophages (Parameswaran and Patial, 2010). It exerts a broad 
range of biological effects, including cell activation and migration, cell proliferation, 
differentiation and apoptosis (Tracey and Cerami, 1993) and it has a well-
characterised role in the pathogenesis of various inflammatory diseases (Plevy et al., 
1997, Brennan et al., 1992). However, apart from the pro-inflammatory role, 
increasing evidence points to anti-inflammatory properties of TNF-α. In the mouse 
model of multiple sclerosis, TNF-α has been shown to be involved in resolution of 
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disease (Kassiotis and Kollias, 2001). Furthermore, TNF-α treatment also 
significantly increased epithelial cell proliferation and repair during ulcer healing 
(Luo et al., 2005).  
 
All known responses to TNF are triggered by binding to two different receptors, 
TNFR1 and TNFR2. These receptors are differentially expressed within the body 
with TNFR1 being expressed on almost all cell types while TNFR2 expression is 
restricted to endothelial cells and immune cells, especially monocytes and 
macrophages (Tartaglia and Goeddel, 1992, Aggarwal, 2003). Both TNFR1 and 
TNFR2 possess sequences that bind to intracellular adaptor proteins and in that way 
link stimulation of receptor to activation of various signalling processes. It has been 
shown that TNFR1 is primarily responsible for initiating inflammatory responses 
(vanderPoll et al., 1996). However, the intracellular region of TNFR1 can also 
interact with a complex of apoptosis-related proteins giving TNFR1 the ability to 
induce cell death (Van Herreweghe et al., 2010). Activation of TNFR2, on the other 
hand, has been shown to be needed for clonal expansion of T-cells in response to 
intracellular bacterial pathogens (Kim et al., 2006) and for the resolution of 
pulmonary inflammation after bacterial challenge (Peschon et al., 1998). However, 
opposite roles were also reported for both receptors with TNFR1 being essential to 
protect mice against tuberculosis and Toxoplasma gondii (Flynn et al., 1995a, 
Deckert-Schluter et al., 1998) while TNFR2 signalling induced the development of 
renal injury in a model of glomerulonephritis (Vielhauer et al., 2005). This is further 
complicated by the fact that both receptors share part of their pathway and TNFR2 
can actually pass the TNF ligand to TNFR1 (Tartaglia et al., 1993).   
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In this chapter we, therefore, sought to investigate the role of TNFR2 on colonic 
macrophages. Firstly we wanted to determine whether TNF receptors are expressed 
on colonic macrophages in homeostasis and then investigate the role of TNFR2 in 
vivo using animal models of disease and in vitro using specific antagonistic 
antibodies to TNFR1 and TNFR2.  
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5.2 RESULTS 
5.2.1 Colonic MØ have higher expression of TNFR2 than peritoneal MØ 
In order to investigate if colonic macrophages express TNFR2 and whether this 
expression is higher than on macrophages from other tissue, we isolated and 
compared macrophage population from the colonic lamina propria and from the 
peritoneal cavity. The peritoneal cavity provides an easily accessible site for the 
harvesting of moderate numbers of resident, non-manipulated macrophages. Unlike 
colonic macrophages, peritoneal macrophages respond to stimulation, produce pro-
inflammatory cytokines and have high expression of co-stimulatory receptors 
(Marcinkiewicz, 1991, Wang et al., 2013a).  
Lamina propria cells and resident peritoneal cells were isolated as described in 
Materials and methods (section 2.12) and stained for the F4/80 macrophage marker 
and two TNF-α receptors, TNFR1 and TNFR2. Cells were gated based on their size 
and granularity (FSC; SSC) and doublets and dead cells were excluded from the 
analysis. Expression of TNFR1 and TNFR2 was then analysed on live F4/80
+ 
cells. 
As we can see in Figure 5.1 colonic macrophages show much higher expression of 
TNFR2 than peritoneal macrophages.  
 
5.2.2 Mouse models of disease 
In order to investigate the potential role of TNFR2 in disease we used two different 
mouse models; DSS-induced colitis which is a model of intestinal inflammation and 
Clostridium difficile -associated model of intestinal infection.   
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5.2.2.1 Clinical assessment of DSS-induced colitis 
 
The DSS model was carried out in collaboration with Dr. Silvia Melgar in the 
Alimentary Pharmabiotic Centre, University College Cork, as described in Materials 
and methods (section 2.13). To assess the development of the disease, mice were 
weighed and scored (every 3-4 days) for disease activity index (DAI) based on stool 
composition, fur texture and posture. As expected, control mice maintained a healthy 
weight gain during study [Figure 5.2A]. DSS treated groups immediately started to 
lose weight, with the biggest weight loss at day 7. Following this, mice started to 
recover and the chronic group returned to their normal weight by the day 26 [Figure 
5.2A]. The DAI showed a similar pattern of a disease progression. No disease 
activity was observed in the control mice, while there was a rapid increase in the 
disease activity scores in all DSS treated groups, with mild recovery in chronic group 
by the end of the study [Figure 5.2B]. At each end point, colons were removed, 
measured and weighed. The weight and length of the colon are useful indicators of 
disease progression as the cell infiltration and inflammation increase the weight of 
the colon and also shrink the colon length (Okayasu et al., 1990a). As we can see in 
Figure 5.2C and D colons from the early (p<0.01) and late (p<0.05) acute group 
were significantly shorter than control, with a recovery in the chronic group. Also, 
there was an increase in colon weight in all the DSS treated groups (p<0.05) [Figure 
5.2E].  
Small sections of distal colon (0.5cm) were removed for histology and stained with 
hematoxylin and eosin (H&E), as described in Materials and methods section 2.13.3. 
The H&E staining of control shows a healthy colon with crypts and goblet cells 
present [Figure 5.3]. In the early and late acute phase we can see a visible reduction 
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in goblet cells, together with loss of crypts and infiltration of inflammatory cells to 
the mucosa [Figure 5.3]. The chronic group shows recovery with the regeneration of 
crypts and re-epithelisation, consistent with the rest of the data [Figure 5.3].   
 
5.2.2.2 Expression of TNF receptors on colonic MØ at different stages of DSS 
colitis 
 
Lamina propria cells were isolated from the colons of healthy mice and mice treated 
with DSS in early acute (day 7), late acute (day 12) and chronic phase (day 26) of 
disease. Cells were then stained with fluorescent antibodies to determine the 
expression of TNF-receptors by flow cytometry. Cells were first gated based on their 
size (FSC) and granularity (SSC) and doublets and dead cells were excluded. 
Expression of TNF receptors was analysed on live F4/80
+
 cells. As shown in Figure 
5.4A colonic macrophages had decreased expression of TNFR1 in the early and 
acute phase of DSS colitis, which then returned to normal in the chronic phase. On 
the other hand, expression of TNFR2 was similar to control in the early and acute 
phase, while macrophages in the chronic phase had increased expression of TNFR2 
[Figure 5.4A].  
Colonic macrophages were sorted and mRNA was isolated using Nucleospin RNA II 
columns (Macherey-Nagel). The gene expression levels of TNFR1 and TNFR2 were 
quantified using qRT-PCR. The expression levels were normalised to 18S levels and 
the gene expression is shown as a fold change relative to the control. qRT-PCR data 
correlates with the protein expression with an increase in TNFR2 mRNA expression 
in the chronic phase (p<0.05) [Figure 5.4B]. Due to a low quality of mRNA isolated 
from the early acute phase, gene expression of TNF receptors in that phase could not 
be determined.  
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5.2.2.3 Expression of TNF receptors and TNF-α in the colonic tissue of DSS-
treated mice 
 
Small sections of distal colon from each mouse were removed and homogenised in 
order to extract mRNA. The levels of TNFR1, TNFR2 and TNF-α mRNA were 
quantified using qRT-PCR. The expression levels were normalised to 18S levels and 
the gene expression is shown as a fold change relative to the control. TNF-α was 
significantly up-regulated in the early acute stage of disease, with a 20-fold increase 
in the expression compared to control (p<0.001) [Figure 5.5]. Levels of TNF-α then 
decreased in the late and chronic phase, but they stayed higher than in the control 
(p<0.01 and p<0.05, respectively). A similar pattern was seen in the expression of 
TNFR1 and TNFR2, with the highest fold increase observed in the early acute phase 
(p<0.001) [Figure 5.5]. The expression of TNFR2 mRNA did not correlate with the 
expression of TNFR2 on colonic macrophages; however increase in the chronic 
phase is consistent [Figure 5.4]. This was not surprising as mRNA was isolated from 
the whole tissue and therefore represents the levels of TNFR2 from all the cells 
present in that tissue. TNFR2 is reported to be highly expressed on regulatory T-cells 
(Treg) (Chen et al., 2008b). Treg can be distinguished by the expression of 
transcription factor Foxp3, which is a key control gene in their development and 
function (Sakaguchi, 2005). To determine whether Treg contribute to the high 
TNFR2 expression in the acute phase of DSS colitis, we analysed the levels of 
Foxp3 mRNA in the colonic tissue. There was a 40-fold increase in the levels of 
Foxp3 during the early and acute phase of colitis, compared to control (p<0.01) 
[Figure 5.6]. In the chronic phase, however, the expression of Foxp3 was not 
significantly different than in the control. This indicates that the increase in TNFR2 
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mRNA in the chronic phase is not due to Treg and may be coming from 
macrophages.   
 
5.2.2.4 Clinical assessment of a mouse model of Clostridium difficile infection 
 
The C. difficile infection model was carried out in collaboration with Pat Casey in 
Alimentary Pharmabiotic Centre & Microbiology Department, University College 
Cork, as described in Materials and methods section 2.13. Two ribotypes (RT) of C. 
difficile were used, 001 and 027, as they differ in the severity of infection. RT 027 
has been described as a more virulent ribotype with higher toxin production and 
increased mortality (McDonald et al., 2005). To assess the development of a disease, 
mice were weighed daily and body weight change was monitored. As expected, 
control mice maintained a healthy weight gain during the study, while mice infected 
with both ribotypes showed a weight loss which peaked on day 3 post-infection 
[Figure 5.7A]. After day 3 mice started to recover with the group infected with RT 
001 recovering quicker than a group infected with RT 027. At day 3 and 7 caeca 
were harvested and the contents were removed for colony forming unit (CFU) 
counts. As expected, the RT 027 infected group had significantly higher numbers of 
C. difficile spores compared to the RT 001 group at day 3 (p<0.01) [Figure 5.7B]. 
Furthermore, at day 7, the RT 027 group still had high counts of C. difficile spores, 
unlike the RT 001 group (p<0.05).  
Small sections of distal colon (0.5cm) were removed for histology and stained with 
hematoxylin and eosin (H&E), as described in Materials and methods section 2.13.3. 
The H&E staining of the control shows a healthy colon, while there is a loss of 
crypts and infiltration of inflammatory cells present on day 3 in both ribotypes 
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[Figure 5.7C].  On day 7, recovery was seen in the RT 001 infected mice but not in 
the RT 027 infected mice, consistent with the rest of the data.   
 
5.2.2.5 Mice infected with 027 ribotype have slower recovery 
 
To investigate the progression of C. difficile infection, small sections of colonic 
tissue collected from RT 001 and RT 027 infected mice were homogenised in order 
to extract mRNA. The levels of the pro-inflammatory cytokines IL-12p40, IL-6 and 
TNF-α and the anti-inflammatory cytokine IL-10 were quantified using qRT-PCR.  
The levels of TNF-α peaked on day 3 in both groups, with 4 fold increase compared 
to control, and then returned to normal levels by the day 7 [Figure 5.8]. The levels 
of IL-6 appeared to be higher in mice infected with RT 001 on day 3, although this 
did not reach statistical significance between the two ribotypes. On day 7 IL-6 was 
significantly higher in the RT 027 group than in the RT 001 group (p<0.05) [Figure 
5.8]. The levels of IL-12p40 were low on day 3 in both groups, however by day 7 
production of IL-12p40 was significantly increased in the RT 027 group compared to 
the RT 001 group (p<0.05) [Figure 5.8]. Levels of the anti-inflammatory cytokine 
IL-10 peaked on day 7 and were significantly higher in mice infected with RT 001 
(p<0.05) [Figure 5.8].  
 
5.2.2.6 TNFR2 is up-regulated only in mice infected with 001 ribotype 
 
The levels of TNFR1 and TNFR2 mRNA were also quantified using qRT-PCR in 
both RT 001 and RT 027 infected mice. While the levels of TNFR1 did not change 
during 7 days of infection, TNFR2 was significantly up-regulated in the tissue of RT 
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001 infected mice on day 3, with a 3 fold difference in the expression compared to 
control (p<0.01) [Figure 5.9]. In the tissue of DSS infected mice the levels of Foxp3 
cells were high [Figure 5.6] and probably contributed to the high levels of TNFR2 
observed. To determine whether the TNFR2 levels in RT 001 infected mice were 
also due to Treg cells, we analysed the expression of Foxp3 mRNA. Foxp3, 
however, could not be detected in the tissue of C. difficile infected mice, indicating 
that TNFR2 comes from the innate immune cells.   
    
5.2.2.7 Colonic epithelial cells contribute to TNFR2 expression in vitro and in 
vivo 
 
In chapter 4 we showed that conditioning with colonic epithelial cells media 
modulates macrophage phenotype into an anti-inflammatory phenotype that 
resembles colonic macrophages. The conditioned macrophages also had an increased 
expression of TNFR2, but not TNFR1, which led us to believe that TNFR2 may be 
contributing to an anti-inflammatory role of colonic macrophages. To determine 
whether conditioned macrophages lose their anti-inflammatory phenotype when 
removed from epithelial cell environment, we conditioned cells for 24h and then 
split them into two groups. Group 1 was conditioned with fresh epithelial cell media 
for another 24h, while the group 2 was removed from conditioned media and 
cultured in unconditioned media for 24h. In Figure 5.10A we can see that 
conditioned macrophages (Group 1) showed an increase in TNF-α and MIP-1α 
production and a decrease in IL-6 production, as observed in chapter 4. They also 
showed decreased expression of CD80, MHCII and TLR4 and increased expression 
of TNFR2 [Figure 5.10B]. Interestingly, when removed from colonic epithelial cell 
media for 24h (Group 2), macrophages lost their anti-inflammatory phenotype and 
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started reverting into their unconditioned phenotype [Figure 5.10A and B]. 
Importantly, the high expression of TNFR2 was also lost [Figure 5.10B]. This 
suggests the importance of epithelial cell soluble factors in the regulation of TNFR2 
expression.     
If macrophages require “signals” from epithelial cells in order to up-regulate 
TNFR2, as we have seen in vitro, then in the case of intestinal inflammation when 
epithelial cell barrier is disrupted, those “signals” would be lost, hence TNFR2 up-
regulation would be disabled. The loss of epithelial barrier function is associated 
with the loss of the tight junction proteins, such as occludin (Mennigen et al., 2009). 
We, therefore, investigated the occludin levels in our animal disease models, to 
determine the level of epithelial cell disruption.  
As shown in Figure 5.11A mRNA expression of occludin in the tissue of DSS-
treated mice is down-regulated in the acute phase of colitis, with gradual recovery 
towards the chronic phase. Importantly, the recovery of epithelial cells correlates 
with the up-regulation of TNFR2 on colonic macrophages [Figure 5.4].  
In the C. difficile model of infection occludin mRNA is significantly down-regulated 
in mice infected with RT 027 on day 3 (p<0.01), but not in mice infected with RT 
001 [Figure 5.11B]. This may explain why mice infected with RT 027 do not show 
up-regulation of TNFR2, while RT 001 infected mice do [Figure 5.9]. This further 
supports the requirement of epithelial cell “signals” for TNFR2 up-regulation which 
is lost during the acute phase of DSS-colitis and during RT 027 infection, because of 
the epithelial cell disruption.  
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5.2.3 The effects of TNF receptor antagonists on cytokine secretion from 
unconditioned and conditioned macrophages 
In order to further examine the role of TNF receptor on macrophages, we used 
receptor blocking antibodies for TNFR1 and TNFR2, on both unconditioned and 
conditioned macrophages, and investigated their cytokine response in a steady state 
and after LPS stimulation.  
J774A.1 macrophages were cultured with conditioned or unconditioned media for 
24h before the addition of TNFR1 antagonist (5µg/ml; R&D) or TNFR2 antagonist 
(5µg/ml; Biolegend) for another 24h. Supernatants were then collected and the levels 
of cytokines were determined by ELISA (R&D). The isotype control antibody for 
TNFR2 antagonist (5μg/ml; Biolegend) was also added to a culture of macrophages 
to determine the specificity of the inhibitory effect (see Appendix G). Both TNFR1 
and TNFR2 blocking antibodies slightly decreased basal levels of anti-inflammatory 
IL-10, from unconditioned and conditioned macrophages [Figure 5.12 and 5.14]. 
TNF-α secretion was significantly up-regulated in response to TNFR1 (p<0.001) or 
TNFR2 (p<0.001) antagonist on unconditioned macrophages, with TNFR2 blocking 
antibody having a much stronger effect [Figure 5.12]. TNFR2 antagonist had the 
same effect on conditioned macrophages, significantly increasing TNF-α levels 
(p<0.001). TNFR1 antagonist however did not have an effect on conditioned 
macrophages [Figure 5.14]. TNF receptor antagonists did not have an effect on IL-
27 secretion from unconditioned macrophages [Figure 5.12]; however blocking 
TNFR2 signalling significantly down-regulated secretion of IL-27 from conditioned 
macrophages (p<0.05) [Figure 5.14]. Levels of IL-12p40 and IL-6 were also 
measured but they could not be detected.  
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To investigate the macrophage response to LPS in the presence of TNFR1 or TNFR2 
blocking antibodies, conditioned and unconditioned macrophages were pre-exposed 
to TNFR1 or TNFR2 antagonist for 1h before the addition of LPS (100ng/ml; Enzo 
Lifesciences). After 24h supernatants were harvested and cytokine levels were 
measured by ELISA (R&D). Both TNFR1 and TNFR2 blocking antibodies 
significantly down-regulated the LPS-induced production of IL-12p40 from 
unconditioned macrophages (p<0.001), with anti-TNFR2 having a slightly stronger 
effect [Figure 5.13]. The production of IL-12p40 on conditioned macrophages was 
however down-regulated only in a response to TNFR2 antagonist (p<0.001) [Figure 
5.15]. TNF-α levels significantly increased when TNFR2, but not TNFR1 signalling 
was blocked, in both unconditioned and conditioned macrophages (p<0.001) [Figure 
5.13 and 5.15]. LPS-induced secretion of IL-6 was down-regulated (p<0.001) and 
IL-10 up-regulated (p<0.001) in response to anti-TNFR1 on unconditioned 
macrophages [Figure 5.13]. LPS-induced IL-6 was also down-regulated in 
conditioned macrophages but in response to both TNFR1 and TNFR2 blocking 
antibodies (p<0.05 and p<0.01, respectively), not only TNFR1 [Figure 5.15]. While 
the TNFR1 and TNFR2 receptor antagonists did not have an effect on IL-27 
production from unconditioned macrophages [Figure 5.13], they significantly 
decreased IL-27 production from conditioned macrophages (p<0.05 and p<0.01, 
respectively) [Figure 5.15].  
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5.2.4 TNF receptor antagonists do not have an effect on surface marker 
expression 
Since the TNFR antagonists showed a strong effect on cytokine production from 
macrophages, we wanted to investigate whether they also affected the expression of 
macrophage surface markers.  
J774A.1 macrophages were incubated with unconditioned or conditioned media for 
24h before the addition of TNFR1 (5µg/ml; R&D) or TNFR2 (5µg/ml; Biolegend) 
blocking antibodies. After 24h cells were collected and stained with appropriate 
fluorescently labelled antibodies. The expression of CD86, CD80, CD40, MHCII, 
TLR2 and TLR4 was then analysed by flow cytometry. There was no change in the 
cell surface marker expression after the addition of the TNF receptor blocking 
antibodies [Figure 5.16 and 5.17].  
 
5.2.5 Phagocytosis is down-regulated in response to TNF receptor 
blocking antibodies 
To determine whether phagocytosis is affected if TNFR1 or TNFR2 receptors are 
blocked, conditioned and unconditioned macrophages were incubated with TNFR1 
(5µg/ml; R&D) or TNFR2 (5µg/ml; Biolegend) blocking antibodies for 24h. After 
24h fluorescent latex beads (20beads/cell; Sigma-Aldrich) were added to the culture 
and macrophages were left to phagocytose for 1h. The up-take of beads was then 
measured by flow cytometry. Phagocytosis was significantly down-regulated from 
both unconditioned (p<0.05) and conditioned (p<0.01) macrophages after the 
addition of TNFR2 blocking antibody [Figure 5.18]. Phagocytosis of conditioned 
macrophages was also affected if we blocked TNFR1 (p<0.01) [Figure 5.18].  
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5.2.6 TGF-β regulates the expression of TNFR2 
Intestinal epithelial cells produce different factors that can regulate intestinal 
environment, such as antimicrobial peptides, cytokines and chemokines. Two of the 
cytokines that have been reported to have immunosuppressive role on underlying 
dendritic cells and T-cells are thymic stromal lymphopoietin (TSLP) and 
transforming growth factor β (TGF-β) (Rimoldi et al., 2005, Das et al., 2013). We, 
therefore, sought to examine whether the presence of these cytokines in conditioned 
media have an effect on the expression of macrophage TNFR2.  
Neutralising antibodies against TSLP (10μg/ml; R&D) or TGF-β (10μg/ml; R&D) 
were added to conditioned media for 2h at 4ºC. Conditioned media with neutralised 
TSLP or TGF-β was then added to J774A.1 macrophages and left for 24h. After 24h 
macrophages were collected and stained with fluorescently labelled antibodies to 
TNFR1 and TNFR2. In parallel, macrophages were grown in conditioned or 
unconditioned media without neutralising antibodies, as a control. As shown in 
Figure 5.19A and B, conditioned macrophages (black histogram) have up-regulated 
TNFR2 expression when compared to unconditioned macrophages (gray histogram). 
However, if we block TGF-β in conditioned media, this up-regulation is lost [Figure 
5.19A]. Neutralisation of TSLP, on the other hand, did not have an effect of TNFR2 
expression on conditioned macrophages [Figure 5.19B]. Additional controls 
showing histograms of control vs. control + anti-TGF-β are added in Appendix F.  
To further examine whether the presence of TGF-β has an effect on TNFR2, we 
incubated J774A.1 macrophages with recombinant TGF-β (10ng/ml; R&D) for 24h. 
Indeed, addition of TGF-β up-regulated the expression of TNFR2, but not TNFR1 
[Figure 5.20A].  
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Our in vitro data indicates a role for TGF-β in the regulation of TNFR2 expression. 
Therefore, we wanted to investigate whether the levels of TGF-β correlate with the 
up-regulation of TNFR2 expression in vivo. As shown in Figure 5.20B the 
expression of TGF-β mRNA is up-regulated in all three phases of DSS-induced 
colitis, similar to TNFR2 [Figure 5.5]. Furthermore, TGF-β is up-regulated in the 
tissue of RT 001 infected mice (p<0.01), but not RT 027 infected mice on day 3 
[Figure 5.20C], correlating with the up-regulated expression of TNFR2 in RT 001, 
but not RT 027 infected mice [Figure 5.9].   
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5.3 FIGURES 
 
 
 
Figure 5.1 Colonic MØ have higher expression of TNFR2 than peritoneal MØ. 
Cells were isolated from the peritoneal cavity and colonic tissue of BALB/c mice, 
stained with fluorescent antibodies against TNFR1 and TNFR2 and analysed by flow 
cytometry. Histograms from a representative mouse show the expression of TNF 
receptors on F4/80
+
 live cells. Filled histograms represent a background fluorescence 
of unstained cells.  
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Figure 5.2 Clinical assessment of DSS-induced colitis. Mice were given 3% DSS in drinking water for 5 days, followed by water only. Mice were then 
sacrificed on day 7 (early acute), day 12 (late acute) and day 26 (chronic) to study the progression from the acute phase to chronic inflammation/recovery. 
Body weight change was calculated by dividing body weight on the specified day by starting body weight and expressed in percentage (A). Daily disease 
activity index (DAI) scores (a combine measure of weight change, stool consistency and fur texture/posture) are reported for each experimental group. A 
higher score depicts a sicker animal (B). Colons were removed and length (C and D) and weight (E) measured. Data presented are mean ± SEM of n=5/early 
acute; 5/late acute; 8/chronic and 6/control group. *P<0.05, **P<0.01 by unpaired t-test, compared to control. 
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Figure 5.3 Histology of DSS-induced colitis. Sections of a distal colon were 
removed and stained with hematoxylin and eosin. The control is showing a healthy 
colon, while loss of crypts, the reduction of goblet cells and infiltration of 
inflammatory cells to the mucosa are visible in the early acute and the late acute 
phase. Regeneration of crypts and re-epithelisation is observed in the chronic phase.  
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Figure 5.4 Expression of TNF receptors on colonic MØ throughout different 
stages of DSS colitis. Colonic lamina propria cells were isolated from the healthy 
controls and diseased mice in different stages of DSS colitis. Cells were stained with 
fluorescently labelled antibodies against TNFR1, TNFR2 and F4/80 and analysed by 
flow cytometry. Histograms from a representative mouse show an expression of 
TNFR1 and TNFR2 on F4/80
+ 
live cells, compared between healthy controls (black 
histogram) and DSS-treated mice (dashed histogram) (A). mRNA was isolated from 
sorted F4/80
+ 
macrophages and the expression levels of TNFR1 and TNFR2 were 
determined by qRT-PCR. The gene expression levels were normalised to 
endogenous control 18S. The mean relative gene expression was calculated using the 
2
-∆∆Ct
 method (B). *P<0.05 vs. control, determined by unpaired t-test 
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Figure 5.5 Expression of TNF receptors and TNF-α in the colonic tissue of DSS-
treated mice. Tissue from each sample was homogenised using the Qiagen 
TissueLyser LT with stainless steel beads. Following homogenisation, mRNA was 
extracted using Nucleospin RNA II kit (Macherey-Nagel) and quantified on the 
nanodrop. Equalised ammounts of mRNA were converted into cDNA using a High 
Capacity cDNA Mastermix (Roche). The cDNA was mixed with primers for 
TNFR1, TNFR2 and TNF-α (all IDT) and analysed on the ABI Prism 7500. cDNA 
samples were assayed in triplicate and gene expression levels were normalised to 
endogenous control, 18S. The mean relative gene expression was calculated using 
the 2
-∆∆Ct
 method. Results are mean ± SEM of 6mice/control, 5mice/early acute 
phase (EA), 5mice/late acute phase (LA) and 8mice/chronic phase (CHRON). 
*P<0.05, **P<0.01, ***P<0.001 vs. control, determined by unpaired t-test 
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Figure 5.6 Expression of Treg transcription factor in the colonic tissue of DSS-
treated mice. Tissue from each sample was homogenised using the Qiagen 
TissueLyser LT with stainless steel beads. Following homogenisation, mRNA was 
extracted using Nucleospin RNA II kit (Macherey-Nagel) and quantified on the 
nanodrop. Equalised ammounts of mRNA were converted into cDNA using a High 
Capacity cDNA Mastermix (Roche). The cDNA was mixed with primers for Foxp3 
(IDT) and analysed on the ABI Prism 7500. cDNA samples were assayed in 
triplicate and gene expression levels were normalised to endogenous control, 18S. 
The mean relative gene expression was calculated using the 2
-∆∆Ct
 method. Results 
are mean ± SEM of 6mice/control, 5mice/early acute phase (EA), 5mice/late acute 
phase (LA) and 8mice/chronic phase. **P<0.01 vs. control, determined by unpaired 
t-test 
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Figure 5.7 Clinical assessment of a mouse model of Clostridium difficile 
infection, using two different ribotypes.  Mice were treated for 3 days with an 
antibiotic mixture of kanamycin (400µg/ml), gentamicin (35 µg/ml), colistin (850 
U/ml), metronidazole (215 µg/ml) and vancomycin (45 µg/ml) in the drinking water. 
On day 5, mice were injected i.p. with clindamycin (10mg/kg). Mice were infected 
with 10
3
 C. difficile spores on day 6 by oral gavage and sacrificed on day 3 and day 7 
post-infection. Body weight change was calculated by dividing body weight on the 
specified day by starting body weight and expressed in percentage (A). CFU counts 
in the caecum were determined for each sample (B). Sections of a distal colon were 
removed and stained with hematoxylin and eosin. The control is showing a healthy 
colon. There is a loss of crypts and infiltration of inflammatory cells present on day 3 
in both ribotypes, with recovery on day 7 in RT 001 infected mice, but not RT 027 
infected mice (C). Results are mean ± SEM of 6mice/group. *P<0.05, **P<0.01 
determined by unpaired t-test 
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Figure 5.8 Differences in a severity of infection between 001 and 027 C. difficile 
ribotypes. Tissue from each sample was homogenised using the Qiagen TissueLyser 
LT with stainless steel beads. Following homogenisation, mRNA was extracted 
using Nucleospin RNA II kit (Macherey-Nagel) and quantified on the nanodrop. 
Equalised ammounts of mRNA were converted into cDNA using a High Capacity 
cDNA Mastermix (Roche). The cDNA was mixed with primers for IL-12p40, TNF-
α, IL-6 and IL-10 (all IDT) and analysed on the ABI Prism 7500. cDNA samples 
were assayed in triplicate and gene expression levels were normalised to endogenous 
control, 18S. The mean relative gene expression was calculated using the 2
-∆∆Ct
 
method. Results are mean ± SEM of 6 mice per group. *P<0.05 determined by 
unpaired t-test. 
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5.9 Expression of TNF receptors in the colonic tissue of C. difficile infected 
mice. Tissue from each sample was homogenised using the Qiagen TissueLyser LT 
with stainless steel beads. Following homogenisation, mRNA was extracted using 
Nucleospin RNA II kit (Macherey-Nagel) and quantified on the nanodrop. Equalised 
ammounts of mRNA were converted into cDNA using a High Capacity cDNA 
Mastermix (Roche). The cDNA was mixed with primers for TNFR1, TNFR2 (all 
IDT) and analysed on the ABI Prism 7500. cDNA samples were assayed in triplicate 
and gene expression levels were normalised to endogenous control, 18S. The mean 
relative gene expression was calculated using the 2
-∆∆Ct
 method. Results are mean ± 
SEM of 6 mice per group. **P<0.01 determined by unpaired t-test. 
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5.10 Conditioned macrophages lose their hypo-responsive phenotype when 
removed from epithelial cell media J774A.1 macrophages were incubated with 
unconditioned media (control) or CMT-93 conditioned media. After 24h, CMT-93 
conditioned macrophages were split in two groups – Group 1 was incubated with 
fresh conditioned media for another 24h while in the Group 2 conditioned media was 
removed and changed with unconditioned media. Cytokine and chemokine 
production was measured in the collected supernatants, using ELISA (R&D) (A) 
Histograms show the expression of surface markers compared between Group 1 
(black line) and Group 2 (dashed line). Grey histograms represent control cells, 
while the filled histograms represent the fluorescence of unstained cells (B). Data are 
presented as mean ± SEM of three replicates and are representative of two 
independent experiments.  
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Figure 5.11 Expression of tight junction protein in the colonic tissue of DSS 
treated mice (A) and C. difficile infected mice (B). Tissue from each sample was 
homogenised using the Qiagen TissueLyser LT with stainless steel beads. Following 
homogenisation, mRNA was extracted using Nucleospin RNA II kit (Macherey-
Nagel) and quantified on the nanodrop. Equalised ammounts of mRNA were 
converted into cDNA using a High Capacity cDNA Mastermix (Roche). The cDNA 
was mixed with primers for Occludin (IDT) and analysed on the ABI Prism 7500. 
cDNA samples were assayed in triplicate and gene expression levels were 
normalised to endogenous control, 18S. The mean relative gene expression was 
calculated using the 2
-∆∆Ct
 method. Results are mean ± SEM. *P<0.05, **P<0.01 EA 
vs. Chron, determined by unpaired t-test. Figure (B) shows statistical significance of 
sample vs. control 
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5.12 Effect of TNF receptor antagonists on cytokine secretion from steady-state 
macrophages J774A.1 macrophages were incubated with TNFR1 (5µg/ml; R&D) or 
TNFR2 (5µg/ml; Biolegend) blocking antibodies for 24h. After 24h cell supernatants 
were collected and cytokine secretion was measured using ELISA (R&D). Levels of 
IL-12p40 and IL-6 were also measured but they could not be detected. Results are 
mean ± SEM of three replicates and are representative of three independent 
experiments. Statistical significance for multiple comparisons was determined by 
one-way ANOVA followed by Newman-Keuls analysis.*P<0.05, ***P<0.001 vs. 
control (untreated cells).  
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5.13 Effect of TNF receptor antagonists on cytokine secretion from LPS 
stimulated macrophages J774A.1 macrophages were pre-incubated with TNFR1 
(5µg/ml; R&D) or TNFR2 (5µg/ml; Biolegend) blocking antibodies for 1h before 
being stimulated with LPS (100ng/ml). After 24h cytokine secretion was measured 
in the cell supernatants using ELISA (R&D). Results are mean ± SEM of three 
replicates and are representative of three independent experiments. Statistical 
significance for multiple comparisons was determined by one-way ANOVA 
followed by Newman-Keuls analysis. ***P<0.001 vs. LPS-treated cells  
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5.14 Effect of TNF receptor antagonists on cytokine secretion from conditioned 
macrophages J774A.1 macrophages were conditioned with colonic epithelial cell 
media for 24h before being treated with TNFR1 (5µg/ml; R&D) or TNFR2 (5µg/ml; 
Biolegend) blocking antibodies. After 24h cell supernatants were collected and 
cytokine secretion was measured using ELISA (R&D). Levels of IL-12p40 and IL-6 
were also measured but they could not be detected. Results are mean ± SEM of three 
replicates and are representative of three independent experiments. Statistical 
significance for multiple comparisons was determined by one-way ANOVA 
followed by Newman-Keuls analysis.*P<0.05, **P<0.01, ***P<0.001 vs. control 
(untreated cells).  
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5.15 Effect of TNF receptors antagonists on cytokine secretion from conditioned 
LPS-stimulated macrophages J774A.1 macrophages were conditioned with colonic 
epithelial cell media for 24h. After 24hh cells were pre-incubated with TNFR1 
(5µg/ml; R&D) or TNFR2 (5µg/ml; Biolegend) blocking antibodies for 1h and then 
stimulated with LPS (100ng/ml). After 24h cell supernatants were collected and 
cytokine secretion was measured using ELISA (R&D). Results are mean ± SEM of 
three replicates and are representative of three independent experiments. Statistical 
significance for multiple comparisons was determined by one-way ANOVA 
followed by Newman-Keuls analysis.*P<0.05, **P<0.01, ***P<0.001 vs. LPS 
stimulated cells  
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5.16 TNF receptor antagonists do not have an effect on the expression of surface 
markers on unconditioned macrophages J774A.1 macrophages were incubated 
with TNFR1 (5µg/ml; R&D) or TNFR2 (5µg/ml; Biolegend) blocking antibodies for 
24h. Macrophages were then stained with appropriate antibodies and the expression 
of surface markers was measured by flow cytometry. Data are representative of three 
independent experiments.  
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5.17 TNF receptor antagonists do not have an effect on the expression of surface 
markers on conditioned macrophages J774A.1 macrophages were conditioned 
with colonic epithelial cell media for 24h before being incubated with TNFR1 
(5µg/ml; R&D) or TNFR2 (5µg/ml; Biolegend) blocking antibodies for 24h. 
Macrophages were then stained with appropriate antibodies and the expression of 
surface markers was measured by flow cytometry. Data are representative of three 
independent experiments.  
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5.18 Phagocytosis is down-regulated in response to TNF receptor blocking 
antibodies J774A.1 macrophages were incubated with conditioned or unconditioned 
medium for 24h, before being treated with TNFR1 (5µg/ml; R&D) or TNFR2 
(5µg/ml; Biolegend) blocking antibodies. After 24h fluorescent latex beads (Sigma-
Aldrich) were added to the culture and macrophages were left to phagocytose for 1h. 
The uptake of beads was then measured by flow cytometry. Results are shown as 
mean ± SEM of three replicates and are representative of three independent 
experiments. Statistical significance for multiple comparisons was determined by 
one-way ANOVA followed by Newman-Keuls analysis. *P<0.05 vs. unconditioned 
control and
 ++
P<0.01 vs. conditioned control 
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5.19. Neutralisation of TGF-β, but not TSLP, in conditioned media down-
regulates macrophage TNFR2 expression J774A.1 macrophages were cultured 
with unconditioned media or CMT-93 supernatants that contained TGF-β 
neutralising antibody (10μg/ml; R&D) (A) or TSLP neutralising antibody (10μg/ml; 
R&D) (B). After 24h cells were stained with fluorescently labelled antibodies against 
TNFR1 and TNFR2 and the expression of receptors was determined by flow 
cytometry. Data are representative of three independent experiments.  
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5.20 TGF-β induces TNFR2 expression in vitro and correlates with TNFR2 
expression in vivo J774A.1 macrophages were cultured with recombinant TGF-β 
(10ng/ml; R&D) or media alone as a control. After 24h hours cells were labelled 
with fluorescent antibodies against TNFR1 and TNF2 and the expression of 
receptors was measured by flow cytometry (A). The expression of TGF-β in the 
colonic tissue of DSS treated mice (B) or C. difficile infected mice (C) was measured 
by qRT-PCR. cDNA samples were assayed in triplicate and gene expression levels 
were normalised to endogenous control, 18S. The mean relative gene expression was 
calculated using the 2
-∆∆Ct
 method. Results are mean ± SEM. *P<0.05, **P<0.01, 
***P<0.001 vs. control, determined by unpaired t-test  
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5.4 DISCUSSION  
 
In chapter 4 we showed that soluble factors secreted by colonic epithelial cells can 
induce anti-inflammatory, colonic macrophage-like phenotype in monocyte-derived 
macrophages. This was accompanied by an increase of TNFR2, but not TNFR1 on 
conditioned macrophages. In this chapter, therefore, we sought to investigate the 
importance of macrophage TNFR2 in vivo and the role of TNFR2 in homeostasis 
and disease.  
 
Firstly, we wanted to investigate the expression of TNFR2 on colonic macrophages 
in a healthy mouse. Peritoneal macrophages, as another example of tissue 
macrophages, were used as a comparison. Peritoneal macrophages are extensively 
studied as they can be easily obtained from a peritoneal cavity. Unlike colonic 
macrophages they respond to stimulation, produce pro-inflammatory cytokines and 
have high expression of co-stimulatory receptors (Marcinkiewicz, 1991, Wang et al., 
2013a). Here we show that the expression of TNFR2 is much higher on colonic 
macrophages than on peritoneal macrophages. Considering the homeostatic role of 
colonic macrophages in the intestine and increasing evidence of TNFR2 in 
immunosuppressive signalling (Kassiotis and Kollias, 2001, Fontaine et al., 2002, 
Hamid et al., 2009), we hypothesised that TNFR2 on macrophages contributes to the 
regulation of gut homeostasis.   
 
To examine this idea further we investigated the role of TNFR2 in disease. We used 
two different mouse models, DSS-induced colitis and C. difficile associated 
intestinal infection, both of which affect the lower intestinal tract, especially the 
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colon. Dextran sulfate sodium induced colitis is a well appreciated and widely used 
model of inflammatory bowel disease. Colitis is induced by addition of DSS to 
drinking water. DSS is toxic to colonic epithelial cells and induces the break-down 
of the epithelial barrier function (Poritz et al., 2007). This allows the entry of 
microorganisms and antigens from the lumen which then results in activation of 
immune cells and inflammation. It is characterised by weight loss, blood in the stool, 
diarrhea and infiltration of immune cells into the lamina propria and submucosa 
(Kullmann et al., 2001). Depending on the concentration, duration and frequency of 
DSS administration, mice can develop acute or chronic colitis (Okayasu et al., 
1990a). In our study, DSS was administered for 5 days, followed by 21 days of 
water. The first group of mice was sacrificed on day 7 which correlates with the 
early acute phase, the second group was sacrificed on day 12 corresponding to late 
acute phase and finally the chronic phase group was sacrificed on day 26. Although 
by day 26 mice did not completely recover, we could observe regeneration of crypts 
and re-epithelisation, the length of the colon returning to control levels, a gain in 
weight and improvement in the DAI scores. This recovery correlated with the 
increased expression of TNFR2 on colonic macrophages, both at the protein and 
mRNA levels, indicating that TNFR2 may be supporting the recovery process. An 
anti-inflammatory role for TNFR2 in disease has been reported previously. 
Kontoyiannis et al. showed that in the mouse model of rheumatoid arthritis (RA), 
TNFR2-deficient mice showed much more aggressive and destructive type of 
arthritis with enhanced swelling of the joints and enhanced destruction of bone and 
cartilage, compared to wild-type (Kontoyiannis et al., 1999). In addition another 
group showed that transplantation of bone-marrow cells lacking TNFR2 into human 
TNF-transgenic mice, which spontaneously develop arthritis, leads to the 
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development of a more severe inflammation with increased levels of joint 
destruction and an increase in bone erosion and osteoclast numbers (Bluml et al., 
2010). Interestingly, both groups reported that deficiency in TNFR1 leads to reduced 
disease pathology.  
 
With this in mind, we expected that the mRNA levels of TNFR2 in colonic tissue 
would also increase with recovery. However, we observed significantly higher levels 
of TNFR2 in all stages of DSS colitis, but the peak of expression was in the early 
acute stage at day 7. Another cell type that preferentially expresses TNFR2 is 
regulatory T-cells (Treg). TNFR2 plays an important role in Treg biology by 
promoting their expansion and function (Chen et al., 2007). Indeed, TNFR2-
deficient Treg have reduced ability to prevent experimental colitis in vivo (Housley 
et al., 2011). Using a distinct marker for Treg, Foxp3 (Sakaguchi, 2005), we showed 
that there is a high expression (40-fold increase in mRNA) of Foxp3
+ 
cells in the 
acute phase of DSS colitis, but not in the chronic phase. This could contribute to the 
peak of TNFR2 we are seeing in the acute phase. Furthermore, TNFR2 is up-
regulated on colonic epithelial cells in patients with inflammatory bowel disease 
(IBD) and mice with experimental colitis (Mizoguchi et al., 2002). However unlike 
on Treg, epithelial cell TNFR2 may be involved in the perpetuation of inflammatory 
processes and altered epithelial cells functions (Mizoguchi et al., 2002). It is possible 
that high TNFR2 expression in the early acute phase, when the disease is in full 
force, is therefore coming from both Treg and epithelial cells, but with a different 
role. In the late acute phase, anti-inflammatory TNFR2 on Treg might slowly start to 
tip the balance towards recovery and then in the chronic phase macrophage TNFR2 
might serve as a mechanism to restore the homeostasis.  
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To further examine this potential role of TNFR2 in resolution or/and homeostasis, 
we used another animal model of disease; C. difficile associated infection. 
Clostridium difficile is a Gram-positive, anaerobic, spore-forming intestinal 
pathogen. It is the leading source of hospital-acquired infections causing antibiotic-
associated diarrhea and pseudomembranous colitis (Bartlett et al., 1978, McDonald 
et al., 2006). The use of almost any antibiotic can lead to C. difficile infection 
(Owens et al., 2008) and the epidemiology of the disease is constantly changing due 
to the emergence of new virulent strains (McDonald et al., 2005). We used two 
different ribotypes of C. difficile, 001 and 027, with 027 being a more virulent strain 
(McDonald et al., 2005). This gave as an opportunity to investigate the difference in 
immune response towards this pathogen. As expected, while both infections peaked 
at day 2 and 3, mice infected with RT 001 recovered more quickly. Mice infected 
with RT 027 had a significantly higher number of C. difficile spores in the ceacum 
on day 3 compared to RT 001 mice and the spore count remained high even on day 
7. This correlated with the cytokine data, with mice infected with RT 027 having 
high expression of pro-inflammatory IL-12p40 and IL-6 mRNA on day 7, while the 
expression of these cytokines in RT 001 infected mice returned to control levels. 
Furthermore, expression of anti-inflammatory IL-10 was lower in RT 027 infected 
mice than RT 001 on day 7. Since IL-10 is an immunoregulatory cytokine which 
ameliorates the excessive Th1 and CD8
+
 T cell response during infection (Couper et 
al., 2008), this further supports slower disease resolution in RT 027 infected mice. 
Interestingly, when we investigated the expression of TNFR2 in these mice, up-
regulated TNFR2 was seen in RT 001 infected mice on day 3. Considering that mice 
infected with RT 001 have a milder disease profile and recover more quickly, it is 
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possible that TNFR2 aids in recovery. Unfortunately, since the mice had to be 
sacrificed in Cork and only snap-frozen tissue was collected and brought to our lab, 
we were not able to isolate colonic macrophages to confirm this high TNFR2 
expression. However, we did show that Foxp3 expression could not be detected in 
the tissue; therefore TNFR2 is most likely coming from the cells of innate immunity. 
It would be interesting to isolate colonic macrophages and evaluate the expression of 
TNFR2 during infection with these two strains. The importance of colonic 
macrophages in the resolution of C. difficile infection is further highlighted in the 
work by Inui et al. showing that mice deficient in CX3CR1, which is a newly 
identified marker for colonic macrophages (Pabst and Bernhardt, 2010, Medina-
Contreras et al., 2011), had increased inflammation following C. difficile challenge 
(Inui et al., 2011). It is possible that more virulent RT 027 somehow stops the up-
regulation of TNFR2 disabling it from exhibiting anti-inflammatory properties, 
while this is not the case in RT 001 infection, which then can be resolved. Our group 
has shown that C. difficile surface layer proteins (SLPs) are recognised by antigen-
presenting cells through TLR4 (Ryan et al., 2011). Sequences of SLPs are highly 
variable between strains which can then potentially affect how they are recognised 
by the innate immune system and therefore may explain why some strains cause 
more severe infections (Ryan et al., 2011). SLPs from RT 027 might escape the host 
defence by not activating the immunosuppressive TNFR2 which may then enable 
pathogen dissemination and more severe pathology. This however needs further 
investigation.  
 
Since we have shown in chapter 4 that colonic epithelial cell conditioning is needed 
to induce TNFR2 up-regulation, we were interested to see what would happen if 
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macrophage – epithelial cell crosstalk was deregulated. In vitro, when conditioned 
macrophages were removed from epithelial cell media, they lost their anti-
inflammatory properties and TNFR2 expression returned to normal (lower) levels. In 
DSS-induced colitis, dextran sulphate sodium induces epithelial cell degeneration 
and necrosis, leading to the break-down in epithelial barrier function (Araki et al., 
2010). The loss of epithelial barrier function is associated with the loss of the tight 
junction proteins, such as occludin (Mennigen et al., 2009) and we have shown that 
occludin mRNA levels are down-regulated in the early acute colitis, with the 
recovery towards the chronic phase. It is, therefore, possible that the recovery of 
epithelial cells in the chronic phase is responsible for “sending a signal” for the up-
regulation of TNFR2 on macrophages. Epithelial disruption in the acute phase would 
then explain the inability of macrophages to up-regulate TNFR2 earlier in order to 
resolve the inflammation and return to homeostasis. This epithelial cell-macrophage 
crosstalk is further supported in the C. difficile model, when on day 3 occludin 
mRNA levels are significantly down-regulated in RT 027 infected mice, but not RT 
001. Consequently TNFR2 is up-regulated in RT 001 infection, but the epithelial cell 
“signal” for TNFR up-regulation is lost in RT 027 infection.   
 
To get further insight into the role of TNFR2 on macrophages, we decided to 
specifically block TNFR1 or TNFR2 signalling in vitro and analyse macrophage 
response in steady-state and after LPS stimulation. Blocking of either of the TNF 
receptor induced a decrease in IL-10 in unstimulated macrophages, although this 
change was really small and we cannot be sure how physiologically relevant it is. 
While the TNFR1 antagonist marginally induced the production of TNF-α from 
steady state macrophages, TNFR2 antagonist, to our surprise, caused complete over-
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production of TNF-α (levels of TNF-α doubled). This was mimicked when the cells 
were incubated with TNFR2 antagonist for 1h before stimulation with LPS (levels of 
TNF-α in the cell supernatant increased from 10ng/ml to 35ng/ml). TNFR1 
antagonist, on the other hand, did not have an effect on LPS-induced TNF-α 
production.  Blocking of TNFR1, however, seemed to induce an anti-inflammatory 
response to LPS, with decreased IL-6 levels and increased IL-10 levels. The 
response of conditioned cells was similar and again we observed marked over-
production of TNF-α when TNFR2 was blocked. This data suggests that the role of 
TNFR2 might be in limiting TNF-α production or in controlling the levels of TNF-α.  
If we look at our mRNA data from colonic tissue in both disease models, we can see 
that TNF-α is up-regulated at the same time as TNFR2, therefore it is possible that 
TNFR2 is trying to “mop up” the excessive TNF production or direct it towards 
immunosuppressive effects. Interestingly, in the C. difficile model RT 027 infected 
mice have up-regulated TNF-α expression on day 3, but do not up-regulate TNFR2 
which then correlates with more severe infection in these mice. TNF-α has also been 
shown to selectively inhibits IL-12p40 transcription in human monocyte-derived 
macrophages (Ma et al., 2000). Our data also shows that by blocking TNFR2 TNF-α 
levels go up while IL-12p40 levels go down. Furthermore, in chapter 4 we showed 
that while conditioned macrophages produce TNF-α, their IL-12p40 levels are 
always down-regulated. This indicates a regulatory mechanism between these two 
cytokines which might be regulated by TNFR2 as suggested by a new study by 
Martin et al. (Martin et al., 2013).   
 
Another interesting observation was that while TNFR1 and TNFR2 antagonists did 
not have an effect on IL-27 production from unconditioned macrophages, IL-27 
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secretion from conditioned macrophages was down-regulated if TNFR2 was 
blocked. This was interesting because IL-27 has been shown to be important for 
limiting intestinal inflammation in a murine model of colitis (Troy et al., 2009). In 
this model, IL-27-IL27R interactions controlled the balance of pro-inflammatory 
cytokine production by intestinal CD4
+
 T cells, decreased the accumulation of 
neutrophils and monocytes and decreased pro-inflammatory cytokine production by 
neutrophils (Troy et al., 2009). Furthermore, recombinant human IL-27 inhibited 
differentiation of both human and mouse Th17 cells and significantly reduced the 
severity of the 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced acute colitis in 
mice (Sasaoka et al., 2011). TNFR2 signalling might therefore contribute to IL-27 
production in the intestine, potentiating the immunosuppressive effect. This 
immunosuppressive effect of TNFR2 was further supported by our finding that 
functional TNFR2 is needed for phagocytosis. Blocking of TNFR2 signalling 
decreased the number of phagocytic macrophages. Interestingly, phagocytosis is also 
down-regulated in patients with IBD (Caradonna et al., 2000).  
 
Intestinal epithelial cells constitutively secrete a broad range of antimicrobial 
peptides that are needed for the neutralisation of luminal bacteria (Artis, 2008). They 
also secrete different chemokines and cytokines that have an effect on antigen-
presenting cells and lymphocytes in the mucosa (Artis, 2008). Two of these 
cytokines have been implicated in the induction of a tolerogenic phenotype of 
intestinal immune cells; thymic stromal lymphopoietin (TSLP) and transforming 
growth factor β (TGF-β).  TSLP is produced mainly by non-hematopoietic cells and 
it is important for the activation of myeloid dendritic cells in the thymus and for the 
positive selection of regulatory T-cells (Watanabe et al., 2004). In in vitro studies 
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Rimoldi et al. demonstrated that TSLP secreted from intestinal epithelial cells can 
limit the expression of IL-12 by dendritic cells and their capacity to promote Th1 cell 
differentiation (Rimoldi et al., 2005). Furthermore, these dendritic cells produced IL-
10 and promoted Treg responses in a TSLP-dependent manner (Rimoldi et al., 
2005). Together with TSLP, TGF-β has been shown to induce a tolerogenic 
phenotype in monocyte-derived dendritic cells in vitro (Zeuthen et al., 2008). TGF-β 
can inhibit NF-κB dependent gene expression and limit the expression of pro-
inflammatory cytokines by dendritic cells and macrophages (Smythies et al., 2005). 
Furthermore, TGF-β modulates T-cells responses in the gut (Das et al., 2013). TGF-
β and TSLP, therefore, were possible candidates to regulate macrophage TNFR2 
expression in our experiments. In order to investigate this, we neutralised TGF-β or 
TSLP in CMT-93 conditioned media and investigated the expression of TNFR2 in 
the absence of these cytokines. While the absence of TSLP did not have an effect on 
TNFR2 expression, lack of TGF-β in conditioned media decreased the expression of 
TNFR2. This was further supported by the increase of TNFR2 when macrophages 
were cultured in the presence of recombinant TGF-β. Furthermore, the expression of 
TGF-β in colonic tissue of DSS-treated and C. difficile infected mice correlated with 
the up-regulated expression of TNFR2.  
 
Taken together our data implicates TGF-β as a possible signal from intestinal 
epithelial cells, involved in the regulation of macrophage TNFR2 expression. 
However, TGF-β most likely is not the only signal for TNFR2 up-regulation. Even 
though its expression was high in early and late acute phase of DSS-colitis, 
macrophages did not exhibit TNFR2 up-regulation in these stages. Presence of other 
soluble mediators from epithelial cells might also be involved in this mechanism. 
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Another possibility is that TNFR2 regulation depends on a certain isoform of TGF-β. 
TGF-β exists in at least three isoforms, TGF-β1, TGF-β2 and TGF-β3 (Cheifetz et 
al., 1987). Interestingly, TGF-β2 has been shown to suppress macrophage 
inflammatory responses in the developing intestine and protects against 
inflammatory mucosal injury (Maheshwari et al., 2011). Therefore, more in-depth 
analysis of the TNFR2 - TGF-β mechanism is needed.  
 
Thus far, TNFR2 has been implicated in deregulation of epithelial cells functions in 
acute colitis (Mizoguchi et al., 2002), but also in expansion and function of 
regulatory T-cells (Chen et al., 2007). Here we show that macrophage TNFR2 might 
have a function in disease resolution and recovery. Furthermore, its role seems to be 
partially driven by TGF-β production from intestinal epithelial cells, indicating the 
importance of crosstalk between different cells in the intestinal environment. This 
crosstalk gets disrupted during intestinal inflammation and finding a way to restore it 
might prove beneficial for the attenuation of acute and chronic intestinal 
inflammation.   
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6.1 GENERAL DISCUSSION 
 
Macrophages are cells of innate immunity that play a central role in inflammation, 
wound healing, tissue homeostasis and tissue remodelling. They are professional 
phagocytes, able to clear pathogens and dying cells. They recognise pathogens 
through their pattern recognition receptors (such as TLRs) and initiate the immune 
response by presenting the antigens to surrounding lymphocytes, while secreting a 
variety of cytokines and chemokines to attract and activate other immune and non-
immune cells (Gordon, 2007). The largest pool of macrophages in the body is the 
intestine (Hume, 2006). Macrophage numbers in different parts of the intestine seem 
to correlate with the relative bacterial load and are, therefore, highest in the colon, 
where the number of commensals is 10
13
 organisms/g luminal content (Lee et al., 
1985). However, despite their large number and exposure to commensal bacteria, 
macrophages in the colon do not initiate an inflammatory cascade in response to 
bacterial overload. Intestinal macrophages have evolved into a specialised population 
of macrophages, distinct from their counterparts in other tissue, with a main goal to 
maintain intestinal homeostasis (Schenk and Mueller, 2007).  
 
Intestinal macrophages are anti-inflammatory and inert to stimuli, which is 
surprising considering that they originate from inflammatory monocytes (Varol et 
al., 2009). Thus, the intestinal environment must be changing and shaping the 
phenotype of monocytes, once they arrive in the gut, so they adapt to the antigen-rich 
environment. Indeed, Bain et al. along with Tamoutounour et al. proved that 
inflammatory blood monocytes change their phenotype and function and become 
anti-inflammatory intestinal macrophages, once they home to the gut (Tamoutounour 
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et al., 2012, Bain et al., 2013). In this thesis, we show that intestinal epithelial cells 
play a major role in this process and provide signals that induce and support 
macrophage differentiation.  
 
Monocyte-derived macrophages conditioned with intestinal epithelial cell media 
showed a gradual, time dependent transition into a colonic macrophage-like 
phenotype. We show that while short 2h conditioning time did induce change in 
some of the parameters, such as decrease in NO and ROS production and increase in 
phagocytosis, the shift towards the anti-inflammatory phenotype was more 
pronounced with longer conditioning. Interestingly, this correlates with in vivo 
observations by a few other groups. Using 5-bromo-2-deoxyuridine (BrdU) 
labelling, to track Ly6C
hi
 inflammatory monocytes, Bain et al. showed that these 
monocytes, once they arrive in the gut, differentiate into resident macrophages 
through a number of transitional stages, which they named P1-P4. The P1 
population, which is similar to inflammatory monocytes, gradually acquires 
tolerogenic properties, and evolves through P2 and P3 stage into the P4 anti-
inflammatory resident macrophages (Tamoutounour et al., 2012, Bain et al., 2013). 
During the first 12h from their arrival into the gut, cells went through P1 and P2 
stage and after 24h they were detectable in P3 and P4 stages (Bain et al., 2013). 
Similar to an early decrease in NO production observed in our experiments, these 
macrophages also show down-regulated iNOS expression (enzyme that catalyses the 
production of NO) early, in the P2 stage. Furthermore, correlating with our 
observation, a decrease in IL-6 was only visible later in P4 stage. Transition from 
P1-P4 was also accompanied by an increase in phagocytosis and hypo-
responsiveness to TLR stimulation, which correlate with our findings (Bain et al., 
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2013). Weber et al. published similar observations. They characterised two distinct 
macrophage populations in the colon, GFP
lo
 and GFP
hi
, which correlate to P1 and P4 
respectively, and showed that GFP
hi
 macrophages secrete significantly lower levels 
of IL-6, but also IL-12, the same as our conditioned macrophages (Weber et al., 
2011).  
 
Both groups also reported an increase in IL-10 mRNA and protein levels from P1-
P4. However, we did not see a change in IL-10 production following conditioning. 
The presence of local microbiota might be needed in order to induce the production 
of IL-10 by colonic macrophages as shown by Ueda et al. and Rivollier et al. Both 
groups showed that IL-10 production from colonic macrophages was severely 
reduced in germ free mice, compared with normal specific-pathogen-free animals 
(Ueda et al., 2010, Rivollier et al., 2012). Our closed in vitro system does not take 
into account the effect of microbiota which can therefore account for the inability of 
our conditioned macrophages to up-regulate IL-10. This is not the only limitation of 
our model. The influence of other cell types present in the gut was also not taken into 
consideration. Furthermore, the vectorial nature of soluble factor secretion is not 
assessed since CMT-93 cells were not grown in polarised state. Addressing these 
limitations could improve our model and give a clearer picture of epithelial cell – 
macrophage crosstalk.   
 
Interestingly, macrophages from P1-P4 maintained their production of TNF-α and 
there was no significant difference in TNF-α mRNA levels between these 
populations (Bain et al., 2013). Also there was no significant difference in TNF-α 
secretion between GFP
lo
 and GFP
hi
 populations (Weber et al., 2011). This correlates 
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with our data showing that while soluble factor from epithelial cells decrease the 
production of other pro-inflammatory mediators, TNF-α is left intact. The reason for 
this is probably that there is an important role for TNF-α in multiple processes, such 
as cell differentiation, proliferation, survival and response to pathogens, and not just 
in tissue damage and disease progression. In fact, TNF-deficient mice have an 
enhanced immune and inflammatory response to DSS, compared to wild type mice, 
which leads to exacerbation of colitis (Naito et al., 2003, Noti et al., 2010). 
However, the question remains about the way in which TNF-α levels are controlled 
so that they do not lead to inflammation, but still exert other homeostatic properties. 
We show, for the first time, that TNF receptors, particularly TNFR2, might play a 
role in regulating TNF-α in the intestine and balancing its homeostatic and disease 
resolution properties.  
 
As mentioned throughout this study, TNFR1 and TNFR2 mostly play opposing roles 
in disease, however they do share a part of the pathway and can enhance or inhibit 
each other’s functions (Fotin-Mleczek et al., 2002, Zhao et al., 2007). TNFR1 
pathway is one of the most studied, while the TNFR2 pathway is less clear due to its 
inability to be properly activated in the laboratory settings (Wajant et al., 2003). 
Also, information about their role in diseases is often contradictory, probably 
because it is based on studies with TNFR1 or TNFR2 deficient animals, while in a 
physiological environment these two receptors exist on the same cell at the same 
time and their ratio could play a critical role in particular settings.  
 
During this study we observed that, together with increased TNF-α levels, 
conditioned macrophages have increased expression of TNFR2 and decreased 
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caspase-3 activity. This led us to believe that TNFR2 plays a regulatory role, 
favouring the protective effects of TNF-α. The much higher expression of TNFR2 on 
colonic macrophages than peritoneal macrophages further supported our idea of the 
importance of TNFR2 in the intestinal environment. The role of TNF receptors in 
intestinal disease, such as DSS-induced colitis has been studied before, however, not 
at a cellular level. Wang et al. showed an opposing role of TNF receptors in DSS-
induced colitis. Ablation of TNFR1 accelerated the onset and enhanced the disease, 
while TNFR2 ablation attenuated the severity of the colitis (Wang et al., 2012). 
While this does not support our data indicating a protective role of TNFR2, it is 
interesting to mention that the authors observed an increase in apoptotic lamina 
propria cells in TNFR2 deficient mice (Wang et al., 2012). Although they do not 
provide details of which particular lamina propria cells underwent increased 
apoptosis, this observation correlates with our data showing that increased 
expression of TNFR2 on conditioned macrophages protects from apoptosis. 
Furthermore, the authors only investigated the early acute phase of colitis, and mice 
were sacrificed on day 8. The early acute phase is characterised by an infiltration of 
many inflammatory cells into the lamina propria, with macrophages and neutrophils 
being amongst the first. Therefore, without the anti-apoptotic effects of TNFR2 in 
TNFR2-deficient mice, these cells probably undergo apoptosis, which reduces their 
number and consequently reduces the inflammation. This would explain the 
attenuated colitis seen in TNFR2 deficient mice. However, this would not be 
beneficial in the later stages of disease when macrophages are needed to clear the 
inflammation. Indeed, we show that macrophage TNFR2 is important in the later 
phase of colitis, probably to aid the recovery. Recently, the same group investigated 
the role of TNF receptors in chronic colitis and showed that TNF-α signalling via 
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TNFR1 and TNFR2 actually has a protective role in chronic intestinal inflammation 
(Wang et al., 2013b). Both TNFR1 and TNFR2 deficient mice had exacerbated 
disease progression with increased production of pro-inflammatory cytokines and 
increased apoptosis of intestinal epithelial cells. The authors conclude that a distinct 
effect of TNF-α signalling via TNFR2 in the acute and chronic phase of colitis might 
be attributed to a different cell type in charge of delivering TNFR2-mediated signals 
at different stages of inflammation (Wang et al., 2013b). It is possible that 
macrophages contribute to the exacerbation of chronic colitis in TNFR2-deficient 
mice as we have shown that TNF-α levels are significantly up-regulated when 
TNFR2 signalling is blocked, while their ability to phagocytose is down-regulated. 
Thus, while in the acute phase TNFR2 deficiency leads to apoptosis, decreases 
macrophage number and attenuates the disease, later in the disease the inability of 
macrophages to up-regulate TNFR2 and consequently control TNF-α levels and 
clear dead cells and debris probably supports and drives the disease. Therefore, lack 
of TNFR2 most likely impairs the resolution of intestinal inflammation.  
 
The role of TNFR2 is resolution is further supported by our finding that mice 
infected with a less virulent 001 strain of C. difficile, unlike mice infected with 
highly virulent 027 strain, up-regulate TNFR2 and successfully clear the infection. 
To our knowledge the role of TNF receptors in C. difficile infection has not been 
investigated yet. However, the importance of macrophage in the clearance of C. 
difficile is demonstrated in the study by Inui et al. showing that mice deficient in 
CX3CR1
+ 
cells have increased inflammation following C. difficile challenge (Inui et 
al., 2011). Furthermore, work in our lab has also highlighted the importance of 
macrophages in the clearance of C. difficile infection. Macrophages exposed to C. 
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difficile surface layer proteins (SLPs) from 001 strain increase their phagocytic 
abilities, probably as an attempt to clear the pathogen (Collins et al, submitted to 
Microbes and infection). It would be interesting to see whether SLPs from RT 027 
inhibit phagocytosis and in that way cause more severe infection. That would 
correlate with our observation that TNFR2 expression positively regulates 
phagocytosis. Inability of RT 027 infected mice to up-regulate TNFR2 on day 3 of 
infection might, therefore, lead to inability to increase phagocytosis in response to 
bacteria.   
 
TNF-α is considered to be a driving force of many inflammatory diseases, including 
IBD (Yapali and Hamzaoglu, 2007). Consistent with this, TNF-neutralising 
antibodies have been shown to successfully improve the outcome of IBD patients 
(Yapali and Hamzaoglu, 2007). Currently there are five different drugs targeting 
TNF, licensed for the treatment of various autoimmune diseases; 4 antibodies 
directed against TNF, infliximab, adalimumab, certolizumab, golimumab and one 
recombinant fusion protein of soluble TNFR2, etanercept (MacDonald et al., 2012). 
However, only 50% of patients respond to anti-TNF therapy and the response 
weakens with time (Colombel et al., 2010). Furthermore, therapy with anti-TNF 
antibodies is associated with the development of other immune-mediated diseases, 
such as lupus, psoriasis and increased risk of infections (Colombel et al., 2010). 
With these adverse effects aside, infliximab and the other three TNF antibodies are 
still effective in maintaining long-term remission in a large number of IBD patients. 
However, other anti-TNF therapies, such as etanercept, a soluble TNFR2 that was 
design to neutralise TNF-α, or LMP-420, an inhibitor of TNF synthesis, show no 
effect in IBD (Sandborn et al., 2001, Hale and Cianciolo, 2008). This poses a 
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question as to whether anti-TNF therapies do indeed work via neutralisation of TNF-
α or they exhibit some other mechanisms.  
 
Recent studies showed a few different mechanisms of action between infliximab 
which is effective in IBD and etanercept which is ineffective. In addition to its role 
in binding and neutralising TNF-α, infliximab is shown to induce apoptosis of 
inflammatory cells, such as T-cells and monocytes (Shen et al., 2005). Etanercept, 
on the other hand, failed to induce apoptosis (Shen et al., 2005). This could account 
for a better prognosis of patients treated with infliximab, because treatment with 
infliximab decreases the number of inflammatory cells which consequently 
attenuates inflammation, but it is also probably responsible for the adverse effects, 
such as recurrent infections. The second difference was surprising as it was shown 
that infliximab, but not etanercept induces the development of regulatory T-cells and 
regulatory macrophages (Ricciardelli et al., 2008, Vos et al., 2011). Infliximab binds 
to membrane TNF-α (mTNF) and soluble TNF-α (sTNF), unlike etanercept that only 
binds to sTNF (Vos et al., 2011). Furthermore, infliximab can induce reverse 
signalling of TNF-α by ligation to mTNF (Waetzig et al., 2002). It is interesting to 
speculate that maybe infliximab, in a way, mimics the effect of TNF receptors or 
induces the TNF receptor pathway upon binding to mTNF. Several groups have 
demonstrated that macrophages in the intestine exist in a continuum, differentiating 
from P1 to P4 phase, probably guided by the epithelial cells as we have shown in our 
study (Weber et al., 2011, Tamoutounour et al., 2012, Bain et al., 2013). In disease, 
cells are arrested in P1 and P2 phase, however there is still a small number of P3 and 
P4 cells present in the intestine (Bain et al., 2013). It would be interesting to 
characterise the expression of TNF receptors on these macrophage populations in 
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health and disease. It is possible that P1 and P2 macrophages have lower TNFR2 
expression than P3 and P4. Indeed, we show that TNFR2 is more highly expressed 
on conditioned macrophages that resemble the P3/P4 phenotype. Binding of 
infliximab to P1 and P2 could then favour TNFR1 pathway and induce apoptosis as 
seen by Shen et al. (Shen et al., 2005). However, binding of infliximab to P3 and P4 
macrophages could induce TNFR2 ligation and therefore induce the development of 
regulatory macrophages. Induction of regulatory T-cells following infliximab 
therapy could also be the effect of infliximab on TNFR2, since it has been shown 
that signalling of mTNF through TNFR2 promotes the expansion and function of 
mouse regulatory T-cells (Chen et al., 2007, Chen et al., 2008b). Rapid elimination 
of inflammatory cells through apoptosis can explain a rapid beneficial response to 
TNF antibodies in the early stages of IBD treatment. The potential effect of 
infliximab on TNFR2 and expansion of regulatory T-cells and macrophages could 
then account for the maintenance of remission. However, since infliximab does not 
selectively target TNFR1 or TNFR2 and can bind to mTNF on any cell, it cannot 
lead to full resolution of disease since its effects are uncontrolled and can, at any 
point, tip TNFR1-TNFR2 signalling to less favourable functions.   
 
Macrophages in the intestine, therefore, exist in a continuum, rather than one 
separate population and we provide evidence that intestinal epithelial cells play a 
role in macrophage adaptation to the unique intestinal environment. Interestingly, as 
mentioned, during inflammation this transition is interrupted and macrophages 
accumulate in P1 and P2 phase (Tamoutounour et al., 2012, Rivollier et al., 2012, 
Bain et al., 2013). This is partially beneficial as P1 and P2 macrophages are able to 
initiate an immune response, but leads to detrimental effects when left uncontrolled. 
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It is still unclear what stops the differentiation of inflammatory macrophages during 
disease, but the loss of immunomodulatory signals from epithelial cells could be one 
of the factors. In the last few years, evidence is accumulating that the disruption of 
epithelial cell barrier could be a driving force behind IBD (Hindryckx P, 2012) and 
we also show that once removed from the epithelial cell media macrophages lose 
their anti-inflammatory properties which supports the importance of epithelial cell – 
macrophage crosstalk. Our main research findings are summarised in Figure 6.1.  
 
Our study also implicates an important role for TNFR2 in the maintenance and 
restoration of intestinal homeostasis. Studies of DSS-induced model of colitis, 
together with the studies of anti-TNF therapy also suggest an important role of TNF 
receptors in the disease progression. Rather than just blocking TNF-α, which is 
needed for a variety of functions, selective blocking or activation of TNF receptors 
could be more beneficial. However, more in-depth understanding of the TNF 
receptor pathway, distribution and the crosstalk is needed, because, as we have 
shown, TNFR1:TNFR2 ratio on a particular cell, stage of disease and a cell type 
itself can contribute to different activity of these receptors. Targeting TNFR2 could 
be a more effective therapy than targeting TNFR1, since TNFR2 is not expressed on 
all the cells, but confined to endothelial and immune cells (Tartaglia and Goeddel, 
1992). However, induction of TNFR2 will have to be cell specific and introduced at 
the right stage of disease. Nevertheless, the potential for “highjacking” the protective 
pathway of TNFR2 as a way of controlling intestinal disease is a promising solution 
that would enhance a physiological mechanism of disease resolution, rather than just 
dealing with the symptoms, as do the currently available therapies.  
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Figure 6.1 Summary of the main research findings Soluble factors produced by intestinal epithelial cells guide the phenotypic and functional 
changes of newly arrived inflammatory monocytes into hypo-responsive, TNFR2
high
 intestinal macrophages. TNFR2 is important for the 
regulation of phagocytosis and TNF-α levels (A). In disease, when epithelial cell barrier is compromised, conditioning factors are lost causing 
the accumulation of inflammatory monocytes and inflammation (B).  
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APPENDIX A 
BUFFERS 
FACS buffer 
FCS     2% 
NaN3     0.05% 
Dissolve in PBS 
 
Phosphate buffered saline (PBS) 
Na2HPO4 x 2H2O   8.0 mM 
KH2PO4    1.5 mM 
NaCl     137 mM 
KCl     2.7 mM 
Dissolve in H2O and pH to 7.4 
 
TAE buffer 
Tris     40 mM 
Acetic acid    20 mM 
EDTA     1 mM 
Dissolve in H2O 
 
Sorting buffer 
FCS     1% 
EDTA     1 mM 
HEPES    25 mM 
Dissolve in PBS 
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APPENDIX B 
 
PHAGOCYTOSIS (controls) 
 
Figure 7.1 Controls used in the phagocytosis assay J774A.1 macrophages and 
CMT-93 colonic epithelial cells were incubated with fluorescent latex beads (Sigma-
Aldrich) in a concentration of 20beads/cell for 6h (A) or 1h (B) at 37ºC. J774A.1 
macrophages were pre-incubated with cytochalasin D (10μg/ml; Sigma-Aldrich) for 
30min before the addition of fluorescent latex beads (B). Uptake of beads was then 
measured by flow cytometry.  
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APPENDIX C 
 
PRIMER SEQUENCES 
 
Foxp3 
Primer 1 5’- CTG TCT TCC AAG TCT CGT CTG – 3’ 
Primer 2 5’- CTG GTC TCT GCA GGT TTA GTG– 3’ 
 
IL-6 
Primer 1 5’- TCC TTA GCC ACT CCT TCT GT– 3’ 
Primer 2 5’- AGC CAG AGT CCT TCA GAG A– 3’ 
 
IL-10 
Primer 1 5’- GGC ATC ACT TCT ACC AGG TAA– 3’ 
Primer 2 5’- TCA GCC AGG TGA AGA CTT TC– 3’ 
 
IL-12p40 
Primer 1 5’- AAG TCC TCA TAG ATG CTA CCA AG– 3’ 
Primer 2 5’- CAC TGG AAC TAC ACA AGA ACG A– 3’ 
 
Occludin 
Primer 1 5’- GTT GAT CTG AAG TGA TAG GTG GA– 3’ 
Primer 2 5’- CAC TAT GAA ACA GAC TAC ACG ACA– 3’ 
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Rps18 
Primer 1 5’- ACA CCA CAT GAG CAT ATC TCC– 3’ 
Primer 2 5’- CCT GAG AAG TTC CAG CAC AT– 3’ 
 
TGF-β 
Primer 1 5’- CCG AAT GTC TGA CGT ATT GAA GA– 3’ 
Primer 2 5’- GCG GAC TAC TAT GCT AAA GAG G– 3’ 
 
TNF-α 
Primer 1 5’- TCT TTG AGA TCC ATG CCG TTG– 3’ 
Primer 2 5’- AGA CCC TCA CAC TCA GAT CA– 3’ 
 
TNFR1 
Primer 1 5’- GCA AAG ACC TAG CAA GAT AAC CA– 3’ 
Primer 2 5’- GCC ACT GCA AGA AAA ATG AGG– 3’ 
 
TNFR2 
Primer 1 5’- CTT GGC ATC TCT TTG TAG GCA– 3’ 
Primer 2 5’- TTG GTC TGA TTG TTG GAG TGA– 3’ 
 
 
  
218 
 
EFFICIENCY AND DISSOCIATION CURVES 
 
Figure 7.2A Evaluation of the IDT PrimeTime qRT-PCR primers A standard curve was created by carrying out a serial dilution of the PCR product. When a standard 
curve correlation coefficient was close to 1, the PCR efficiency was determined using the following formula: 
     
 
 
               
 
To assess the specificity of the SYBR
® 
green assay the dissociation analysis was performed for each product. The dissociation step was added after the final PCR cycle. 
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Figure 7.2B Evaluation of the IDT PrimeTime qRT-PCR primers A standard curve was created by carrying out a serial dilution of the PCR product. When a standard 
curve correlation coefficient was close to 1, the PCR efficiency was determined using the following formula: 
     
 
 
               
 
To assess the specificity of the SYBR
® 
green assay the dissociation analysis was performed for each product. The dissociation step was added after the final PCR cycle. 
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Figure 7.2C Evaluation of the IDT PrimeTime qRT-PCR primers A standard curve was created by carrying out a serial dilution of the PCR product. When a standard 
curve correlation coefficient was close to 1, the PCR efficiency was determined using the following formula: 
     
 
 
               
 
To assess the specificity of the SYBR
® 
green assay the dissociation analysis was performed for each product. The dissociation step was added after the final PCR cycle. 
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Figure 7.2D Evaluation of the IDT PrimeTime qRT-PCR primers A standard curve was created by carrying out a serial dilution of the PCR 
product. When a standard curve correlation coefficient was close to 1, the PCR efficiency was determined using the following formula: 
     
 
 
               
 
To assess the specificity of the SYBR
® 
green assay the dissociation analysis was performed for each product. The dissociation step was added 
after the final PCR cycle. 
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Figure 7.3 Evaluation of the IDT PrimeTime qRT-PCR Taqman assay A standard curve was created by carrying out a serial dilution of the 
PCR product. When a standard curve correlation coefficient was close to 1, the PCR efficiency was determined using the following formula: 
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PCR GEL 
 
 
 
 
Figure 7.4 DNA product analysis by gel electrophoresis DNA samples were 
mixed with loading buffer (Fermentas) and loaded onto the 2% agarose gel, together 
with GeneRuler 100bp DNA ladder (Termo-Fisher Scientific). Gels were run for 1h 
in 1x TAE buffer at 100V and visualised using the G-box imaging system 
(Syngene).   
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ENDOGENOUS CONTROLS  
 
 
 
 
Figure 7.5 Endogenous controls tested on a colonic tissue B2M, Beta-2-
microglobulin; s18, ribosomal protein s18; GAPDH, Glyceraldehyde 3-phosphate 
dehydrogenase; UBC, ubiquitin C; HPRT, Hypoxanthine Phosphoribosyltransferase; 
PPIA, Peptidylprolyl Isomerase A 
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APPENDIX D 
 
 
 
Primary cell isolation procedure 
 
 
 
 
 
 
Figure 7.6 Schematic of the procedure for isolation of lamina propria 
macrophages Flow diagram depicting a tissue digestion and cell purification 
method, optimised to obtain live, F4/80
+
 lamina propria macrophages 
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APPENDIX E 
 
Revised gating strategy  
 
 
Figure 7.7 Revised gating strategy used to exclude F4/80
+
 eosinophils Isolated 
lamina propria cells were stained with fluorescently labelled F4/80 antibody. Dead 
cells and doublets were exluded and F4/80
+
 cells were further gated based on their 
FSC and SSC properties. Eosinophils are also F4/80
+
 but they have the forward and 
side scatter properties of granulocytes, unlike macrophages.  
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APPENDIX F 
 
Additional controls for Figure 4.7 
 
 
 
Figure 7.8 Expression of surface markers on CMT-93 conditioned macrophages 
following TLR4 ligation J774A.1 macrophages were incubated with CMT-93 
conditioned medium for 2h before adding LPS (100ng/ml). After 24h cells were 
stained with fluorescently labelled antibodies for CD86, CD80, CD40, MHCII, 
TLR2 and TLR4 and expression was measured by flow cytometry. Histograms show 
surface marker expression of conditioned cells (black line) compared to conditioned 
LPS-stimulated cells (dashed line). Filled histograms represent fluorescence of 
unstained cells. Data are representative of three independent experiments. 
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Additional controls for Figure 5.19 
 
 
Figure 7.9 Neutralisation of TGF-β does not affect unconditioned cells TGF-β 
neutralising antibody (10μg/ml; R&D) was added to J774A.1 macrophage culture for 
24h and the expression of TNFR1 and TNFR2 was measured by flow cytometry. 
Data are representative of three independent experiments 
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APPENDIX G 
 
 
 
TNFR2 antagonist isotype control 
 
 
 
 
 
Figure 7.10 TNFR2 antagonist isotype control J774A.1 macrophages were 
incubated with TNFR2 antagonist (5μg/ml; Biolegend) or appropriate isotype control 
(5μg/ml; Biolegend) for 24h. Fluorescent latex beads (20beads/cell) were then added 
to the cell culture and macrophages were left to phagocytose for 1h at 37ºC. Uptake 
of beads was measured by flow cytometry (A). Concentration of TNF-α in cell 
supernatants was measured by ELISA (R&D) (B) 
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